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 ABSTRACT 
Oxygen deficiency, known as hypoxia, in arterial walls has been linked to increased 
intimal hyperplasia, which is the main adverse biological process causing in-stent 
restenosis. Stent implantation can have significant effects on the oxygen transport into 
the arterial wall. Helical flow has been theorised to improve the local haemodynamics 
and the oxygen transport within stented arteries.  
In this study an advanced oxygen transport model was developed to assess different 
stent designs. This advanced oxygen transport model incorporates both the free and 
bound oxygen contained in blood and includes a shear-dependent dispersion coefficient 
for red blood cells. In two test cases undertaken the results predicted by the advanced 
oxygen transport model were compared those predicted by simpler models, and in vivo 
measurements. Two other test cases analysed the predicted oxygen transport in three 
different stent designs, and the effects of helical flow on the haemodynamics and 
oxygen transport in stented coronary arteries.  
The advanced model showed good agreement with experimental measurements within 
the mass-transfer boundary layer and at the luminal surface; however, more work is 
needed for predicting the oxygen transport within the arterial wall. Simplifying the 
oxygen transport model within the blood produces significant errors in predicting the 
oxygen transport in arteries. It was found that different stent designs can produce 
significantly different amounts of hypoxic regions within the stented region. 
Additionally, helical flow increases the amount of oxygen transferred into the arterial 
wall, but only in a helical ribbon through the stented region that also experiences high 
wall shear stress spatial gradients.  
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CHAPTER 1 
Chapter 1. Background Material 
1.1 Introduction 
This chapter provides the initial background material required for this project. First, the 
cardiovascular system is introduced with specific reference to the heart, blood, coronary 
arteries, and cardiac veins. Following this, the burden of coronary artery disease (CAD) 
is highlighted along with the biological understanding of how atherosclerotic lesions 
form and their classifications. The available treatments for CAD are listed and 
described. One treatment option, specifically relevant, is angioplasty with stenting 
which is considered the standard treatment for patients with CAD presenting with either 
stable or unstable angina, or with acute myocardial infarction (MI).
178
 The history and 
current status of stent technology is discussed briefly with a mention of one limitation 
of stent technology which is the re-narrowing of the stented artery post-implantation, 
known as in-stent restenosis (ISR) (this is discussed in greater detail in Chapter 2). 
Hypoxia is briefly described followed by the reasoning behind using computational 
software for prediction of hypoxic regions and in the analysis of stent designs. A brief 
introduction to helical flow is given which is directly linked to one of the aims of this 
research. Finally, the aims, structure, novelty and contribution, and relevant publications 
of this research are highlighted. 
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1.2 Cardiovascular System 
As a whole, the cardiovascular system is responsible for the transportation of oxygen, 
carbon dioxide (CO2), nutrients, hormones, chemical messengers, immune cells, stem 
cells, platelets, proteins, and waste products throughout the body, as well as acting as a 
system for temperature regulation. The cardiovascular system comprises the heart, 
approximately five litres of blood and the blood vessels.  
1.2.1 Blood 
Blood consists of liquid plasma in which three types of cellular elements are suspended: 
red blood cells (RBCs), white blood cells (leukocytes) and platelets. Plasma is a dilute 
electrolyte solution mainly composed of water (approximately 95% by volume) which 
contains about 8% by weight of proteins (fibrinogen, globulin, prothrombin, and 
albumin), as well as glucose, clotting factors, hormones, and dissolved oxygen and CO2. 
About 45% by volume of the blood consists of cellular elements with RBCs constituting 
about 95% of the cellular elements, leukocytes constituting about 0.13% of the cellular 
elements, and platelets constituting the remaining 4.9%.
121
 RBCs are the main carriers 
of oxygen in the blood. Leukocytes are responsible for fighting infections and disposing 
of damaged cells. Platelets are part of the primary response to injury of the arterial wall 
and form a critical element of the initial healing process following injury.  
1.2.2 Heart 
The heart is a muscular organ that serves to pump blood around the vessels and beats 
approximately 100,000 times per day, continuously, for the duration of a person’s life. 
The human heart is approximately the size of two hands entwined and is located just 
left-of-centre in the upper chest cavity. The heart is comprised of four chambers: the left 
ventricle and atrium, and the right ventricle and atrium, as shown in Figure 1.1. Both 
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atria are thin-walled, low-pressure chambers that act predominantly as reservoirs for the 
two ventricles, which act as the pumping chambers.  
The cardiovascular system can be divided into the pulmonary circulation and the 
systemic circulation, which are linked through these four chambers of the heart. The 
pulmonary circulation is primarily responsible for the exchange of oxygen and CO2 
with the atmosphere through the lungs, and the systemic circulation delivers oxygenated 
blood to the body’s cells and returns deoxygenated blood back to the heart.  
The pulmonary circulation begins in the right ventricle where the blood is propelled into 
the pulmonary artery. The pulmonary artery feeds into the lungs where the blood is 
oxygenated and then returns to the left atrium in the heart through the pulmonary veins. 
From here the oxygenated blood enters the left ventricle, the systemic circulation 
pumping chamber, which propels the blood out into the aorta. Through a network of 
connected arteries, arterioles and capillaries it is then distributed to every part of the 
body. It is predominantly as the blood passes through the capillaries that the oxygen 
leaves the blood and diffuses out into the surrounding tissue. The deoxygenated blood 
then returns to the right atrium of the heart through the connected capillaries, venules 
and veins, completing the systemic circulation. The deoxygenated blood then enters the 
right ventricle of the heart to begin the pulmonary circulation again.  
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Figure 1.1: A cross-section of the human heart with the relevant chambers, 
arteries, veins and valves annotated. The path of the blood flow is marked by blue 
(deoxygenated) and red (oxygenated) arrows.
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The four chambers of the heart are separated by four valves which help control the flow 
of the blood through the heart. The right atrium receives the deoxygenated blood back 
from the systemic circuit through the superior vena cava and the inferior vena cava. The 
right atrium is separated from the right ventricle by the tricuspid valve which is 
composed of three fibrous flaps. These flaps are connected to papillary muscles on the 
inner wall of the right ventricle which open when the right ventricle is expanding 
allowing blood to flow through from the right atrium. Once at full capacity the right 
ventricle then contracts, the tricuspid valve closes preventing blood back-flow into the 
right atrium and the pulmonic valve opens, allowing the blood to pass into the right and 
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left pulmonary arteries feeding the lungs. The oxygenated blood then returns to the left 
atrium through the right and left pulmonary veins. The mitral valve, which is composed 
of two flaps connected to papillary muscles on the inner wall of the left ventricle and 
separates the left atrium from the left ventricle, remains closed until shortly after the left 
ventricle begins to expand. Once the expansion of the left ventricle is complete and it 
begins to contract, the mitral valve closes, preventing back-flow of the blood into the 
left atrium, and the aortic valve opens. The blood then flows into the aortic arch and on 
into the rest of the systemic circulation. 
The walls of the heart are composed of three layers: the epicardium, the myocardium 
and the endocardium. The epicardium is a smooth membrane that covers the outer 
surface of the heart. The myocardium is the muscular wall of the heart which forms the 
four chambers. Within this layer is the cardiac muscle, the blood vessels which feed 
these muscles and the nerves which help control the muscles. The endocardium is a 
layer of cells, similar to endothelial cells (ECs) discussed later, which covers the inner 
surfaces of the four chambers and the valves and serves to protect the underlying 
muscle. The two ventricles differ in size with the muscular walls of the left ventricle 
thicker than the right. This is because of the extent of the vascular network and its 
respective resistance which needs to be overcome in order to pump the blood around the 
body compared with the resistance experienced through the lungs.  
1.2.3 The Coronary Arteries 
The muscles of the heart need to be constantly supplied with oxygen and nutrients to 
maintain their functionality, and this is accomplished by the coronary arteries. The 
coronary arteries originate at the base of the ascending aorta, immediately downstream 
of the aortic valve, and follow the curvature of the outer surface of the heart muscle. 
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There are two coronary arteries: the left and the right with their origins in the aortic arch 
as shown in Figure 1.2. The right coronary artery (RCA) supplies blood to right atrium, 
portions of both ventricles and areas of the heart which deal with regulating the heart 
rate. The RCA gives rise to one or more marginal arteries and also supplies the posterior 
descending artery as shown in Figure 1.3. The left coronary artery (LCA) supplies blood 
to the left atrium and ventricle, and the wall which divides the two ventricles. The artery 
itself gives rise to the circumflex artery (LCX) and also the left anterior descending 
artery (LAD). There are some interconnections between the left and right coronary 
arteries which help keep the blood supply constant despite fluctuations between heart 
beats which can be seen in Figure 1.2. 
 
Figure 1.2: Coronary vessels supplying and draining blood to the anterior surface 
of the heart.
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Figure 1.3: Coronary vessels supplying and draining blood to the posterior surface 
of the heart.
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Figure 1.4: Typical arterial wall composition.
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All arterial walls, including those of the coronary arteries, are composed of three 
separate layers: the intima, media and adventitia, as shown in Figure 1.4. The intima is 
the inner layer of the arterial wall and is comprised of an endothelium, a thin basement 
membrane and a thin layer of elastic fibres called the internal elastic lamina (IEL). The 
endothelium, comprised of ECs lining the luminal surface, serves several important 
functions: to present a smooth surface to the blood flow, regulate the influx of 
molecules from the blood into the arterial wall, control the tone of the smooth muscle 
cells within the arterial wall and respond to changes in the local haemodynamic 
environment.
205
 The basement membrane supports the endothelium and regulates 
molecular movement. The IEL acts as the boundary between the intima and the media. 
The media is commonly the thickest layer and is comprised of several concentric sheets 
of vascular smooth muscle cells (VSMCs) contained within a framework of 
extracellular matrix. The extracellular matrix is predominantly composed of elastin and 
collagen which provides support for the VSMCs and forms the primary load-bearing 
components of the arterial wall.
40
 The elastin fibres provide a degree of compliance in 
the artery allowing for the changes in pressure throughout the cardiac cycle. The 
VSMCs are responsible for changing the calibre of the arteries by contracting, causing 
vasoconstriction of the vessel, and relaxing, causing vasodilation of the vessel. Chronic 
vasoconstriction can lead to high blood pressure (hypertension) and excessive 
vasodilation can occur when a patient goes into shock and leads to low blood pressure. 
The media is separated from the adventitia by the external elastic lamina. The adventitia 
consists of elastin and collagen fibres, with nerves and small capillaries running through 
it. These small capillaries are known as vasa vasorum (vessels within vessels) and are 
critical in providing oxygen to the cells contained within the media.  
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1.2.4 The Cardiac Veins 
The blood which supplies the heart muscles with oxygen and nutrients is drained away 
by a series of veins which include the great cardiac vein, the posterior cardiac vein, the 
middle cardiac vein, the small cardiac vein and the anterior cardiac veins. Each of which 
drain the blood away from different areas of the heart and empty into the coronary 
sinus, which in turn empties into the right atrium, near the base of the vena cava. The 
cardiac veins contain valves to prevent blood backflow and typically are not prone to 
atherosclerotic plaque development.  
1.3 Coronary Artery Disease 
In order for the heart to function properly its muscles must receive a constant supply of 
blood. Restriction of the blood flow to the heart muscles can result in the muscles dying 
due to lack of oxygen. This is called myocardial infarction, or death of the myocardial 
muscle, and can be fatal. Coronary artery disease refers to areas within the coronary 
arteries where the blood flow is partially or fully blocked, and is predominantly caused 
by atherosclerosis. The risk factors for CAD include, but are not limited to poor diet, 
smoking, lack of exercise, obesity, diabetes, genetic predisposition to CAD, 
hypertension and high cholesterol.
77
 Atherosclerosis is characterised by the build-up of 
fatty plaque deposits or lesions within the arterial wall of the coronary artery. Reasons 
why some regions within arteries are more prone to atherosclerosis compared with 
others is not known, although it is thought to be related to the haemodynamic features.
24
  
To understand the process through which atherosclerotic lesions develop it is first 
required to look at the formation of lipoproteins in the liver and small intestine. Lipids, 
of which cholesterol is one, are not commonly water soluble and, consequently, do not 
dissolve in the blood. The body needs cholesterol for many functions, including the 
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maintenance of cell membranes and the production of crucial hormones and vitamins. 
Therefore, it needs to transport it around the body within the blood. To make cholesterol 
more dissolvable in blood, and hence easier to transport, it is combined with 
lipoproteins in the liver. The two main lipoproteins are low-density lipoproteins (LDLs) 
and high-density lipoproteins (HDLs). LDLs have been implicated in the development 
of atherosclerotic lesions and HDLs, though, remove excess cholesterol from cells and 
transport it to the liver for elimination. 
Figure 1.5 shows the typical progression of an atherosclerotic lesion over time. An 
atherosclerotic lesion begins when excess LDLs penetrate the arterial wall under the 
endothelium and accumulate within the intima. This penetration of the endothelium by 
LDLs has been linked to a dysfunctional endothelium possibly caused by pro-
atherogenic local haemodynamics; however, what constitutes pro-atherogenic local 
haemodynamics is debateable.
161
 The lipids and proteins in the LDLs then begin to 
oxidise, i.e. lose electrons, and bind to sugars within the arterial wall. In response the 
ECs on the surface and the VSMCs within the media release chemical messengers 
which attract monocytes (a type of leukocyte) from the blood into the wall, where they 
change to macrophages. These macrophages then begin consuming the oxidised LDL 
particles. After a period of time the macrophages become laden with these LDL 
particles, developing into foam cells. Another type of leukocyte, i.e. T-cells, are also 
among the first cells to be recruited within the atheroma and by releasing cytokines 
further increase the inflammatory response.
2
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Figure 1.5: A typical progression of an atherosclerotic lesion over time (adapted 
from Koenig and Khuseyinova.
123
 
The cytokines released by the macrophages encourage the proliferation and migration of 
VSMCs from the media into the intima.
254
 The migrated VSMCs can then form a cap 
over the plaque, separating it away from the lumen. Through this remodelling of the 
arterial wall the calibre of the lumen can be maintained and the lesion has less impact on 
the blood flow. However, this method of mitigating the effects of the lesion only 
functions up to when the lesion occupies 40% of the area encompassed by the IEL.
76
 
After this, the arterial wall can no longer accommodate the lesion growth and the lesion 
begins to grow into the lumen; thus, it increasingly restricts the blood flow downstream. 
In advanced lesions the macrophages undergo apoptosis, i.e. programed death, which 
can lead to the development of a necrotic core when they are not properly cleared away. 
The necrotic core can slowly expand over time and result in the disruption of the plaque 
stability and acute thrombosis.
175
 When the fibrous cap over the atherosclerotic plaque 
ruptures, releasing thrombotic agents from the T-cells into the blood stream, this results 
in the instigation of a thrombotic cascade and the formation of clots and emboli, which 
block the vessels downstream, resulting in MI.  
Time Progression 
CHAPTER 1: Background Material 
 
12 
 
1.3.1 Classification of Atherosclerotic Lesions 
Stary et al. classified atherosclerotic lesions into eight types according to the stage of 
development:  
 Type I: the lesion contains enough atherogenic LDLs to encourage increased 
macrophage infiltration and there is evidence of isolated macrophage foam cells 
 Type II: the lesions primarily contain layers of macrophages and lipid-laden 
VSMCs 
 Type III: an intermediary stage between Type II and IV, consists of scattered 
collections of extracellular lipid droplets which can not only disrupt the 
coherence of the VSMCs but also are precursors to more serious Type IV lesions 
 Type IV: presence of lipid core and a fibrous cap 
 Type V: lipid core with thick layers of fibrous connective tissue and possibly 
calcific lesion  
 Type VI: lipid core with fissure, hematoma and thrombus 
 Type VII: calcification predominates, possibly replacing the accumulated 
remnants of dead cells and extracellular lipid 
 Type VIII: fibrous tissue changes predominate with the normal intima replaced 
and thickened with fibrous connective tissue.
238
 
1.4 Treatment of CAD 
The type of treatment to be recommended for CAD is predominantly based on how far 
the disease has progressed, or essentially how severe the atherosclerotic lesion, or 
lesions, has developed. In the initial stages of the disease lifestyle changes are the 
recommended treatment. These include quitting smoking, regular exercise, eating 
healthily, losing excess weight and reducing stress. Additionally, drugs may be 
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prescribed, such as statins, which lower the level of LDLs in the blood, or aspirin, 
which helps to thin the blood, reducing its tendency to clot. If these measures fail to 
produce satisfactory outcomes further treatment is recommended in the form of a 
coronary artery bypass graft (CABG) or angioplasty, with or without stenting. 
1.4.1 Coronary Artery Bypass Graft 
In the case of atherosclerotic lesions in the later stages of development, where the 
restriction or narrowing of the coronary artery is considerable, more immediate and 
aggressive treatment is needed. CABG is one of the treatments offered to patients with 
stable angina and suitable coronary anatomy where their symptoms are not satisfactorily 
controlled by lifestyle changes and medication.
179
 CABG is classed as a major surgery 
as it is termed open-heart surgery, meaning the risk of infection post-surgery is not 
negligible. CABG is generally recommended over angioplasty in cases of multi-vessel 
coronary disease where it is seen to lead to a reduction in long-term mortality, MI and 
repeat revascularisations.
87,233
 Guidelines for managing stable angina recommend that 
both options are presented and discussed with patients, as there are other factors, such 
as diabetes, which can affect the decision.
179
 The procedure itself involves opening the 
patient’s chest and sternum, exposing the heart, stopping the heart and keeping the 
blood pumping through a mechanical pump. Once this is achieved a blood vessel is 
taken from another part of the body and used to bypass the site of the restriction(s). 
Originally the greater saphenous vein from the leg was the vessel of choice for the 
bypass graft; however, the internal mammary arteries from the chest or the radial artery 
from the forearm are currently favoured as they are less likely to re-block. Previously, 
the only treatment option in the late stages of CAD, CABG has seen a decline in use 
since the introduction of angioplasty.
233
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1.4.2 Angioplasty 
Balloon angioplasty was developed by Charles Dotter in the 1960s as a minimally 
invasive treatment for arterial narrowing caused by atherosclerotic lesions in the 
peripheral arteries.
54
 Later, in the 1970s, it was applied to renal, coronary and iliac 
arteries by Andreas Gruentzig and co-workers.
83–85
 The procedure is also referred to as 
percutaneous transluminal coronary angioplasty (PTCA). It involves making a small 
incision in the groin to gain access to the femoral artery (or in the arm to gain access to 
the radial artery) whereupon a hollow tube, called a catheter, is threaded up through the 
femoral artery, the iliac artery, the descending aorta, around the aortic arch, through to 
the ascending aorta and down into the relevant coronary artery. Once within the 
coronary artery a contrast agent is injected into the catheter and released into the 
coronary artery. This helps highlight the site of the restriction or narrowing on an X-ray 
to the cardiologist, who then feeds the tip of the catheter to the site. Once in position, a 
balloon on the end of the catheter is inflated, pushing the plaque out against the arterial 
wall and restoring blood flow to the tissue downstream. 
Re-blockage of a treated coronary artery following this procedure, known as restenosis, 
was reported in 30-60% of patients,
73
 with these patients consequently needing re-
treatment with either additional percutaneous methods or bypass surgery. Restenosis 
following balloon angioplasty is attributed to three key responses: acute elastic recoil, 
negative wall remodelling (reduction in lumen area without a change in wall mass) and 
arterial wall thickening into the lumen (due to an increase in the number of cells within 
the arterial wall).  
CHAPTER 1: Background Material 
 
15 
 
1.4.3 Angioplasty with Stenting 
Bare metal stents (BMS) were first used in an angioplasty procedure by Puel and 
Sigwart in 1986,
230
 and were gradually incorporated in the 1990s to serve as a rigid 
scaffold, thus eliminating elastic recoil and reducing wall remodelling,
92
 with some 
cases of positive remodelling reported.
176
 A stent, generally, is a cylindrical metal mesh 
that is crimped onto the angioplasty catheter, which upon expansion of the catheter 
balloon is expanded radially out against the arterial wall. BMSs are commonly made of 
316L stainless steel, platinum-iridium alloy, tantalum, cobalt-chromium alloy, titanium, 
pure iron, magnesium alloys or nitinol.
147
  
The most common type of stent is balloon expandable, although nitinol stents are self-
expanding. Self-expanding stents make use of the superelastic behaviour of the nitinol 
material, whereby the stent can transition between a strong Austenite phase and a 
weaker Martensite phase when stressed. For implantation of these stents a balloon is not 
needed and instead a sheath is withdrawn and the stent expands to a predetermined 
shape; however, balloon angioplasty may be carried out prior to implantation. Even 
though stenting reduced restenosis rates to between 22% and 32%,
61,73,223
 it still 
continued to be a burden. Restenosis with stents, known as ISR, is mostly due to arterial 
wall thickening. Understanding and consequently devising ways of reducing the 
frequency of ISR has been a continuing goal of research into improved stent designs. 
From this research drug-eluting stents (DES) were developed which use anti-
proliferative, immunosuppressive, pro-healing and anti-inflammatory drugs in an 
attempt to prevent ISR. DESs have proved effective, with ISR rates at six-month 
follow-up as low as 2.6-10.1%.
240
 As a result, DESs have surpassed BMSs as the 
preferred stent choice, with 70-80% of stent procedures in the US carried out with DESs 
by mid-2009.
67,125
 However, ISR is still a problem along with stent thrombosis, and 
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delayed re-endothelialisation (re-growth of the endothelium) due to the anti-
proliferative properties of some DES drugs.
70
 Newer stents currently in development or 
undergoing clinical trials are predominantly variations of the DES design with 
perceived improvements, such as biodegradable polymer and polymer-free coatings, 
novel coatings which encourage re-endothelialisation, and completely biodegradable 
platforms.
98,163
 However, there are other ideas for reducing ISR which are beginning to 
show promise, based on the fact that the biological healing response to stent 
implantation is partially dependent on local haemodynamics in the stented artery. These 
will be discussed in detail in Chapter 4. BMSs are still implanted in patients with a high 
bleeding risk or who may not be able to conform to dual antiplatelet therapy (DAPT) 
required post-implantation. Therefore, research into how to improve the long-term 
outcomes of angioplasty with stenting using means other than drugs is warranted.  
1.5 Hypoxia 
The delivery of oxygen to the cells within an arterial wall is crucial to maintaining a 
healthy artery. The blood passing through the vasa vasorum within the adventitia 
supplies most of the oxygen needed to the media, and the intima is predominantly 
supplied through diffusion from the blood contained within the central lumen Hypoxia, 
a deficiency in the amount of oxygen reaching the cells within the arterial wall, has been 
found to exacerbate some of the biological processes which can result in ISR.
20,134,215,216
 
The amount of oxygen diffusing into the arterial wall can be affected by the 
haemodynamic conditions within the lumen.  
The geometry of an implanted stent can have a significant impact on the haemodynamic 
conditions within the artery. The main beneficial effect is the restoration of blood to the 
downstream vasculature; however, locally within the stented region recirculation zones 
can be created around stent struts which can influence the amount of oxygen reaching 
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the underlying arterial wall cells. Predicting the amount of oxygen that reaches the 
arterial wall cells is valuable so that the design of stents, and other medical devices, can 
be improved upon.  
1.6 Computational Analysis of Coronary Stents 
With the aforementioned dependency of the biological processes that can result in ISR 
on the local haemodynamics and oxygenation of the arterial wall, analysis of these 
features is required. Given the small size of the coronary arteries and the scale of the 
haemodynamic features that takes place within the artery computational analysis 
techniques have proved to be powerful tools. Considering the complexity of the 
biological processes that take place within a coronary artery, with a degree of 
simplification computational techniques can focus on certain aspects of the physical 
phenomena and help predict the impact of stents on the artery environment. 
Traditionally, there are two aspects which are focused upon using computational 
analysis: the structural injury inflicted on the arterial wall and the luminal 
haemodynamic environment created by stent implantation. The stresses placed upon an 
arterial wall by stent implantation, which inflict the structural injury, are analysed using 
advanced finite element analysis (FEA) software and the local haemodynamics are 
analysed using computational fluid dynamics (CFD).  
For predicting the oxygen transport in arteries there are three types of studies which are 
commonly employed: lumen-free analyses, wall-free analyses and lumen-wall coupled 
analyses. In lumen-free analyses a constant value for oxygen concentration is imposed 
on the luminal surface; hence, the impact of the blood flow is neglected. For wall-free 
analyses a constant oxygen concentration value is applied on the luminal surface and the 
oxygen flux into the wall is quantified using a dimensionless variable, the Sherwood 
number (discussed in more detail in Section 3.4). Finally, lumen-wall coupled analyses 
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are beneficial because the unrealistic assumption of a constant oxygen concentration on 
the luminal surface is not made and a more detailed indication of oxygen concentration 
levels, and consequently the extent of hypoxia, within the arterial wall is given. 
1.7 Helical Flow 
Local hemodynamics have a significant influence on the cellular activity within an 
arterial wall. Atherosclerosis has been found to preferentially develop in areas of 
disturbed flow and regions of low wall shear stress (WSS).
59,176,182,183,185
 Natural blood 
flow in the arterial system has been found to be helical in nature, meaning it has a 
secondary circular motion in addition to the primary forward motion. The 
beneficial/detrimental implications of helical flow in the cardiovascular system are open 
to conjecture;
186
 however, two novel stent designs are being developed that endeavour 
to elicit helical flow and take advantage of its beneficial characteristics in terms of 
inhibiting neo-atherosclerotic lesions (new lesions formed within the stented region) 
post-implantation and ISR. These two novel stent designs are the BioMimics 3D stent 
as developed by Veryan Medical Ltd, which is currently undergoing assessment in the 
MIMICS-2 clinical study with a total of 271 patients, and the Vascular Flow 
Technologies Ltd spiral flow inducer which originally had some success in synthetic 
grafts and may also be incorporated into stent designs. Data is available from the first 
MIMICS study where 76 patients undergoing femoropopliteal artery intervention were 
enrolled of which 50 were implanted with the BioMimics 3D stent and 26 were 
implanted with a straight control stent. There were two key findings from this two-year 
study. First, the Kaplan Meier survival analysis of freedom from loss of primary 
patency at two years was 72% for the BioMimics 3D subjects vs. 55% for the control 
group (P=0.0497). Second, there was no increase in the clinically driven target lesion 
revascularisation rate in the BioMimics arm between 12 and 24 months (9% at both 
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time-points) compared to an increase of 16% (8% at 12 months and 24% at 24 months) 
in the control arm.
272
 Significantly for this work, the data indicated a correlation 
between primary patency and stent curvature.
272
 Helical flow and these two devices will 
be discussed in greater detail in Chapter 4 with direct relevance to Test Case 4 presented 
in Chapter 8 which assesses the effects of helical-flow-inducing stent designs on oxygen 
transport. 
1.8 Aim of this Research 
The aim of this research was to develop an advanced oxygen transport model that 
incorporates both the free oxygen dissolved in plasma and the bound oxygen contained 
in RBCs, and also accounts for the shear-induced dispersion of RBCs, which could be 
used to assess stent designs. More detail on the reasoning for this is discussed in 
Chapter 3. Additionally, this research was undertaken to demonstrate both the 
limitations of simpler models and also, potential applications of the advanced model; 
specifically, assessment of oxygen transport in stented coronary arteries. Finally, 
assessment of the theoretical benefits of helical flow in terms of local haemodynamics 
and oxygen transport in stented coronary arteries was undertaken. 
1.9 Structure of Thesis 
Chapter 2 provides the background material to the instigating factors and biological 
processes involved in ISR. Chapter 3 gives an introduction to fundamental fluid 
dynamics theory and the haemodynamic variables used, the oxygen transport theory and 
relevant variables, and also numerical methodologies employed by the CFD software, as 
used in this study. Chapter 4 is a thorough literature survey of previous work in the 
areas of oxygen transport, haemodynamic assessment of stent designs, and helical flow. 
Chapter 5 is a prelude to the four test cases describing the aims of each. Chapter 6 
presents the results of Test Case 1 where the results of five different oxygen transport 
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models were compared with experimental results from dog carotid arteries. The five 
different oxygen transport models were also compared with experimental results from 
rabbit aortae in Test Case 2, as presented in Chapter 7, along with Test Case 3 which 
compares three different coronary stent designs using the most advanced oxygen 
transport model. Finally in Chapter 8, the predicted haemodynamics and oxygen 
transport in five helical stent designs are compared with those of a straight stent. The 
limitations and conclusions of the work undertaken, and also possible future work, are 
discussed in Chapter 9. Appendix A presents some relevant validation test cases and 
appendix B describes the required mesh convergence tests. 
1.10 Novelty and Contribution 
This research contributes to two specific biomedical fields: oxygen transport modelling 
and assessment of coronary stents. The novelty of the research is that it is the first time 
that: 
1. An oxygen transport model has incorporated the free and bound oxygen along 
with a variable shear-induced dispersion coefficient. 
2. The simplifications of blood oxygen transport models, which are prevalent in the 
literature, have been assessed in 3D geometries and their effects on the PO2 
profile within the arterial lumen and wall have been analysed. 
3. It is the first time that the oxygen transport has been modelled in three different 
stent designs with the predicted low and hypoxic PO2 volumes within the arterial 
wall assessed. 
4. An advanced oxygen transport model has been used to assess different helical-
flow-inducing stent designs. 
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1.11 Publications 
The work presented in this thesis has led to publications in three peer-reviewed journals: 
Oxygen mass transport in stented coronary arteries, Murphy, E.A., Dunne, A.S., Martin, 
D.M., Boyle, F.J., Annals of Biomedical Engineering, Volume 44, Issue 2, 2016. 
Computational fluid dynamics analysis of balloon-expandable coronary stents: 
influence of stent and vessel deformation, Martin, D.M., Murphy, E.A., Boyle, F.J., 
Medical Engineering and Physics, Volume 36, Issue 8, 2014. 
Reducing in-stent restenosis through novel stent flow field augmentation, Murphy, E.A., 
Boyle, F.J., Cardiovascular Engineering and Technology, Volume 3, Issue 4, 2012. 
Additionally, this work has been presented at several conferences: 
Oxygen transport in stented arteries using computational fluid dynamics, Eoin A 
Murphy, Fergal J Boyle, John G Houston. University of Dundee Medical Symposium, 
Crieff, February 2016. (Poster) 
Assessing the effect of helical flow on the hemodynamic environment post-stent-
implantation in the coronary artery, Proceedings of the 20th Annual Bioengineering in 
Ireland Conference, Co. Limerick, Ireland, 2014 
An improved methodology for hemodynamic analysis of stent designs with an 
application to helical-flow-inducing stents, Proceedings of the 19th Annual 
Bioengineering in Ireland Conference, Co. Meath, Ireland, 2013 
The influence of stent and vessel deformation on wall shear stress and wall shear stress 
gradient in a stented LAD coronary artery, Proceedings of the Bioengineering Society 
(UK) Conference, Oxford, England, 2012 
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CHAPTER 2 
Chapter 2. In-Stent Restenosis 
2.1 Introduction 
In this chapter the biological background material relevant to the project is described. 
This chapter is crucial in detailing the biological processes which take place at a cellular 
level within the human arterial wall post-stent-implantation, highlighting how they 
interact, and are influenced by their instigating factors. This offers a justification, in 
addition to reasons given in Section 1.8, as to why one would be interested in 
numerically modelling the local haemodynamics and oxygen transport within a stented 
coronary artery. 
2.2 In-Stent Restenosis 
A diagram of a healthy arterial wall is shown in Figure 2.1; however, the exact 
composition of an atherosclerotic artery deviates from this ideal form with plaque, 
inflammation, and intimal hyperplasia. Stent implantation has three effects on a treated 
artery: it induces structural injury, introduces a foreign body and alters the local 
haemodynamics. These three effects instigate and influence four interacting biological 
processes which can lead to re-narrowing of the stented artery, known as ISR. ISR is 
defined as angiographic evidence of a loss of greater than 50% of the lumen diameter 
post intervention.
159
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Structural injury is inflicted on the arterial wall during the implantation procedure. The 
stent and balloon denude most of the endothelium on contact, exposing the underlying 
collagen fibres and leaving some damaged ECs directly adjacent to the stent struts.
208
 
Stent implantation stretches, and therefore stresses, the arterial wall and as a result the 
cellular structure of VSMCs present in the media can be disrupted, and the IEL and the 
media can rupture. Atherosclerotic lesions present at an implantation site are inelastic 
and frequently split rather than stretch upon stent implantation. This combined damage 
induces a healing response within the arterial wall.  
Media
Adventitia
IEL
EEL
EC
Collagen Fibres
Fibroblast
Connective Tissue
VSMC
Arterial
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Figure 2.1: Simplified diagram of a healthy artery showing the separate layers and 
the main cellular components and fibres. Abbreviations: internal elastic lamina 
(IEL), external elastic lamina (EEL), endothelial cell (EC) and vascular smooth 
muscle cell (VSMC). 
When a stent is inserted in the artery its non-biological surface composition induces a 
foreign-body response. This response is dependent on properties such as the 
biocompatibility of the surface material and the surface roughness, along with the 
existence of contaminants on the surface of the stent. The surface material and 
roughness of a stent affects how quickly the arterial wall heals over the struts. 
Contaminants, such as powder from surgical gloves, have been found on a stent surface 
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due to handling before catheter insertion.
11
 The improved biocompatibility of stent 
materials and the rinsing of stents before implantation reduce the foreign-body 
response; however, the non-biological nature of stents instigates cells and proteins in the 
body to react to what they perceive as a foreign invader. 
When a stent is implanted in a diseased artery the geometry of the artery is altered, 
which in turn augments the local haemodynamics. The lesion is compressed out against 
the arterial wall, clearing the lumen blockage and reinstating blood flow. The stented 
artery adopts a new geometry based on the stent strut configuration with the struts 
pressed against the arterial wall and prolapsed tissue between them. In some cases of 
over-inflation of the balloon, a step-up phenomenon at the ends of the stent can occur, 
creating recirculation zones at these points. Also, some degree of longitudinal 
straightening by stent implantation has been reported in curved arteries, although with 
more flexible stent designs currently on the market this is no longer a serious issue.
86
 
These changes are a deviation from the smooth surface presented to the blood flow by a 
healthy artery and lead to disturbed flow within the stented artery. This disturbed flow 
can encompass flow separation and reattachment, stagnation and recirculation zones, 
long particle residence times, low and high shear stress (SS) within the blood flow, low 
and high WSS zones, oscillatory WSS, and high WSS gradient (WSSG) and angle 
gradient (WSSAG). Cellular components of the arterial wall are impelled to respond to 
this augmentation of the local haemodynamics in order to return the artery to a circular 
luminal cross-section with smooth walls. Also, some of the changes in the local 
haemodynamics are not conducive to the natural healing of the arterial wall and instead 
hinder or adversely affect it, which consequently can lead to ISR. 
It is important to note that historically it was thought that human arteries try to maintain 
a physiological WSS value of approximately 15dyne/cm
2
 (1.5Pa), although this has 
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since been refuted with one of the current hypotheses being that the WSS varies 
inversely with vessel radius, becoming larger when the vessel radius decreases.
37
 
Although, conveniently here, in the case of coronary arteries the basal physiological 
WSS has been observed to be approximately 1.5Pa.
37
 Additionally, physiological WSS 
values have also been shown to vary across different species which is worth noting as 
studies involving animals are referenced throughout this section with different values 
for low WSS values adopted by the researchers involved. 
The four interacting biological processes, instigated by these three effects of stent 
implantation, are thrombus formation, inflammation, neointimal hyperplasia (NIH) and 
re-endothelialisation. These biological processes, their interactions and the influences of 
the three instigators on each are described in the following sections. Separate to this, 
hypoxia and how it affects the biological processes is described in Section 2.3. Also, the 
influence of stent design on these instigators and biological processes is discussed in 
Section 2.4. 
2.2.1 Thrombus Formation 
Thrombus formation, in general, is the body’s emergency response mechanism to 
structural injury and entails primary and secondary haemostasis. Primary haemostasis 
involves blood-borne platelets quickly adhering to form a plug at an injury site. 
Occurring in parallel with this is secondary haemostasis which involves the formation 
of fibrin fibres through the coagulation cascade, and these fibrin fibres bind the adhered 
platelets together at the injury site.  
When structural injury is inflicted on an artery by stent implantation, platelets present in 
the bloodstream are activated by exposed collagen and plaque, and by proteins 
expressed by damaged ECs (e.g. fibronectin and von Willebrand factor (vWf)). 
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Activated platelets are more sensitive to chemical signals and adhere to the collagen, 
plaque and proteins on the arterial wall, changing their cytoskeleton (cell scaffolding) to 
become more flexible and capable of spreading out over the injury site. Activated 
platelets also release platelet activating factor (PAF), adenosine diphosphate (ADP) and 
thromboxane A2 into the bloodstream which in turn activate more platelets and aid in 
the aggregation of platelets at an injury site. The coagulation cascade involves several 
coagulation factors present in the bloodstream and those released by adhered platelets 
and leukocytes, and VSMCs (e.g. tissue factor). Through the coagulation cascade 
prothrombin, present in the blood plasma, is converted to thrombin which both activates 
more platelets and causes soluble fibrinogen molecules in the blood plasma to convert 
into fibrin monomers. These fibrin monomers form fibrin fibres that bind the platelets 
that have aggregated together at the injury site, forming a thrombus.  
In addition to this response to structural injury, thrombus formation is also initiated by 
the presence of a foreign body. Blood-soluble proteins adsorb onto the stent surface, 
forming a thin film which provides a provisional matrix that controls the subsequent 
biological processes of the foreign-body response.
3
 Different proteins (e.g. albumin, 
fibrinogen, fibronectin, vitronectin and y-globulin) adsorb onto the stent surface 
depending on the properties of the surface material.
3
 These adsorbed proteins produce 
different effects; fibrinogen for example is pro-thrombotic, promoting activation and 
adhesion of platelets, whereas albumin reduces platelet adhesion and aggregation.
138
 
Fibrinogen is adsorbed preferentially over other proteins on many surfaces, especially 
polymers,
138
 and thus facilitates thrombus formation at a stent implantation site. 
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Figure 2.2: Diagram showing the cells, pro-thrombotic agents and proteins 
involved in thrombus formation at an injury site around a stent strut. 
Thrombus formation has been found to be heavily flow dependent. The platelets, 
coagulation factors and chemical substances involved in thrombus formation are 
predominantly blood-borne particles and as such their movements are dictated by the 
local haemodynamics. High particle residence times at the injury site facilitate increased 
platelet exposure times to thrombotic arterial wall components and activating chemical 
substances. This increased exposure time results in a greater probability of platelet 
activation with enhanced platelet activation being observed in low flow conditions.
9
 
Increased platelet adhesion has been observed downstream of recirculation zones, where 
the main flow reattaches to the arterial wall, due to the convection of platelets towards 
the arterial wall.
56,221
 RBCs can also get trapped by fibrin monomers in the thrombus 
within recirculation zones or other low SS regions. Also, in regions of low WSS (<1.0 
to 1.2 Pa) ECs respond by down-regulating the release of anti-thrombotic agents and 
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up-regulating the expression of pro-coagulant and pro-thrombotic agents, thus also 
instigating thrombus formation. High SS within the blood flow can also activate 
platelets; this depends on the magnitude of the SS and the exposure time of platelets to 
the high SS.
31
 Figure 2.2 shows the cells (platelets, RBCs and ECs), pro-thrombotic 
agents and proteins involved in thrombus formation. 
2.2.2 Inflammation 
Inflammation involving leukocytes (e.g. lymphocytes, monocytes/macrophages, 
neutrophils, eosinophils and basophils.) is the body’s primary defence mechanism 
against infection. Leukocytes are attracted to an injury site in order to prevent the spread 
of the tissue damage and infection, and to aid in wound healing and tissue repair.
158
  
Structural injury to the arterial wall by stent implantation triggers the expression of 
several cell adhesion molecules which mediate four steps, shown in Figure 2.3, that 
each leukocyte undergoes in order to infiltrate an injury site. These four steps are the 
initial contact (tethering), leading to rolling and activation of the leukocyte, followed by 
firm adhesion and finally transmigration into the arterial wall. Tethering and rolling are 
mediated by cell adhesion molecules P-selectin (expressed by adhered platelets and 
damaged VSMCs) and E-selectin (expressed by damaged ECs) which interact with 
ligands expressed on the leukocyte surface. Firm adhesion is mediated by platelet 
glycoprotein (GP) Ib-𝛼, vascular cell adhesion molecule 1 (VCAM-1) and intercellular 
adhesion molecule 1 (ICAM-1) expressed on the luminal surface of the damaged wall, 
which interact with integrins expressed on the surface of the leukocytes, e.g. 
macrophage-1 antigen (MAC-1). The final step is driven by concentration gradients of 
chemokines (chemotactic cytokines) released by damaged ECs and VSMCs, and by the 
leukocytes already present at the injury site. Neutrophil infiltration of the injury site 
represents the initial acute phase of the inflammatory response and they are present up 
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to, but not beyond, 30 days after BMS implantation.
59
 The chronic phase of the 
inflammatory response involving lymphocyte and monocyte infiltration of the injury 
site, extends from three days to beyond six months for BMSs.
59
 When monocytes 
migrate across the platelet/fibrin thrombus to the site of initial injury, they differentiate 
into macrophages. These cells consume the damaged cells around the injury site and 
also secrete interleukins which attract more leukocytes to the area. 
Stent Strut
Tethering Rolling
Firm Adhesion
Transmigration
Activated Platelets:
P-selectin, GPIb-𝛼
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Figure 2.3: Diagram showing the four steps leukocytes undergo in order to 
infiltrate the injury site. 
The thin layer of proteins adsorbed onto the implanted stent surface not only mediates 
the adhesion of platelets, but also controls the inflammatory phase of the foreign-body 
response to the stent. The complement system, which consists of more than 20 plasma-
based proteins, is a primary contributor to the innate immune system and is activated by 
the adsorbed protein layer. Activation of the complement system promotes the 
formation of enzymes and binding proteins which regulate the inflammatory response to 
a foreign body. Leukocytes, particularly neutrophils and monocytes, follow increased 
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concentration gradients of chemo-attractant anaphylatoxins, such as C5a, which are 
fragments produced by activation of the complement system. Other products of 
complement activation, such as C3b and iC3b, through a process called opsonisation 
mark foreign particles for phagocytic removal (ingestion) by leukocytes and subsequent 
proteolysis (digestion) by proteases (cellular enzymes). This is the case for any 
contaminants on the stent surface; however, in the case of a relatively large foreign 
body, such as a stent, which cannot be ingested, adhered neutrophils and monocytes 
undergo a frustrated phagocytosis whereby they release their array of potent oxygen 
metabolites and proteolytic enzymes.
81
 This can lead to an unresolved chronic 
inflammatory response exemplified by the increased fusion of macrophages into foreign 
body giant cells around an implanted stent. Platelets which adhere to the adsorbed 
protein layer on stent struts also release P-selectin to aid leukocyte adhesion and these 
adhered leukocytes can also encourage thrombus formation through elevated expression 
of tissue factor.
57
 Products of the complement system can interact with proteins 
involved in thrombus formation and thus, can also regulate each other. Metallic stent 
struts or the presence of a polymer coating on a stent can induce an allergic 
inflammatory reaction in some people, which is observed as eosinophil activation and 
presence at the implantation site.
185
 
The local haemodynamics can also mediate the adhesion of leukocytes at an 
implantation site. With increased thrombus formation due to the haemodynamics in 
certain regions, e.g. re-attachment areas where flow is directed towards the arterial wall, 
there is a greater amount of cell adhesion molecules available to capture passing 
leukocytes. In addition to this, it has been found that local vascular haemodynamics can 
affect leukocyte ligand expression,
65
 shape
46
 and consequently interaction with other 
cells.
246
 Leukocyte-EC interaction is heavily influenced by the local haemodynamics 
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which becomes more relevant as the endothelium reforms over the implantation site. 
For instance, leukocytes retract their pseudopodia (temporary projections from 
leukocytes used to adhere to a surface) when exposed to nitric oxide (NO),
160
 which is 
produced by functioning ECs in response to physiological WSS (1.5 to 7 Pa).
32
 
However, when ECs are exposed to low WSS (<1.0 to 1.2 Pa) or disturbed flow they 
decrease their expression of anti-inflammatory mediators (e.g. NO) and upregulate cell 
adhesion molecules (e.g. E-selectin, VCAM-1 and ICAM-1).
32
 Increased 
macromolecule transport across the endothelium, as a result of abnormal endothelial 
permeability, has been shown to occur in reattachment zones of high WSSG 
(>0.85Pa/mm).
195
 This may lead to increased uptake of monocytes across the 
endothelium in reattachment zones, for instance, downstream of stent struts. Therefore, 
the establishment of normal physiological blood flow within a stented artery following 
the procedure is crucial to avoiding prolonged inflammation and consequently possible 
ISR. 
2.2.3 Neointimal Hyperplasia 
NIH takes place up to 18 months post-implantation, results in a thickening of the intimal 
layer, and is the main cause of ISR. NIH involves the migration and proliferation of 
VSMCs originating in the media, and also differentiating from fibroblasts in the 
adventitia and bone-marrow-derived stem cells in the bloodstream. In addition, the 
VSMCs synthesise extracellular matrix (ECM). The degree of NIH is heavily 
influenced by the degree of thrombus formation and inflammation which takes place at 
an implantation site.  
Damaged ECs and VSMCs, adhered leukocytes and platelets release cytokines (proteins 
used for intercellular communication) and mitogens (proteins which encourage a cell to 
commence the cell-division cycle) which encourage NIH at an injury site. The 
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migration of the VSMCs is stimulated by cytokines (e.g. tumour necrosis factor (TNF) 
and interleukin-1 (IL-1)) released by macrophages and also by some of the mitogens 
(e.g. platelet-derived growth factor (PDGF)). PDGF is capable of stimulating migration 
at a much lower concentration level than that needed for cell division and therefore, 
migration is an earlier response than proliferation.
82
 In order for migration to occur 
enzymes (e.g. matrix metalloproteinase (MMP)-9) released by adhered leukocytes and 
VSMCs help in the dissolution of the IEL and the existing ECM. This dissolution, along 
with the disruption to the ECM caused by stent implantation, allows the medial VSMCs 
and myofibroblasts (activated fibroblasts) to migrate through to the neointimal region of 
the arterial wall. The proliferation of VSMCs is instigated by mitogens (e.g. serotonin, 
thromboxane A2, PDGF and basic fibroblast growth factor (bFGF)) which are released 
by damaged ECs and VSMCs, adhered leukocytes and platelets. This proliferation 
produces a greater amount of neointimal cells than does migration. In addition to 
VSMC migration and proliferation, inflammatory and hematopoietic cytokines (e.g. 
granulocyte colony-stimulating factor (G-CSF)) produced by ECs and leukocytes at the 
injury site mobilise stem cells from the bone marrow to enter the bloodstream.
108,109
 
These stem cells can differentiate into smooth muscle progenitor cells (SPCs), which 
adhere to fibronectin and differentiate into VSMC-like cells in the presence of PDGF-
BB (a PDGF isoform) at the injury site.
89,232
 The stretching of the original VSMCs in 
the arterial wall stimulates them to synthesise collagen, a component of ECM, which 
may serve to alleviate the additional stress caused by stent implantation, but also 
increases the overall wall volume.
137
 This, along with the synthesis of ECM by 
neointimal VSMCs can contribute up to 80% of the resultant wall thickening.
73
  
Leukocytes and platelets attracted to a foreign body can also release cytokines and 
mitogens which encourage NIH. Macrophages activated by biomedical polymers in 
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vitro have been shown to stimulate fibroblast activity.
3
 In addition to this, macrophages 
and foreign-body giant cells on a biomaterial surface modulate ECM fibrosis. This 
results in the formation of a fibrous capsule, mainly comprised of collagen fibres and 
leukocytes, which isolates the stent from the surrounding tissue and blood.
3
  
NIH can also be induced and influenced by local haemodynamics within the stented 
arterial region. Where local haemodynamics cause increased thrombus formation and 
inflammation, due to the release of mitogens by adhered leukocytes and platelets, this 
subsequently induces increased NIH. In regions where the endothelium has been 
denuded and the IEL damaged by stent implantation, underlining VSMCs may be 
exposed and affected by the local haemodynamics. Human VSMCs exposed to 
physiological or high WSS, taken as 1.4 and 2.8 Pa respectively in this particular study, 
for 24 hours show an increase in transforming growth factor (TGF)-𝛽1 expression 
which inhibits their proliferation, in comparison with a static control.
260
 High WSS 
(>1.5 Pa) also stimulates the release of stored mitogens (PDGF and bFGF) within 
VSMCs into the bloodstream while low WSS increases VSMC susceptibility to these 
mitogens.
239
 Thus, in a stented artery where there is variability between high and low 
WSS across the stent and arterial wall, increased proliferation would occur in low WSS 
zones.
173
 In a study by Papadaki et al. into the effects of different shear stresses (0.5, 
1.1, 1.5, 1.75 2.15, and 2.5 Pa) on a layer of human aortic VSMCs on glass slides found 
that above 1.5 Pa the VSMCs showed decreased proliferation over a 24 hour period.
187
 
In addition, pulsatile turbulent WSS has also been found to stimulate VSMC 
proliferation,
227
 and murine VSMCs exposed to steady laminar WSS of 1.5 Pa have 
been found to transdifferentiate into ECs.
266
 Within the arterial wall, VSMCs and 
myofibroblasts are exposed to transmural interstitial shear stress, estimated to be 
normally around 0.1 Pa, which can be increased by endothelium denudation, activating 
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these cells and promoting their migration into the intima or wound site.
225
 ECs present 
in the stented region downregulate anti-proliferative gene expression and upregulate the 
release of VSMC growth factors in response to low WSS.
32
 Areas experiencing elevated 
WSSG (>0.2Pa/mm) in the toe region of an end-to-side arterial anastomosis have been 
found to develop increased NIH.
129,136,184
 The oxygen flux from the blood into the 
arterial wall, which is also heavily flow dependent, has also been found to influence 
VSMC behaviour. NIH has been found to be reduced in rabbits treated with 
supplemental oxygen,
135
 and areas of low WSS where the oxygen flux into the arterial 
wall is low are hypothesised to experience increased NIH.
252
  
2.2.4 Re-Endothelialisation 
The endothelium fulfils several important physiological functions which include acting 
as a selective permeability barrier, participation in cardiovascular homeostasis and 
inflammatory responses, regulation of cellular growth and proliferation within the 
arterial wall, angiogenesis and tumour metastasis.
214
 Considering its importance, once 
denudation by stent implantation has occurred, its reinstatement, i.e. re-
endothelialisation, is critical in order for the artery to return to its normal functioning 
behaviour. 
Damaged ECs, adhered platelets, VSMCs and macrophages present at the injury site 
release mitogens capable of instigating re-endothelialisation. These mitogens include 
vascular endothelial growth factor (VEGF), PDGF and bFGF and induce the ECs 
remaining around the stent struts and outside the stented area to migrate and proliferate 
into the denuded section. In addition, increased levels of VEGF circulating in the 
bloodstream induce precursors of endothelial cell colony forming units (EC-CFUs) 
(angiogenic monocytes and lymphocytes) and endothelial progenitor cells (EPCs) 
derived from bone marrow stem cells, to mobilise, enter the bloodstream and home in 
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on the injury site. It has been hypothesised that EC-CFUs precursors arrive earlier than 
EPCs to provide rapid coverage of the injury site and secret angiogenic factors (e.g. 
VEGF and G-CSF) which encourage EPC homing and proliferation.
186
 EPCs attach to 
proteins and adhesion molecules on the arterial wall and subsequently differentiate into 
mature ECs.  
 
Figure 2.4: Phase-contrast monographs of confluent bovine aortic endothelial 
monolayers show a distinct difference between ECs under static flow conditions 
(A) and those exposed to physiological WSS for 24 hours (B). Reproduced and 
adapted with permission from the Journal of Cell Science.
145
 
ECs or EPCs will not adhere directly to, or proliferate over, a normal stent surface and 
as such re-endothelialisation over the stent struts cannot occur without an adsorbed 
protein layer and adhesion molecules expressed by cells adhered to the surface.
48
 Some 
stent designs endeavour to promote re-endothelialisation by applying coatings to the 
stent surface.
13,48,224
 The surface texture of a stent also influences re-endothelialisation 
and thus some new stents are exploring different surface modifications which may aid 
re-endothelialisation.
17
 In addition to this the surface chemical composition also affects 
re-endothelialisation, e.g. endothelial migration onto stainless steel via interaction with 
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adsorbed fibrinogen is significantly greater than that observed onto gold surfaces. This 
could be due to the surface charge, hydrophobicity, or chemical composition of the 
surface material.
235
 
Local haemodynamics at a stent implantation site also have an effect on the initial and 
continued adherence of ECs and EPCs. Large WSS oscillations over positive and 
negative values, i.e. 1Hz reversing sinusoidal WSS of mean 2.0 Pa with an amplitude of 
4.0 Pa, has been found to cause the detachment of cultured bovine aortic ECs,
94
 which 
would delay re-endothelialisation. ECs have been shown to migrate downstream of an 
area where the WSSG is above 0.3 Pa/mm.
47,255
 The migration of ECs into denuded 
areas from adjacent areas with an intact endothelium has been shown to be increased 
when exposed to undisturbed laminar flow as opposed to disturbed laminar flow or 
static flow.
106
 Re-endothelialisation of the stent surface has also been found to be WSS 
dependent, with low WSS regions experiencing delayed re-endothelialisation and high 
WSS encouraging EC migration onto stent surfaces.
234
 In addition to this, as the healing 
process progresses and the endothelium layer reforms, ECs can sense and are responsive 
to WSS conditions. In physiological flow conditions ECs align themselves in the flow 
direction and are in an atheroprotective state, releasing anticoagulants, antioxidants and 
vasodilators such as NO. When ECs are in regions of low WSS or high WSSG they 
switch to an atherogenic state in which they adopt a cobblestone shape in a more 
random arrangement, shown in Figure 2.4, no longer aligned with the flow and 
presenting gaps in the endothelial layer, thus encouraging cellular and lipid 
infiltration.
195,211–213
 In this form they also up-regulate inflammatory mediators, 
adhesion molecules, pro-coagulant and pro-thrombotic agents, and VSMC growth 
factors, all of which can lead to increased NIH and result in ISR.
144
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2.3 Hypoxia 
Oxygen is critical for the maintenance of arterial wall physiology and is supplied to the 
cells within the arterial wall from both the luminal blood and blood passing through 
vasa vasorum in the adventitia. The vasa vasorum generally supplies the outer two 
thirds of the arterial wall, with the inner third supplied by diffusion from the lumen.
95
 
Oxygen is transported in blood as free oxygen dissolved in plasma and oxygen 
reversibly-bound to haemoglobin within the RBCs. In the arterial wall oxygen can 
diffuse up to a maximum of 300μm, and as the thickness of the arterial wall increases 
due to the formation of atherosclerotic plaque more of the arterial wall is in danger of 
becoming hypoxic. Hypoxia can contribute in the formation of foam cells from 
macrophages in atherosclerotic lesions and also causes an increase in the secretion of 
interleukins.
20,215
 Therefore, hypoxia can influence the severity of inflammation in 
atherosclerotic lesions. Hypoxia has been associated with increased adventitial vasa 
vasorum
34
 and IH in animal studies.
216,218
 When VSMCs become hypoxic they express 
growth factors, such as VEGF and PDGF, that play a critical role in both 
neovascularisation and IH.
34
 VEGF encourages the proliferation of vasa vasorum into 
the medial layer.
216,262
 Although this proliferation of the vasa vasorum may be an 
adaptive mechanism to counteract hypoxia, it can also promote plaque rupture.
156
 When 
the endothelium is exposed to hypoxic levels of oxygen concentration in the short term 
it expresses vaso-constricting effectors which results in reversible augmentation of the 
local blood flow.
58
 However, when exposed to chronic hypoxic levels of oxygen 
concentration growth factors are expressed that result in VSMC proliferation and 
remodelling of the arterial wall, which have more lasting effects on the artery and local 
blood flow. Additionally, the growth factor expression can induce EC apoptosis which 
can increase LDL transport through leaky junctions.
252
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In terms of the augmentation of the haemodynamic environment, stenting produces a 
predominantly beneficial effect, i.e., restoration of required blood flow to downstream 
vasculature; however, locally within the stented region, the haemodynamics impact the 
natural healing processes within the arterial wall. This local augmentation of the 
haemodynamic environment due to the presence of a stent in turn affects the oxygen 
flux into the arterial wall which can result in hypoxia in some regions. Conversely, as 
mentioned earlier, Lee et al. (2001) found that rabbits treated with supplemental oxygen 
following graft-to-artery anastomosis had reduced NIH.
135
 Although, it should be noted 
that the routine use of high-flow oxygen in uncomplicated MI has been found to result 
in greater infarct size and possibly increase the risk of mortality and high oxygen partial 
pressures within blood have been found to act as a vasoconstrictor.
197,269
 Therefore, 
although there may not be any benefit in treatment with supplemental oxygen, the 
oxygen mass-transfer from the blood into the arterial wall has a crucial role to play in 
the control of NIH in arteries post stent implantation. 
2.4 Influence of Stent Design on ISR 
There are many different stents available on the market with varying strut 
configurations, thicknesses, materials, and deployment mechanisms, and in the case of 
DESs different coatings, drug types, doses and drug release kinetics. These varying 
designs produce different degrees of structural injury, foreign-body reactions and 
haemodynamic flow field alterations, which in turn affect the biological processes 
taking place within the stented artery and the resultant ISR rates. A study by Kastrati et 
al. (2001) of 3,370 patients (4,229 stented lesions) who underwent angioplasty with 
stenting using different BMS types concluded that following vessel size, stent design 
was the second strongest factor in determining the occurrence of ISR.
118
  
CHAPTER 2: In-Stent Restenosis 
 
39 
 
The structural injury caused by stent implantation to the arterial wall is assumed to be 
proportional to the stress induced within the wall, which is dependent, in part, upon the 
stent design. Self-expanding stents have been found to cause less injury to the 
endothelium than balloon-expandable stents, because only the stent struts, in contrast 
with both the struts and an expanded balloon, are in contact with the arterial wall.
90
 The 
injury caused by the balloon depends on the inflation pressure, stent geometry and 
distance between struts.
209
 Stent foreshortening upon expansion, elastic recoil,
55
 and 
deformations of the stent under flexion,
267
 have been studied using FEA and are 
hypothesised to affect the degree of injury inflicted upon the arterial wall. High stresses 
within the arterial wall can cause increased damage, and in cases of medial injury or 
lipid core penetration by stent struts there is a propensity for increased inflammation.
59
 
By reducing the number of strut-strut intersections by one third, disruption of the IEL 
and the media layer were reduced by nearly one half in a study of steel stents deployed 
in denuded rabbit iliac arteries.
207
 Several clinical studies have linked the degree of 
arterial wall prolapse between stent struts with the occurrence of ISR.
101,110,199
 The 
amount of prolapse between stent struts is also dependent on the strut spacing. 
Following implantation, a stent must also be able to withstand additional stresses placed 
upon it from vessel deformation. In the case of coronary arteries the beating of the heart 
causes slight movements and deformations of the arteries.
49–51
 Also, in peripheral 
arteries, such as the femoral, popliteal and tibial arteries, deformation is caused by the 
flexion of the hip, knee or ankle, which in some cases can cause fracture of an 
implanted stent possibly resulting in renewed injury to the arterial wall and ISR.
219
 
Therefore, not only does the stent design have an effect on the structural injury inflicted 
on the arterial wall initially, but the properties of the stent material and its ability to 
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withstand cyclic loading of the heart beating or a limb moving can also affect the 
probability of ISR occurring during the lifetime of a stent.  
The stent material also has implications for each biological process in the response to a 
foreign body. Stainless steel, used in most BMSs, is found to oxidise in the body 
causing varying degrees of cell toxicity.
270
 First-generation DES permanent polymer 
coatings were found to cause delayed healing, impaired stent-strut endothelialisation, 
and hypersensitivity reactions, which can culminate in stent thrombosis in some 
cases.
70,75,113,114,182,265
 In a study of different DESs implanted in rabbits by Joner et al. it 
was found that struts lacking endothelial coverage at 14 days showed focal aggregates 
of platelets and inflammatory cells, including foreign body giant cells.
114
 Therefore, in 
the absence of complete endothelialisation of polymeric strut surfaces increased 
inflammation and thrombus formation may result. New DES coatings such as 
phosphorycholine and the co-polymer poly(vinylidene fluoride-co-
hexafluoropropylene) mimic the phospholipids on the outer surfaces of RBCs.
151
 This 
improves the biocompatibility of the DES by masking its foreign nature. As a result of 
the observed detrimental effects of permanent polymers implanted in the body, 
biodegradable polymer coatings and completely polymer free stents are also being 
developed.
71
 
The resultant local haemodynamics created within the stented lumen are also partially 
dependent on the stent design. Thrombus formation, as mentioned previously, is heavily 
flow dependent with highest platelet deposition occurring where flow is directed 
towards the arterial wall.
56
 Monocyte adhesion rates were found to be affected by not 
only the local WSS, but also the radial component of velocity and the dynamics of the 
recirculation region and flow reattachment.
201
 Flow separation away from the arterial 
wall and recirculation zones occur both upstream and downstream of rectangular cross-
CHAPTER 2: In-Stent Restenosis 
 
41 
 
sectional stent struts. Platelets within these zones experience long particle residence 
times in proximity to activating substances, which increases their probability of 
activation. With thinner and more streamlined stent struts, the recirculation zones, and 
also consequently, the particle residence times can be reduced.
111
 WSS, WSSG and 
WSSAG within an idealised stented artery can be predicted using CFD and different 
stent designs have been shown to produce significantly different distributions of 
each.
132,133,173
 The angle that stent struts make with the primary direction of blood flow 
has been shown to strongly influence the amount of intrastrut area of the luminal wall 
exposed to low WSS.
133
 Stents with a greater final diameter than the implanted artery 
not only cause increased damage within the arterial wall, but also increase the cross-
sectional area of the stented artery, reducing the blood flow velocity and as a result 
reduce the WSS within that region. Alternatively, stent undersizing can result in stent 
strut malapposition to the arterial wall, thus increasing the resistance to flow and 
decreasing the WSS.
35
 
2.5 Summary 
The biological processes: thrombus formation, inflammation, NIH, and re-
endothelialisation, that can result in ISR are instigated, and significantly affected by, the 
damage caused by stent implantation, the presence of a foreign body and the local 
abnormal haemodynamics created within a stented artery, as summarised in Figure 2.5. 
The haemodynamics can in turn impact the oxygen transport from the luminal blood 
into the arterial wall. Analysis of the haemodynamics and the oxygen transport within a 
stented artery is warranted to elucidate beneficial stent design characteristics that may 
improve the conditions within a stented artery post-implantation. The next chapter will 
present the fundamental fluid mechanics and oxygen transport theory relevant to the 
project. 
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Figure 2.5: Summary of biological processes instigated by stent implantation that can result in ISR.                                                     
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CHAPTER 3 
Chapter 3. Fundamental Theory 
3.1 Introduction 
To study the flow of blood through, and the oxygen transport within, an artery using 
CFD, it is important to first understand the fundamental theory applicable to both and 
also how they are modelled in the CFD software. In this chapter the theory will be given 
which includes the derivation of the fluid stress tensor, the haemodynamic variables of 
interest to this study, the oxygen transport theory, and the oxygen transport variable of 
interest. Also the CFD governing equations, discretisation technique, and how the 
equations are employed in the software are presented.  
3.2 Fluid Mechanics Theory 
The fluid stress tensor, as described below, is used in the calculation of WSS and 
WSSG (Section 3.3), and the shear-rate dependent dispersion coefficient (Section 
3.4.1). To derive the fluid stress tensor consider a fluid element in a Cartesian 
coordinate system with side lengths of dx, dy and dz in the x, y, and z direction 
respectively, and analyse all the forces acting upon it, as shown in Figure 3.1. The 
forces that act on a fluid element can be classified as body forces and surface forces. 
Body forces include the forces experienced by the fluid element due to gravity, 
electromagnetic and nuclear interactions. The surface forces which the fluid element 
will be subjected to are forces normal and tangential to its surfaces that could result in 
deformation of the fluid element. Looking at a fluid element in isolation within a flow, 
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it is understood to possibly undergo four types of deformation: translation, rotation, 
linear strain and shear strain. Considering that a fluid element may be in constant 
motion within a flow, and for the purpose of the derivation of the momentum equations, 
these deformations are studied in terms of rates and a Cartesian coordinate system is 
used as shown in Figure 3.1. 
 
Figure 3.1: Fluid element in a Cartesian coordinate system with side lengths of dx, 
dy and dz, in the x, y, and z direction respectively, used for analysis of 
deformations and derivation of momentum equation. 
3.2.1 Rate of Translation 
Translation is the distance a fluid element has moved through in a certain period of 
time. The rate of translation is the velocity of a fluid element which is represented by 
the velocity vector in Cartesian coordinates: 
 u v w  V i j k  (3.1) 
where u, v and w are the velocity magnitudes in the x, y and z directions respectively, 
with i, j and k defined as the Cartesian unit vectors in these directions also. To calculate 
the translation distance after an infinitesimally small increment of time dt, the velocity 
magnitudes are multiplied by dt, i.e. udt, vdt and wdt. 
dz 
dy 
dx 
y 
x 
z 
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Figure 3.2: The relevant velocities and distances for derivation of the deformations 
imposed on a two-dimensional (2D) face of a fluid element during time increment 
dt. The 2D face is shown at time t as ABCD, and time t+dt as A’B’C’D’. 
3.2.2 Rate of Rotation 
The rate of rotation at a point, also known as the angular velocity, is the average rotation 
rate of two initially perpendicular lines which meet at that point. For simplicity, here the 
rate of rotation is derived for a 2D face on the x-y plane of a fluid element in motion 
from time t to t+dt, as shown in Figure 3.2. For the purpose of this derivation the point 
B at time t is considered along with the two initially perpendicular lines labelled as AB 
and BC. The velocity magnitudes in the x and y directions are also shown at point B. 
Because the velocities vary with position, the velocities at points A and C are slightly 
different and for clarity only the relevant velocity at both points are shown as first order 
Taylor series: u+
∂u
∂y
dy at point A and v+
∂v
∂x
dx at point C. At time t+dt the points have 
A 
B 
D 
C 
A’ 
B’ 
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all moved through certain distances as prescribed by these velocities with the 
assumption that the accelerations do not vary over such small distances within the flow. 
The four points at time t+dt are labelled as A’, B’, C’ and D’. Lines A’B’ and B’C’ 
have rotated through angles dβ in a clockwise direction and dα in a counter-clockwise 
direction, respectively, about the z-axis. The average rotation about the z-axis at point B 
is: 
  
 z
1
d d d
2
     (3.2) 
where dβ, clockwise, is defined as negative. To derive the rate of rotation the angles are 
divided by the time increment: 
 
zd 1 d d
dt 2 dt dt
   
  
 
 (3.3) 
The angles can be calculated based on the inverse tan of the opposite and adjacent sides, 
as shown in Figure 3.2. For the purpose of this derivation, the angles can be related to 
the velocity derivatives through the limits of the angles as dt→0 given as follows: 
  
 
1
dt 0
v dxdt ux
d lim tan dt
u xdx dxdt
x


 
   
   
 
 (3.4) 
  
 
1
dt 0
u dydt
y u
d lim tan dt
yvdy dydt
y


 
  
   
 
 
 (3.5) 
Substituting Equations (3.4) and (3.5) into Equation (3.3), and cancelling dt on the 
right-hand-side results in a formula for the rate of rotation about the z axis at point B: 
 
zd 1 v u
dt 2 x y
   
  
  
 (3.6) 
The rate of rotation around the x and y axis can also be derived in a similar fashion and 
are: 
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xd 1 w v
dt 2 y z
   
  
  
 (3.7) 
 
yd 1 u w
dt 2 z y
   
  
  
 (3.8) 
These angular velocities are conventionally written as ωx, ωy and ωz and collectively 
define the rate of rotation vector in the Cartesian coordinate system as: 
 
x y z  ω i j k  (3.9) 
 1 w v 1 u w 1 v u
2 y z 2 z y 2 x y
          
          
          
ω i j k  (3.10) 
By defining a new vector ζ , the vorticity of the fluid, the halves can be cancelled: 
  w v u w v u
2
y z z y x y
          
           
          
ζ ω i j k  (3.11) 
Here, the three components of the vorticity vector are recognised as the curl of the 
velocity vector V, and hence: 
 ζ V  (3.12) 
where   is the gradient operator defined as: 
 
x y z
  
   
  
i j k  (3.13) 
With this two types of flow can be defined:  
 Rotational flow where V 0   at every point, and the fluid elements move, 
deform and rotate. 
 Irrotational flow where V 0   at every point, and the fluid elements 
move, and deform, but do not rotate. 
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3.2.3 Linear Strain Rate 
Linear strain is defined as the change in length divided by the original length, and the 
linear strain rate is the rate of change of the linear strain and can be defined for each 
Cartesian direction. Referring to the line labelled BC and the deformed line at time t+dt 
B’C’ in Figure 3.2, the x component of the rate of linear strain is defined as follows: 
 
xx
u
dx dxdt dx
d ux
dt dx x
   
        
 
 
 
 (3.14) 
Conventionally, εij corresponds to the strain in the i direction and acting on the surface 
which has its surface normal vector in the j direction. For example, the notation in this 
case, εxx corresponds to the linear strain rate in the x direction which is exerted on a 
surface which is perpendicular to the direction of the strain. The corresponding rate of 
linear strain in the z and y direction can also be defined accordingly as: 
 
yy
v
y

 

 (3.15) 
 
zz
w
z

 

 (3.16) 
3.2.4 Shear Strain Rate 
The shear strain rate in 2D is defined as the average rate of decrease in the angle 
between two lines, here taken as AB and BC for the face of the fluid element parallel to 
the xy plane in Figure 3.2, which are initially perpendicular at time t. The average shear 
strain rate is defined as: 
 
xy
1 d d 1 v u
2 dt dt 2 x y
     
      
    
 (3.17) 
Likewise, the shear strain rate can be defined for the faces parallel to the yz and zx faces 
also: 
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yz
1 w v
2 y z
  
   
  
 (3.18) 
 
zx
1 u w
2 z x
  
   
  
 (3.19) 
The shear strain rate is symmetric and hence:  
 
yx xy zy yz xz zx, ,          (3.20) 
 
3.2.5 Strain Rate Tensor 
The linear strain rate and shear strain rate of the fluid element can be combined into one 
symmetric second-order tensor: 
 
xx xy xz
ij yx yy yz
zx zy zz
u 1 v u 1 u w
x 2 x y 2 z x
1 v u v 1 w v
2 x y y 2 y z
1 u w 1 w v w
2 z x 2 y z z
       
     
       
             
                           
                   
 (3.21) 
A fundamental property of symmetric tensors is that there is at least one coordinate 
system for which the off-diagonal components of the tensor are reduced to zero. For 
convenience, the coordinate system here is assumed to be coincident with the principle 
axes of the strain tensor. Therefore, the principle diagonal terms remain and the off 
diagonal terms, where i≠j, reduce to zero. Hence the strain rate tensor reduces to: 
 
1
ij 2
3
0 0
0 0
0 0
 
 
   
  
 (3.22) 
where ε1, ε2 and ε3 are referred to as the principle strain rates. 
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3.2.6 Fluid Stress Tensor 
For an infinitesimally small cubic fluid element fixed within a fluid domain, as shown 
in Figure 3.3, the total forces acting on it are composed of body and surface forces. 
Body forces consist of the forces experienced by the fluid element due to gravity, 
electromagnetic and nuclear interactions.  
In the case of surface forces, these comprise of forces due to pressure within the fluid 
that act normal to the surfaces, and the viscous forces that act tangentially and 
perpendicularly to the surfaces. For the purpose of this derivation the surfaces of the 
fluid element are assumed to be parallel with the Cartesian coordinate planes. A second 
order stress tensor is defined as: 
 
xx xy xz
ij yx yy yz
zx zy zz
   
 
     
    
 (3.23) 
where σij correspond to the stress exerted in the i direction and acting on the surface 
which has its surface normal vector in the j direction. Therefore, the diagonal terms 
where i=j represent stresses exerted in the same direction as the surface normal vector 
and when i≠j the stresses are acting tangentially to the surface, as shown in Figure 3.3. 
When the fluid is stationary the only stresses acting on the surfaces of the fluid element 
is the hydrostatic pressure and hence, the stress tensor reduces to: 
 
xx xy xz
ij yx yy yz
zx zy zz
P 0 0
0 P 0
0 0 P
     
   
         
       
 (3.24) 
where P is the pressure which acts normal to the surface and inwardly, hence the 
negative sign. 
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Figure 3.3: The nine positive stresses exerted on a fluid element. An additional nine 
negative stresses would also act on the other three surfaces of the fluid element. 
When the fluid is in motion the total stresses acting on the fluid element are comprised 
of the hydrostatic pressure stresses, as above, and also the viscous stresses. This is 
represented by the viscous stress tensor, τij , which combined with the hydrostatic 
pressure stresses gives the total stress on the fluid element as: 
 
xx xy xz xx xy xz
ij yx yy yz yx yy yz
zx zy zz zx zy zz
P 0 0
0 P 0
0 0 P
          
    
              
              
 (3.25) 
To complete the derivation of the stress tensor it is necessary to relate the viscous stress 
tensor to the previously derived strain rate tensor. To this end, the fluid is assumed to be 
incompressible and Newtonian, i.e. the viscous stress tensor is linearly proportional to 
the strain rate tensor, and isotropic. As a consequence of these assumptions the 
divergence of the velocity, .V , is zero and the dynamic viscosity, μ, is constant and 
therefore, the two tensors are related by: 
 
ij ij2    (3.26) 
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This results in a new equation for the stress tensor: 
 
ij
u v u u w
2
x x y z x
P 0 0
v u v w v
0 P 0 2
x y y y z
0 0 P
u w w v w
2
z x y z z
       
        
       
                                      
                      
 (3.27) 
Crucially, this equation allows the viscous stresses to be calculated from the velocity 
gradients and is directly applicable here to the oxygen transport model used, as 
discussed in Section 3.4.1, and also the post-processing of the results in the form of the 
WSS and WSSG, as discussed in Section 3.3. 
3.2.7 Shear Rate 
The strain rate tensor, as defined in Equation (3.21), has three invariants, one of which 
is referred to here as the shear rate and is defined by: 
 
ij ij2 :     (3.28) 
where γ̇ is the local shear rate and εij is the strain rate tensor. To find the magnitude of γ̇ 
Equation (3.28) is expanded upon, whereby the double product of the strain rate tensor 
results in: 
1
2 2 22 2 2 2
u v w u w v u w v
2 2 2
x y z z x x y y z
                   
                    
                    
 
(3.29) 
This is used in both the calculation of the non-Newtonian viscosity of blood using the 
Bird-Carreau model, as shown below, and the shear-induced dispersion coefficient, as 
described below in Section 3.4.1.  
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3.2.8 Bird-Carreau Model 
Human blood is a non-Newtonian fluid, in that its viscosity varies non-linearly 
proportionally to the shear rate being exerted on it. Blood is a shear-thinning fluid 
where the viscosity increases significantly with decreasing shear rate below a shear rate 
of 100s
-1
.
1,22,66
 This effect is modelled using the Bird-Carreau model as described by: 
 
 
  q 1 /22
0 t( ) 1


        
   
(3.30) 
where:  μ0 is the low shear dynamic viscosity  
 μ∞ is the high shear dynamic viscosity 
 λt is the time constant 
 n is the power law index 
3.3 Haemodynamic Variables of Interest 
As discussed in Chapter 2 there are certain key haemodynamic variables which are 
applicable to the assessment of stented arteries. The biological processes that are 
instigated by stent implantation, namely thrombosis, inflammation, NIH and re-
endothelialisation, are affected by the haemodynamics which take place at the luminal 
surface of the artery. In the work presented here the predicted WSS and WSSG 
distributions are analysed. The WSS vector is a measure of the viscous stresses 
imparted by the flowing blood on the luminal surface and is defined by:  
 
i ijWSS  n  
(3.31) 
This can be written as: 
 i ij 1 xx 2 yx 3 zx 1 xy 2 yy 3 zy
1 xz 2 yz 3 zz
(n n n ) (n n n )
(n n n )
              
    
n i j
k
 
(3.32) 
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where the normal vector, ni, is: 
 
i ij 1 2 3n n n    n i j k  
(3.33) 
For the purposes of CFD where the wall cell face normal vector may not be aligned 
with the Cartesian coordinate frame the normal vector is written as: 
 
i ij x y za a a    n i j k  
(3.34) 
where 
 
     
yx z
x y z
2 2 2 2 2 2 2 2 2
x y z x y z x y z
aa a
a ,a ,a
a a a a a a a a a
  
     
 
(3.35) 
and ax, ay, and az are the components of the wall cell face area in the x, y, and z 
directions respectively. 
The spatial gradient of the WSS vector with respect to the Cartesian coordinate frame 
describes the rate of change of each of the three WSS components in the three Cartesian 
directions. In reference to the study here, the rate of change of the WSS parallel and 
perpendicular to the local WSS vector is important for analysing the stent geometries, as 
mentioned in Chapter 2. Therefore, the WSSG variable adopted in this study is the 
magnitude of the rate of change of the WSS parallel (m-direction) and perpendicular (n-
direction) to the local WSS vector, as given by: 
 2 2
wm wnWSSG
m n
    
    
      
(3.36) 
where: τwm is the WSS in the m direction, i.e. parallel to the local WSS vector 
 τwn is the WSS in the n direction, i.e. perpendicular to the local WSS vector 
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Finally, for the purpose of quantifying the strength and extent of the helical flow within 
the geometries studied in Test Case 4 the helicity of the blood flow is needed. The 
kinetic helicity density is defined as: 
  kH V V    (3.37) 
As described by Morbiducci et al., this variable can be normalised with respect to the 
vorticity and velocity magnitudes resulting in the local normalised helicity (LNH):
165
 
  
 
V V
LNH cos
V V
 
  

 
(3.38) 
where θ is the angle between the velocity and vorticity vectors. The LNH is a measure 
of the alignment/misalignment of the local velocity and vorticity vectors and has a range 
of -1≤LNH≤1 where positive values are present in left-hand rotating flows and negative 
values are present in right-hand rotating flows, when viewed in the direction of the 
forward motion.
38
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3.4 Oxygen Transport Theory 
Blood consists of liquid plasma in which three types of cellular elements are suspended: 
RBCs, white blood cells and platelets. RBCs constitute about 45%, by volume, of whole 
blood and are the main carriers of oxygen. The coronary arteries act as a conduit for the 
blood to deliver oxygen and nutrients to the heart muscle downstream. Oxygen is 
critical for the maintenance of arterial wall physiology and is supplied to the cells 
within the arterial wall from both the luminal blood and blood passing through vasa 
vasorum in the adventitia.  
3.4.1 Blood Oxygen Transport 
Oxygen is transported in blood as free oxygen dissolved in plasma and oxygen 
reversibly-bound to haemoglobin within the RBCs. The concentration of free oxygen 
dissolved in plasma is quantified by the oxygen tension, i.e. the partial pressure of 
oxygen in plasma. The oxygen tension is related to the free oxygen concentration by 
Henry’s law: 
 
2
C
PO 

 
(3.39) 
where PO2 is the oxygen tension, α is the solubility of oxygen in plasma, and C is the 
concentration of free oxygen in plasma. The amount of bound oxygen contained in the 
RBCs in the form of oxyhaemoglobin is proportional to the PO2 within the surrounding 
plasma and can be approximated using the Hill equation (oxygen dissociation curve, as 
shown in Figure 3.4): 
 n
2
n n
2 2,50
PO
S
PO PO


 
(3.40) 
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where S is the ratio of oxyhaemoglobin to total haemoglobin in the RBCs (commonly 
expressed as a percentage), PO2,50 is the PO2 value at which the haemoglobin is 50% 
saturated and n is the Hill parameter.  
 
Figure 3.4: Oxygen dissociation curve for n=2.7. 
For the purpose of modelling oxygen transport in blood, difficulty arises when the 
bound oxygen is included in the model because of the non-linear nature of the Hill 
equation. When included, the transportation of both free oxygen and bound oxygen in 
the blood can be modelled using two advection-diffusion equations given as Equations 
(3.41) and (3.42) respectively:  
 
 b 2
2 . D PO r
t
PO
      
(3.41) 
 
     cHb Hb . D S r
t
     
(3.42) 
where / t  is the substantial derivative, Db is the diffusivity of free oxygen in the 
blood, r is the rate of release of oxygen from the haemoglobin, [Hb] is the total oxygen 
carrying capacity of haemoglobin in blood, and Dc is the diffusivity of oxyhaemoglobin 
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in blood. [Hb] is assumed to be constant, thus ignoring the plasma skimming layer 
which has little effect on the oxygen transport.
162
 Oxyhaemoglobin is encapsulated in 
RBCs and therefore the Dc value is interpreted as the shear-augmented dispersion 
coefficient of RBCs in blood flow. 
RBCs are present in the blood in high concentrations with approximately 5 × 109 RBCs 
per cubic millimetre of blood. Due to these high concentrations, there are continuous 
intercellular collisions and deformation of the RBCs. Through these collisions 
individual RBCs have been seen to disperse radially within the blood flow. This radial 
dispersion has been found to be proportional to the shear rate of the blood flow and also 
improves the diffusion of molecules contained within the blood. Crucially, in the case of 
oxygen transport, this radial dispersion of RBCs increases the effective diffusion of 
oxygen within the blood because of the oxygen contained within them in bound form. 
Because of the size of RBCs and the concentrations commonly found in vessels, 
quantifying the magnitude of radial dispersion has proved to be difficult. To combat the 
difficulty in the tracking of individual RBCs in blood flowing through a tube, some 
researchers have resorted to using ghost RBCs, i.e. RBCs which have had the internal 
contents, including the haemoglobin, removed through a process known as haemolysis. 
By using ghost RBCs this improves the signal-to-noise ratio of the detection equipment 
used, which allows tracer RBCs to be tracked more accurately. There is some debate as 
to the effects of haemolysis on the mechanical properties of the ghost RBCs membrane 
and, consequently, their dynamic properties when compared with RBCs.
28,80
 Therefore, 
although the majority of the studies done on the dispersion coefficient of RBCs have 
been done using ghost cells, there is a degree of uncertainty in the calculated 
coefficients relative to normal RBCs.  
CHAPTER 3: Fundamental Theory 
 
59 
 
 
Figure 3.5: Dc as extrapolated from experimental studies for the shear rates 
ranging from 1 - 500s
-1
. 
In previous studies Dc is taken as 1.5×10
-11
m
2
/s,
162
 which is the dispersion coefficient 
for red tracer cells in a straight glass tube at an approximate shear rate of 20s
-1
.
28
 Higher 
shear rates are encountered in carotid and coronary arteries and therefore, a variable 
dispersion coefficient is employed, for the first time, in this work. This was extrapolated 
from three separate studies by Goldsmith, Goldsmith and Marlow, and Cha and 
Beissinger, as described in Equations (3.43) & (3.44), with the resultant Dc plotted 
against the shear rate shown in Figure 3.5:
30,79,80
 
 
For 
10  100s 
: 
12 13
cD 5.00 10 5.00 10  
       
(3.43) 
 For 
1100s 
: 
11 13
cD 3.68 10 1.96 10  
       
(3.44) 
where   is the local shear rate, as described in Section 3.2. The two constants used in 
Equation (3.43) are deduced from RBC ghost cell experiments by Goldsmith, and 
Goldsmith and Marlow between average shear rates of 2-20s
-1
 at haematocrits of 39% 
and 40% respectively.
79,80
 The two constants used in Equation (3.44) were deduced 
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from the shear-induced particle diffusivity calculated by Cha and Beissinger at shear 
rates between 200s
-1
 and 1000s
-1
 at a RBC ghost volume fraction of 0.45 corresponding 
to the average haematocrit for a human male.
30
 It should be noted here that the model is 
therefore only applicable for haematocrits within this range because the local Dc value 
has been shown to vary with haematocrit.
139
 
 
Figure 3.6: The gradient, dS dPO2⁄ , of the oxygen dissociation curve plotted 
against PO2. 
To reduce complexity when performing numerical simulations the two advection-
diffusion equations given above can be added together to form a single equation, as 
described in Moore and Ethier:
162
 
     c
2 b 2
2
b 2
Hb Hb DdS dS
1 1
dPO D
PO
. D PO
t dPO
   
   
  
    
         
 (3.45) 
where the term dS/dPO2, as shown in Figure 3.6, is the slope of the oxygen dissociation 
curve given by:  
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2
2n n
2 2,50
2
2,50
nPOdS 1
dPO PO
PO
1
PO


  
  
   
 
(3.46) 
Given the shape of the oxygen dissociation curve, non-linearity enters the oxygen 
transport equation through this term. In order to implement Equation (3.45) in the 
commercially-available CFD software package used here it must be rearranged into the 
form: 
 
   2 2
PO
. D PO Source
t
    (3.47) 
where the diffusivity coefficient D’ and the source term {Source} are given in Equations 
(3.48) and (3.49) respectively:  
 
   c
b
b 2 2
Hb HbD dS dS
D' D 1 1
D dPO dPO
    
            
 (3.48) 
      
2
c
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b 2 2
2
2
Hb HbD dS dS
Source D 1 1
D dPO dPO
Hb dS
PO .
dPO
    
 
 
      
  
 
   
 
(3.49) 
Equations (3.47) - (3.49) represent the complete non-linear blood oxygen transport 
model, referred to herein as Model 1, which incorporates both the free oxygen and 
bound oxygen. 
3.4.1.1 Simplifications of the Blood Oxygen Transport Model 
Previous studies have used simpler models in order to reduce computational expense. 
Firstly, the non-linearity can be removed by replacing dS dPO2⁄  with a constant mean 
value of  dS dPO2⁄̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅  calculated as follows:
162
 
 
 
2 2
dS nS
1 S
dPO PO
 
  
 
 
(3.50) 
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where PO2̅̅ ̅̅ ̅ is a mean reference value fixed at 75mmHg and replaces PO2 in the Hill 
equation in order to evaluate S̅, as shown in Equation (3.51): 
 n
2
n
n
2 2,50
PO
S
PO PO


 
(3.51) 
Secondly, the dispersion of the RBCs can be ignored by setting Dc=0, and finally, the 
bound oxygen can be completely disregarded by setting [Hb]=0.  
Similar to the study by Moore and Ethier (1997) the following five models were 
employed as described below and summarised in Table 3.1: 
Model 1: Both the free and bound oxygen are modelled and the non-linearity of the Hill 
equation is retained. 
Model 2: Both the free and bound oxygen are modelled and the non-linear element, 
dS dPO2⁄ , is replaced with the constant value dS dPO2⁄̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅  evaluated using Equation (3.50). 
Model 3: Both the free and bound oxygen are modelled and the non-linearity of the Hill 
equation is retained, but Dc=0 , thus neglecting the shear-augmented dispersion of 
RBCs. 
Model 4: Both the free and bound oxygen are modelled and the non-linear element, 
dS dPO2⁄ , is replaced with the constant value dS dPO2⁄̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ , and Dc=0. 
Model 5: Only the free oxygen is modelled, i.e. [Hb]=0. 
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Models Free O2 Bound O2 Dc dS dPO2⁄  
1 Y Y Eqn. (3.43 & 3.44) Eqn. (3.46) 
2 Y Y Eqn. (3.43 & 3.44) 0.00184 mmHg
-1 
3 Y Y 0 m
2
/s Eqn. (3.46) 
4 Y Y 0 m
2
/s 0.00184 mmHg
-1
 
5 Y N - - 
Table 3.1: Summary of simplifications adopted for the blood oxygen transport 
models. 
3.4.2 Arterial Wall Oxygen Transport 
As previously discussed, the arterial wall consists of three layers: the intima, media and 
adventitia. In this study only the two inner layers, i.e. the intima and media, are included 
in the arterial wall models, because the adventitia is supplied with oxygen through the 
vasa vasorum, with distinct transport parameters assigned to each based on a study by 
Richardson.
206
 In this study, the convection by the interstitial fluid in the arterial wall is 
ignored as the convective velocity of interstitial fluid is two orders of magnitude lower 
than the diffusive velocity.
162
 It is also assumed that the endothelial cells lining the 
artery offer no resistance to the oxygen transport,
237
 and as oxygen diffuses through the 
arterial wall it is consumed by the cells within.
252
 The consumption rate of oxygen 
within the wall can be affected by a number of different variables, e.g. thickness of 
arterial wall, presence of inflammation/atherosclerotic plaque, subject species and 
age.
206
 For the purposes of this study the Michaelis-Menten Kinetics model was 
employed to model the oxygen consumption within the arterial wall: 
 
2
0
2 2,M
PO
M M
PO PO


 
(3.52) 
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where M is the consumption rate of oxygen, M0 is the maximum consumption rate and 
PO2,M is the value of PO2 at which the rate of reaction is half-maximal.
200
 The resultant 
diffusion equation employed for the prediction of the transport of oxygen in the arterial 
wall is: 
 
 2 T 2
T
dPO M
. D PO
dt
  

 
(3.53) 
where DT is the diffusivity of oxygen and αT is the solubility of oxygen in the arterial 
wall tissue. Unless otherwise stated the values listed in Table 3.2 are used for the 
parameters in all simulations and the boundary conditions are given at the end of each 
test case description. 
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Symbol Units Blood Intima Media Reference 
α mlO2/mlblood/mmHg 3.0×10
-5
 - - 
198
 
Db m2/s 1.2×10
-9
 - - 
162
 
[Hb] ml O2/ml blood 0.2 - - 
198
 
PO2,50 mmHg 26 - - 
162
 
n - 2.7 - - 96 
DT m
2
/s - 0.9×10-9 1.05×10-9 
206
 
αT mlO2/mltissue/mmHg - 2.4×10
-5
 2.4×10-5 
206
 
M0 mlO2/mltissue/s - 2.1×10
-5
 1.21×10-5 
206
 
PO2,M mmHg - 1 1 
78
 
Table 3.2: List of parameter values used for the blood and arterial wall oxygen 
transport model. 
3.4.3 Sensitivity Analysis 
Of the values listed in Table 3.2 α, Db, and [Hb] are constant in human blood; although, 
in reality there is some variability in the other parameter values,
198
 except for the 
solubility of oxygen in the media layer tissue, αT, media, which is considered to be fixed 
because the cellular composition of the media does not vary extensively for the arteries 
assessed here.
206
 To assess the impact of variability of the other values on the oxygen 
transport a sensitivity analysis was carried out whereby a simplified straight coronary 
artery segment was modelled as shown in Figure 3.7. The radius of the lumen was 2.70 
mm and the thickness of the intima and media were 0.24 mm and 0.32 mm, 
respectively. Model 1, as defined in , was used to model the oxygen transport with 
boundary conditions as follows: PO2,in=100 mmHg, PO2,adventitia=45 mmHg, PO2,out=0 
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mmHg. An entry region was placed at the inlet to allow for development of the flow 
with a zero oxygen flux boundary condition placed on the luminal wall surface.  
Each parameter was assessed separately and varied according to minimum and 
maximum values as listed in Table 3.3 while all other values were fixed at the values 
defined in Table 3.2. Additionally, two other simulations were carried out where, first, a 
fixed Dc value of 1.5×10
-11
 m
2
/s was used, as adopted by Moore and Ethier (1998),
162
 
and second, intima layer properties were set which represented a high fat content in line 
with a late-stage atherosclerotic plaque lesion, although the thickness was not increased. 
To represent the effect of varying the parameter value in one number the difference 
between the test and standard minimum PO2 value predicted in the intima domain is 
shown in Figure 3.8.  
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Figure 3.7: (a) Geometry and domain set up used for sensitivity analysis, (b) mesh 
employed and (c) typical contour plot of PO2 along a slice within the lumen, 
intima, and media. 
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Parameter Value used Min Max 
PO2,50 26.6 23.1 30.6 
n 2.7 1.7 3.2 
DT, intima 0.9×10
-9
 0.72×10-9 0.9×10-9 
DT, media 1.05×10
-9
 0.75×10-9 1.05×10-9 
αT, intima 2.4×10
-5
 2.4×10-5 3.8×10-5 
M0, intima 2.1×10
-5
 1.68×10-5 2.9×10-5 
M0, media 1.21×10
-5
 1.21×10-5 1.89×10-5 
PO2,M 1 0.5 1 
Table 3.3: List of parameter values that were assessed for the sensitivity analysis. 
For each parameter the value used in the Test Cases 1, 2, 3 & 4 is given along with 
the minimum and maximum values possible in the human vasculature. 
3.4.3.1 Results of Sensitivity Analysis 
The oxygen dissociation curve is affected by several factors: blood temperature, pH, and 
carbon dioxide concentration, and is defined by two values: the PO2,50 and n. PO2,50 is 
the PO2 value at which the haemoglobin within the RBCs is at 50% saturation.
88
 The 
typical value within the arterial system is 26.6 mmHg, although it can vary depending 
on the pH of the blood which is affected by the amount of carbon dioxide (CO2) 
dissolved in the blood. This is known as the Bohr effect and is actually useful in the 
body because when CO2 dissolves in the water within the blood carbonic acid is formed 
and the pH of the blood decreases resulting in the haemoglobin exhibiting less affinity 
for oxygen, thus releasing oxygen to tissues most in need of oxygen that are producing 
the CO2 as a waste product.
174
 The effects of changes in the partial pressure of CO2 and 
pH in blood on PO2,50 was assessed by Hamilton et al. (2004),
88
 and the minimum and 
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maximum PO2,50 values shown in Table 3.3 correspond to the range observed and are 
taken here as 23.1 mmHg and 30.6 mmHg, respectively. As can be seen in Figure 3.8 
the variation of PO2,50 has a small effect on the oxygen transport with a slightly 
increased amount of oxygen reaching the intimal tissue in the case when PO2,50 is 
minimum and the opposite with PO2,50 in maximum. 
 
Figure 3.8: Variability in minimum PO2 within the intima domain with respect to 
standard case. 
Conversely, n is shown to have a significant effect on the amount of oxygen reaching 
the arterial wall as shown by a significant increase in the minimum PO2 in the intima. 
This can be explained by the considerable increase in the slope of the dissociation 
curve, dS dPO2⁄ , when n=3.2 which means that for a small change in PO2 there is a 
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large change in S. Therefore, the oxygen transport is sensitive to small changes in the n 
value. 
In the case of DT, intima the minimum value of 0.72×10
-9
 m
2
/s, which corresponds to the 
lower diffusivity experienced in a six month old baby’s intima, has an almost negligible 
effect on the oxygen transport into the arterial wall, as shown in Figure 3.8. DT, media has 
a more noticeable effect with the minimum value of 0.75×10
-9
 m
2
/s, which likewise 
corresponds to the lower diffusivity experienced in a six month old baby’s media, 
exhibiting a drop in the minimum PO2 value in the intima of 5.77 mmHg. The standard 
values of both DT, intima and DT, media are both the maximum values recorded in the 
literature which do not vary significantly throughout the life of the arterial wall even in 
the presence of a lesion.
206
 
The maximum value of αT, intima, which represents the predicted solubility in an intima 
with a high fat and calcium content, i.e. with a significant plaque lesion present,
206
 
produces a significant change in the minimum PO2 levels within the intima with an 
increase of 12.36 mmHg, as shown in Figure 3.8. This may on initial inspection appear 
to mean that the presence of a plaque lesion in the intima produces a positive outcome 
in terms of oxygen transport, but it should be noted that this simulation assumes 
everything else remains equal which it would not in the case of a plaque lesion with the 
consequence of increased intimal thickness increasing the diffusion distance and 
eventually resulting in a necrotic plaque core. Nevertheless, αT, intima does have a 
significant effect on the oxygen transport.  
In the case of M0, intima this shows the largest effect on the oxygen transport into the 
arterial wall, as shown in Figure 3.8, with maximum value producing a drop in the 
minimum PO2 value of 15.78 mmHg, and the minimum value of M0, intima producing an 
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increase of 7.11 mmHg. The maximum value of M0, intima corresponds to the value 
predicted by Richardson (2008) in a 24 year old human with no plaque lesion present.
206
 
Also noted in that study was that the oxygen consumption is predicted to decrease over 
time in human arterial wall free of atherosclerosis. As such, the minimum M0, intima value 
corresponds to the value predicted in a 70 year old with an 88% stenosis. It should be 
noted again that this simulation assumes everything else remains constant including the 
intimal thickness. However, it is clear that M0, intima has a significant impact on the 
oxygen levels in the arterial wall. Likewise, the maximum value of M0, media also 
produces a predicted decrease of 9.79 mmHg in the minimum PO2 value; however, it 
should be noted that this value is theorised to only exist in a 6 month old baby.
206
 The 
PO2, M minimum value of 0.5 mmHg is shown to have an almost negligible effect on the 
oxygen levels, as would be expected considering the standard value used is 1 mmHg. 
To demonstrate the effect of including a variable shear-induced dispersion coefficient, 
Dc, a simulation was run with Dc=1.5×10
-11
 m
2
/s. As shown in Figure 3.8, by ignoring 
the increase in Dc caused by the higher shear rates experienced in coronary arteries there 
is a significant decrease of 20.65 mmHg in the predicted minimum PO2 value within the 
intima. This provides an initial support for the use of a variable Dc value and shows one 
disadvantage of simplification of the blood oxygen transport model. 
Finally, a simulation was carried out to assess the effects of combining the two relevant 
consequences of the presence of a 88% stenosis, i.e. an increased αT, intima value of 
3.8×10
-9 mlO2 mltissue⁄ mmHg⁄  and a decreased M0, intima value of 1.68×10
-5 
mlO2 mltissue⁄ s⁄ . This is predicted to have a positive effect with a significant increase 
of 16 mmHg in the minimum PO2 value in the intima shown in Figure 3.8. This is again 
with the stipulation that the increased intimal thickness is not factored in, but 
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demonstrate how the plaque lesion properties could potentially affect the PO2 levels in 
the arterial wall.  
3.5 Oxygen Transport Variable of Interest – Sherwood Number 
The Sherwood number (Sh) is a dimensionless mass-transfer coefficient and is used in 
Test Cases 2 and 3, discussed in Chapter 6, along the luminal surface using:  
 
 
2
2,in 2,w
dPO
Dia
dn
Sh = -
PO - PO
 
 
   
(3.54) 
where Dia is the diameter of the artery, dPO2/dn is the gradient of PO2 normal to the 
wall, PO2,in is the PO2 set at the inlet and PO2,w is the PO2 predicted at the arterial wall 
luminal surface. Low Sh highlights potential areas on the luminal surface where the 
underlining cells may be in danger of hypoxia. To establish what constitutes low Sh the 
Damkholer number (Da), a dimensionless reaction rate coefficient, is first calculated 
using: 
 
0
T 2,iT n
M TDia
Da =
α D PO
 (3.55) 
where T is the arterial wall thickness. Using the assigned parameters for the coronary 
artery models presented here the calculated Da≈17. When Sh≫Da the supply exceeds 
the demand within the arterial wall; however, as Sh→Da  the PO2 levels become 
increasingly dependent upon the blood oxygen transport.
252
 Therefore, as the Sh drops 
towards this calculated value of Da the PO2 levels within the arterial wall will decrease 
to possible hypoxic levels. 
3.6 Computational Fluid Dynamics 
All simulations for this study were carried out in the commercial CFD software ANSYS 
CFX 15.0 (ANSYS Inc., Canonsburg, PA, USA) which uses an element-based finite 
volume method. ANSYS CFX makes the assumption of a continuum medium where the 
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fluid is assumed to be evenly distributed throughout the domain. The information 
presented here is adapted from the ANSYS Theory Guide with additional information 
from books on the topic as referenced throughout.  
3.6.1 Governing Equations 
CFD is based on three fundamental governing equations of fluid dynamics: the 
continuity, momentum and energy equations, which are based on three physical laws: 
1. Continuity equation – mass is conserved, i.e. Law of Conservation of Mass 
2. Momentum equation – net force on a body is equal to the mass of the body 
multiplied by the acceleration, i.e. Newton’s Second Law 
3. Energy equation – energy is conserved, i.e. Second Law of Thermodynamics 
The energy equation is neglected in this instance as the process taking place is assumed 
to be adiabatic and no mechanical energy is exchanged. If the flow is assumed to be 
incompressible; i.e., there is no change in density, the continuity and momentum 
equations in Cartesian coordinates can be presented as: 
 0 V  (3.56) 
 
ij bf
t
 
     
 
V
V V
 
(3.57) 
The left hand side of Equation (3.57) represents the density multiplied by the 
acceleration of the fluid element and the right hand side is the sum of all the forces 
acting on the fluid element. Within the first term on the right σij represents the stress 
tensor, as derived earlier in Section 3.2.6, and fb represents the body forces exerted on a 
fluid element, which in this case is assumed to only consist of the force due to gravity, 
ρg. In accordance with Equation (3.25), the first term on the right of Equation (3.57), 
∇ ∙ σij , becomes (-∇P+∇∙(μeff∇V)) for a Newtonian fluid, where μeff is the effective 
viscosity. Thus, the momentum equation is expressed as: 
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   effP
t
 
         
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V
V V V g
 
(3.58) 
Equation (3.58) is known as the Navier-Stokes equation and can be expressed in the 
form of the transport (advection-diffusion) equation, Equation (3.59). The transport 
equation is also used for modelling the transport of a passive scalar, such as PO2. 
 
 eff
advection diffusion source
transient
S
t

 
 
      
  
 
V
 
(3.59) 
where φ is the conserved variable, Гeff is the effective diffusivity and Sφ is the source 
term. Each of the terms in the transport equation represent a different component of the 
overall transport of the conserved variable as signified by the notation under each. The 
first term, 
∂φ
∂t
, is called the transient term and represents how the conserved variable 
changes with time. The second term, V , is the advection term and describes how 
the conserved variable is affected by the velocity of the fluid. The third term, 
 eff   , is the diffusion term and describes how the conserved variable is affected 
by diffusion due to gradients in values between neighbouring control volumes. In the 
case of the Navier-Stokes equation V is the conserved variable, μeff (dynamic viscosity) 
is the effective diffusivity and the source term is the sum of the pressure and gravity 
forces. In the case of the transport of PO2, D’ is the effective diffusivity and the source 
term is as described in Section 3.4.1.  
3.6.2 Discretisation 
As mentioned previously, ANSYS CFX uses an element-based finite volume method 
and in order to solve the governing equations they need to discretised according to this 
method. Firstly, the computational domain is spatially discretised into control volumes 
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using a mesh. The mesh is comprised of nodes, where all solution variables and fluid 
properties are stored, and these are surrounded by the control volumes. A control 
volume is formed around a node by joining the centre points of all the surrounding mesh 
elements and edge midpoints, as shown in a basic 2D mesh in Figure 3.9. Once the 
computational domain is spatially discretised the governing equations are integrated 
over each control volume. Taking the general transport equation, Equation (3.59), as 
representative of all three governing equations, it can be integrated over the control 
volume as follows: 
 
     eff
v v v v
dv dv dv S dv
t


        
   
V
 
(3.60) 
where v denotes the volume. Using the divergence theorem the second and third terms 
can be converted from volume integrals to surface integrals: 
 
     eff
v s s v
dv nds nds S dv
t


        
   
V
 
(3.61) 
where n represents the surface normal vector. The surface integrals represent a 
summation of all the fluxes crossing the boundaries of the individual control volumes 
and the volume integrals represent source or accumulation terms. Once these integrals 
have been derived they must be numerically discretised, essentially replacing each 
integral with an algebraic equation. 
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Figure 3.9: Sample 2D mesh with control volume defined around node. 
Looking at Equation (3.61) there are four terms, two of which have volume integrals 
and two of which have surface integrals. Volume integrals are discretised within each 
element sector and then the total for each control volume is a summation of all the 
sector values within that control volume. The surface integrals are discretised at 
integration points, located at the midpoint of sector edges as shown in Figure 3.10, and 
then distributed to the adjacent control volumes. The surface integrals are equal in 
magnitude and opposite in sign for the two control volumes to which they are 
distributed to. 
Element centre 
Element 
Control Volume 
Node 
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Figure 3.10: 2D Mesh element taken from Figure 3.9 with integration points and 
element sector highlighted. 
The transient term in Equation (3.61) is a volume integral and discretising it using the 
second-order backward Euler method results in the algebraic equation: 
 
       
n n 1 n 2
v
v 3 1
dv 2
t t 2 2
   
          

 
(3.62) 
where v represents the control volume, ∆t is the time step, and the superscripts n, n-1 
and n-2 represent the current, previous and second previous time steps respectively. The 
advection term in Equation (3.61) is a surface integral and is discretised as the sum of 
fluxes over all the faces of the control volume: 
 
   
a
ipips
ip 1
ds ds

      V n V n
 
(3.63) 
where ds V n  represents the mass flow rate normal to the control volume face 
containing the integration point (ip) and φip is the conserved variable at that integration 
point (total number of integration points represented by a). The solution variables are 
Element Sector 
Element Centre Integration Points 
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stored at the nodes and therefore, the face values are approximated at the integration 
points using: 
 
ip up   r  
(3.64) 
where φup is the value of the conserved variable at the node directly upwind from the 
integration point, β is the blend factor, ∇φ is the gradient of the conserved variable and 
r is the vector from the upwind node to the integration point. The high resolution 
scheme was implemented in all simulations herein, for which 0≤β≤1 and a nonlinear 
recipe is used to calculate β at each node based on the boundedness principles used by 
Barth and Jesperson.
8
 The gradients of conserved variable is calculated using shape 
function which are linear in terms of the parametric coordinates. The diffusion term is 
also a surface integral and is approximated as: 
 
   
a
eff eff
s
ip 1
ds ds

       n n
 
(3.65) 
The source term is a volume integral and is approximated as follows: 
 
v
S dv S v   (3.66) 
where S̅φ is the average value of the source term within the control volume and v is the 
volume of the control volume. When all four terms are discretised the resultant equation 
is: 
         
a a
n n 1 n 2
ip effip
ip 1 ip 1
v 3 1
2 ds ds S v
t 2 2
 

 
 
                
 V n n
 
(3.67) 
By putting the diffusion term on the right hand side, the equation becomes: 
         
a a
n n 1 n 2
ip effip
ip 1 ip 1
v 3 1
2 ds ds S v
t 2 2
 

 
 
                
 V n n (3.68) 
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When this equation is applied to all control volumes throughout the computational 
domain all of the algebraic equations can be combined into a matrix of the form: 
     A b 
 
(3.69) 
where [A] represents the sparse coefficient matrix, [φ] is the solution vector containing 
the variable values at the nodes and [b] is the right hand side of Equation (3.68). 
3.6.3 Solution 
The discretised algebraic equations are solved in ANSYS CFX using an implicitly 
coupled multigrid accelerated incomplete lower upper factorisation technique. This is an 
iterative technique that involves the solution converging towards an exact solution over 
the course of numerous iterations. The multigrid process comprises of early iterations 
being solved on a fine mesh and later iterations being solved on progressively courser 
virtual meshes.
4
 The results are then transferred from the coarsest mesh back to the 
original fine mesh. This technique has the advantage of decreasing the time taken to 
reach a converged solution.  
Looking at Equation (3.69) above, the solution is reached by first using an approximate 
solution of φ, φn, and improving this by a correction, φ’, which results in the solution 
after a time step, φn+1, being closer to the exact solution, where: 
 n 1 n '   
 
(3.70) 
The correction term is calculated using: 
 nA ' r 
 
(3.71) 
where r
n
 is the residual of the previous time step calculated using: 
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 n nr b A  
 
(3.72) 
The residuals are normalised for monitoring the solution and setting the convergence 
criteria. 
3.7 Summary 
In this chapter the fundamental theory relevant to the study was presented. First, the 
derivation of the fluid stress tensor was shown along with the haemodynamic variables 
of interest to this study. Second, the oxygen transport theory relevant to both the blood 
and the arterial wall was described along with the oxygen transport variable of interest, 
Sh. The results of a sensitivity analysis of the oxygen transport model were presented 
with variation of several parameters shown to have a significant effect on the amount of 
oxygen reaching the arterial wall. Specifically, the Hill coefficient (n), the solubility of 
oxygen in the intima (αT, intima), and the consumption of oxygen in both the intima (M0, 
intima) and media (M0, media) all play a dominant role in the oxygen transport. These also 
are the parameters that would vary the most in diseased arterial walls and their effects 
were previously assessed by Richardson (2008); however, the luminal oxygen transport 
was ignored with a constant PO2 value fixed on the luminal surface.
206
 The effect of 
using a constant Dc value of 1.5×10
-11
 m
2
/s as done previously by other researchers was 
assessed and showed to have a significant effect on the oxygen transport in coronary 
arteries where the shear rates are much higher than the shear rate where the fixed Dc 
value is valid, i.e. 20 s
-1
. Finally, the CFD governing equations, discretisation technique, 
and how the equations are employed in the software was presented. In the next chapter a 
thorough review of the literature particular to this study is discussed. 
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CHAPTER 4 
Chapter 4. Literature Survey 
4.1 Introduction 
In this chapter literature reviews of previous studies in the areas of oxygen transport in 
arteries and haemodynamic analysis of stents are presented. In addition to this, with 
specific relevance to Test Case 4, a thorough review of helical flow in the 
cardiovascular system is given along with the studies related to two stent devices being 
developed that not only re-establish blood-flow in an obstructed artery but establish 
haemodynamics that theoretically inhibit ISR. 
4.2 Oxygen Transport Analyses 
The biological processes that can result in ISR are instigated by the effects of stent 
implantation and include structural damage to the arterial wall, augmentation of the 
local haemodynamic environment and the presence of a foreign body.
171
 In terms of the 
augmentation of the haemodynamic environment, stenting produces a predominantly 
beneficial effect, i.e. restoration of required blood flow to downstream vasculature; 
however, locally within the stented region, the haemodynamics impact the natural 
healing processes within the arterial wall. This local augmentation of the haemodynamic 
environment due to the presence of a stent in turn affects the oxygen flux into the 
arterial wall which can result in a deficiency of oxygen, known as hypoxia, in some 
regions. Hypoxia has been associated with increased adventitial vasa vasorum
34
 and IH 
in animal studies.
216,218
 Therefore, given that hypoxia and increased IH may result in 
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ISR, investigation of the local oxygen transport within stented artery models using CFD 
is important in order to elucidate the effects of stenting on the arterial wall cellular 
components and also to aid in the design of future coronary stents. 
Hypoxia is known to cause atherosclerosis in large arteries.
252
 Because of this, the 
majority of numerical studies of oxygen transport in three-dimensional (3D) arteries 
have been in relation to arteries with no implanted device. Many of these numerical 
studies fall into the category of wall-free models where only the oxygen transport in the 
blood is modelled and a constant value of oxygen concentration/PO2 value is specified 
on the luminal surface.
45
 Another category of oxygen transport studies employs fully 
coupled blood and arterial wall models, where diffusion and consumption of oxygen in 
the arterial wall are modelled, and a constant flux or concentration/PO2 value boundary 
condition is specified on the media/adventitia boundary interface.
23,248
 These models 
offer the advantage of a more realistic representation of the oxygen transport conditions; 
however, in these simulations the arterial wall was modelled as homogeneous which is 
not physiologically correct. In contrast, a third analysis type is lumen-free models which 
ignore the haemodynamic conditions within the lumen and assume a constant oxygen 
concentration/PO2 value on the luminal surface. As an example, Richardson modelled 
the oxygen transport within heterogeneous coronary arterial walls only, with varying 
parameters according to age and stenosis, while ignoring the flow within the lumen.
206
 
Considering the influence of haemodynamics on the oxygen transport into the arterial 
wall, the wall-free and coupled analyses are discussed below. 
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4.2.1 Wall-Free Analyses 
Wall-free models are the simplest models as they just account for the mass transport 
within the blood. The effects of the transport into the arterial wall are accounted for by 
applying an appropriate set of boundary conditions. In oxygen mass transport studies 
this is generally a PO2 value of 60mmHg, or equivalent in concentration/normalised 
concentration values, being imposed on the luminal surface. This simplification 
essentially ignores the oxygen consumption and diffusion in the arterial wall and is used 
when the study of the haemodynamic effects are preferred. In these cases the Sh is 
valuable as it can be calculated based on the spatial gradient of the PO2 normal to the 
wall surface. For interpretation of the Sh there are three different scenarios where the 
flow is: directed towards the wall, flowing parallel to the wall, and directed away from 
the wall. In case (1), the mass transport boundary layer (MTBL) is relatively narrow 
which results in a high PO2 gradient normal to the wall and consequently a high Sh. In 
case (2), the MTBL is free to develop and will gradually increase until a constant 
thickness is reached. For the PO2 gradient and Sh this results in a gradual transition 
from high values to low values longitudinally along the wall. In case (3), a relatively 
thicker MTBL is created and consequently, both the PO2 gradient and the Sh are 
reduced. Areas of low Sh are then interpreted as areas which are prone to hypoxia 
occurring in the underlying tissue and possibly increased IH and atherosclerosis.  
One of the earliest numerical studies of oxygen transport in arteries was carried out by 
Friedman and Ehrlich and published in 1975.
64
 They modelled the oxygen transport in a 
2D arterial bifurcation in steady flow conditions and analysed the effects of spatial 
variations in shear on the oxygen flux to the wall. It was found that there was as much 
variation in the wall flux and concentration values as there was in shear. In a study 
published in 1977 Back et al. examined the oxygen transport in 2D representations of 
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partially obstructed human coronary arteries and found that the oxygen flux into the 
arterial wall was reduced in the flow separation region downstream of plaque locations.
5
 
One of the recommendations of this study was that in vivo measurements with oxygen 
microelectrodes in animals were needed to learn more about the variations in oxygen 
transport in plaque regions. Two such studies carried out by Santilli et al. in 1995 and 
2000 are used in Test Case 1 and 2 (Chapters 6 and 7) to compare the transport models 
adopted in this work.
217,218
  
In terms of 3D studies, Rappitsch et al. (1997) presented a numerical scheme for the 
simulation of unsteady flow and mass transport in large arteries where the flow is 
unsteady and the resistance of the arterial wall to transmural transport is governed by a 
shear-dependent wall permeability model.
204
 The methodology is demonstrated in a 90° 
arterial bend and the key observation noted is that the mass transfer flux is reduced on 
the inner wall of the bend, which is critical in the modelling of not only oxygen 
transport, but also of macromolecules such as LDLs and albumin. The shear-dependent 
wall permeability model adopted was noted to not be valid for oxygen transfer through 
the wall, but it would be important for future studies in the mass transport of 
macromolecules such as albumin or LDL.
204
 
In the same year Ma et al. (1997) published a study where they conducted a 3D 
simulation of steady flow and oxygen transport in an idealised carotid bifurcation with a 
constant PO2 value imposed at the arterial wall surface and predicted the oxygen flux 
distribution over the inner wall surface.
142
 The geometry used was based on 
measurements of biplanar angiograms of 57 patients by Bharadvaj et al. (1982a, b)
15,16
 
which were also used in studies by Tada and Tarbell, discussed below.
248,249
 The mass 
transfer was found to be five times lower along the outer wall of the carotid sinus in 
comparison with the arterial wall immediately upstream or downstream of the sinus. 
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Areas of predicted low mass transfer was found to correlate strongly with areas prone to 
intimal thickening in humans, as shown in Figure 4.1. This study was important in that 
it supported the relatively new hypothesis put forward by Simanonok in 1996 that non-
ischemic hypoxia of the arterial wall is the primary cause of atherosclerosis.
231
 This 
hypothesis was proposed to replace the dominant model of atherosclerosis at the time 
which was the response-to-injury hypothesis which was originally proposed by Ross 
and Glomset in 1976.
210
 This is a reoccurring theme in CFD simulations, in that there 
are assumptions made throughout the process including in geometry generation which 
affect the perceived accuracy of the simulations.  
 
Figure 4.1: Low mass transfer rate is directly related to measured intimal 
thickness with a correlation coefficient of 0.944. Thus, low mass transfer may be an 
indication of plaque localisation and atherogenic growth.
142
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Qiu and Tarbell (2000) modelled the oxygen mass transfer in a compliant curved tube 
model of a coronary artery.
202
 In this study they modelled the movement of the coronary 
artery arterial wall as predicted would occur due to the motion of the heart. In this study 
the curvature of the coronary artery caused a difference between the Sh value on the 
inner and outer, in terms of the centreline curvature, luminal surface of several 
magnitudes which implied that the oxygen content of the arterial wall could be limited 
by the flow conditions in this region. Interestingly, the effects of the movement of the 
coronary artery caused by the motion of the heart on the results was not discussed by 
the authors. In this study the authors neglected the bound oxygen transport and reasoned 
that the Sh with the bound oxygen would be 2.5 times the predicted Sh without the 
bound oxygen. This assumption is based on the results from the paper by Moore and 
Ethier (1997) which compared five different models, similar to the models discussed in 
Chapter 3. The validity of this assumption will be revisited in Chapter 9.  
These results from Qui and Tarbell (2000) were found to be in agreement with a 
separate study by Kaazemput-Mofrad and Ethier (2001) analysing the oxygen transport 
within an anatomically realistic human RCA.
116
 The results of this study showed how 
the oxygen concentration field within the RCA closely followed the primary and 
secondary flow features. The secondary flow features mentioned are two Dean vortices 
which are formed due to the curvature of the RCA centreline. As the flow develops 
further one vortex becomes more dominant and as a result the concentration field is 
pulled away from the inner wall leaving a zone of reduced oxygen concentration near 
the inner wall. The importance of the secondary flow structure is a reoccurring issue in 
the study of oxygen mass transport and will be elaborated on later. In this study the Sh 
was found to vary by 800 fold from the inner to the outer wall of the curved RCA; 
however, it was noted that with the addition of flow pulsatility and diameter reduction 
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of the artery, this may be reduced to 23 fold. In comparison with the study by Qui and 
Tarbell, the range of Sh was smaller and this was deemed to have been caused by the 
enhanced mixing produced in a more realistic geometry.
116
  
 
Figure 4.2: Velocity and concentration profiles in the non-symmetric stenosis 
model.
117
 
In 2005 Kaazempur-Mofrad and Ethier published a study where they analysed the 
difference in terms of oxygen transport within a coronary artery partially obstructed by 
axisymmetric and asymmetric plaque lesions, as shown in Figure 4.2.
117
 This again was 
a wall-free model where the oxygen concentration was fixed on the arterial wall luminal 
surface and the flux was analysed using the local Sh. The results indicated that there is a 
considerable difference in mass transfer patterns between both models, concluding that 
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accurate representations of the arterial geometries is essential in order to predict the 
mass transfer in partially obstructed arteries. 
Kolandavel et al. (2006) modelled both the LDL and oxygen mass transport in an 
idealised moving coronary artery model under both steady and pulsatile flow 
conditions.
124
 A physiological velocity profile was imposed at the inlet and the 
curvature of the artery was varied according to a sinusoidal waveform over the period of 
a cardiac cycle. In comparison with the steady flow simulation, the pulsatility was found 
to decrease the oxygen flux to the inner wall. Conversely, with the addition of wall 
motion an increase in oxygen flux in the distal region of the inner wall was observed. 
Overall the oxygen wall flux was found to not vary appreciably over the course of a 
cardiac cycle. 
Tada and Tarbell (2006) modelled the oxygen transport in a compliant carotid 
bifurcation model with realistic blood flow waveforms and PO2=0mmHg imposed on 
the luminal surface.
250
 As with previous papers, the Sh was used to quantify the oxygen 
flux into the arterial wall. A region of low Sh was predicted on the outer wall of the 
carotid sinus where the flow separates away from the wall. Therefore, it was concluded 
that flow separation provides a very strong haemodynamic barrier to oxygen transport. 
Dramatic differences in the Sh were seen during the cardiac cycle between the 
compliant model and rigid model; however, crucially, these transient differences did not 
translate into significant differences in the time-mean Sh, as shown in Figure 4.3. 
Additionally, the time-mean Sh values did not show considerable difference with the 
transient models. Thus, neglecting the compliance of the arterial wall and the pulsatility 
of the flow in simulations of oxygen transport in arteries is justifiable.  
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Figure 4.3: Profiles of the time-mean Sh along the outer wall of the common 
carotid artery and internal carotid artery, the outer wall of the CCA and external 
carotid artery, and the periphery of the ICA sinus for three different 
haemodynamic models: transient with compliant arterial walls (elastic mean), 
transient with rigid walls (rigid mean) and steady state with rigid walls (steady) 
from Tada and Tarbell (2006).
250
 
Although slightly off topic, in terms of simulating oxygen transport in arteries, a 2D 
study by Zierenberg et al. (2007) analysing the oxygen transfer from a circular cylinder 
filled with an oxygen source to surrounding blood is worth mentioning.
275
 The 
investigation was a fundamental study into the gas exchange and haemodynamic 
conditions needed for the proper working of an artificial lung. In this particular study 
the authors used an oxygen transport model which incorporated the bound oxygen as 
well as the free oxygen present in the plasma. This is similar to the oxygen transport 
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model adopted here, although a constant shear-augmented dispersion coefficient 
(1.5×10
-11
m
2
/s) of RBCs was used and also the calculated Schmidt number (Sc) was 
lower (1000) compared with other studies (~3600). Sc is a dimensionless number that is 
defined as the ratio of the viscous diffusion rate and the mass diffusion rate, Sc=
ν
D
, 
where in this case ν is the kinematic viscosity of blood and D is the mass diffusivity of 
oxygen in blood. This study demonstrates some of the other applications of an accurate 
oxygen transport model in the design of medical devices. 
Coppola and Caro (2008) analysed the oxygen mass transport in two U-bends: one with 
a straight centreline and one with a helical centreline.
43
 The adopted oxygen transport 
model only incorporated the free oxygen, with the effect of the bound oxygen accounted 
for by using the same correction factor of 2.5 as used by Qiu and Tarbell (2000)
203
 
based on results from Moore and Ethier (1997).
162
 They observed that the WSS and 
oxygen supply uncoupled downstream of planar bends, and that secondary motion 
resulting from the 3D geometry can influence both the WSS and Sh distribution.
44
 In 
2009 Coppola and Caro analysed the WSS distribution and oxygen mass transport in an 
artery with a helical section with a pulsatile inlet velocity.
45
 The pulsatile flow was 
sinusoidal in nature with the effects of variation of the amplitude and frequency studied. 
It was found that there is a sweeping motion of the Dean Vortices and with increasing 
amplitude the WSS and oxygen flux increases. Increasing the frequency of the pulsatile 
waveform increased the WSS, but had no effect on the oxygen mass transfer. 
Liu et al. (2010) analysed the effect of spiral flow on the oxygen mass transfer in the 
aorta.
140
 The simulations were carried out in four difference models of the aorta: a 
realistic model constructed from MRI images with all geometrical features of the aorta 
intact, and three other models with decreasing amounts of features included. They 
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concluded that spiral flow may have physiological significance and enhance oxygen 
flux into the arterial wall, which will be discussed further in Section 4.4. 
Carroll et al. (2010) conducted an experimental validation of advection-diffusion 
discretisation schemes used for solving mass transport numerically.
29
 In this study the 
authors simulated the mass-transport of a species concentration in an idealised 
aneurysm geometry solved using four different discretisation schemes: first-order 
upwind, power law, second-order upwind and quadratic upstream interpolation for 
convective kinetics (QUICK). The results of these simulations were then compared with 
the experimental results taken from fluid samples extracted from a glass aneurysm 
model. They concluded that second order or QUICK discretisation schemes are most 
appropriate and produce the most accurate prediction of the mass transfer field when 
compared with the experimental results.
29
 
One interesting study was conducted by Biasetti et al. (2014) who assessed four patient-
specific geometries for low oxygen mass flux into the arterial wall by locating regions 
of low haematocrit.
18
 This was interesting because instead of modelling the oxygen 
transport the authors modelled the RBC transport and from the results induced that areas 
where the haematocrit was low must coincide with areas that the oxygen flux into the 
arterial wall was low. The RBCs were modelled using the Phillips’ shear-induced-
model for RBC dispersion where the RBCs are assumed to be rigid particles.
196
 The 
areas located matched with areas know to be prone to formation of atherosclerotic 
lesions with an example shown in Figure 4.4. The authors also found that the shear-
induced migration of the RBCs away from the arterial wall surface could be enhanced 
or dampened by secondary flows within the blood flow that convect RBCs away or 
towards the arterial wall. With the exception of this study by Biasetti et al. and the 
previously mentioned study by Zierenberg et al. all of the above studies only included 
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the free oxygen in their blood oxygen transport models. Additionally, the oxygen 
concentration at the arterial wall surface was assumed to be constant with the Sh used to 
analyse the oxygen flux. The test cases presented in Chapters 6 and 7 will consider the 
advantages and disadvantages of this approach. 
 
Figure 4.4: Wall haematocrit in the patient-specific normal carotid bifurcation 
during the cardiac cycle at t=0.10s from Biasetti et al. (2014).
18
 
4.2.2 Coupled Blood-Arterial Wall Analyses 
Oxygen transport models which incorporate the blood and the arterial wall have an 
advantage over the previous wall-free models in that the interaction between the mass 
transport processes ongoing in both domains can be studied. These also offer the 
advantage of predicting the effects of haemodynamic conditions on the oxygen 
concentration in the wall more accurately in comparison with using the Sh. The 
disadvantage of these models is that there are many factors that affect the oxygen 
consumption and diffusion within the wall which could lead to a lot of variability in the 
oxygen levels in reality. For the purpose of analysis, the standard approach is to use 
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constant consumption and diffusion parameters for the arterial wall. The results 
obtained in this case are only varied according to the set parameters, the haemodynamic 
conditions, the thickness of the arterial wall and the boundary conditions. Thus the 
effects of different cell composition, atherosclerotic lesion progression, inflammatory 
cellular activity and vasa vasorum penetration are ignored. 
 
Figure 4.5: (a) Model geometry and velocity vector plot for steady flow through the 
stenosis (b) Local Sh and (c) dimensionless surface PO2, (PO2-PO2,w)/(PO2,in-PO2,w), 
as a function of dimensionless axial position for all five cases with fluid side 
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transport coupled to an oxygen consuming wall. Adapted from Moore and Ethier 
(1997).
162
 
Coupled wall-lumen models of oxygen transport have the advantage over wall-free 
models in that they can provide information on the concentration profiles within the 
arterial wall. Moore and Ethier (1997) analysed the oxygen transport within a 2D 
geometry of a 89% area reduction axisymmetric stenosis under steady flow conditions, 
as shown in Figure 4.5.
162
 The consumption of oxygen in the arterial wall is included 
along with the non-linear oxygen binding properties of haemoglobin. As part of the 
study the authors analysed the effects of simplifying the blood oxygen transport model 
used, and of artificially decreasing Sc. As well as demonstrating the disadvantages of 
simplifying the blood transport model, the authors concluded that further studies of 
oxygen transport in large arteries must include the oxygen transport into an accurate 
model of the arterial wall. This study is important for the work presented here because 
the blood oxygen transport models, as described in Chapter 3, were based on those used 
by Moore and Ethier. How their study differed was that they assumed a constant shear-
induced RBC dispersion coefficient, 1.5×10
-11
m
2
/s, whereas the models used here 
adopted a variable dispersion coefficient that was dependent on the shear rate. This is 
more reflective of the range of shear rates experienced in the arteries modelled here. As 
mentioned previously, many subsequent studies reference Moore and Ethier’s results 
when simplifying their oxygen transport models, for instance neglecting the bound 
oxygen. The validity of this is debated in the conclusions section of Chapter 7. 
Perktold et al. (2002) modelled the oxygen transport, along with wall and suture 
mechanics, in anatomically-correct bypass configurations.
193
 Three different types of 
anastomosis were modelled: conventional, Taylor-patch and Miller-cuff with venous 
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interposition grafts of different modifications.  The haemodynamic conditions were 
assessed for each geometry and it was found that there was a correlation between low 
WSS and reduced oxygen flux into the arterial wall. 
One particular study published by Banerjee et al. (2008) modelled the oxygen transport 
in a simplistic 2D avascular arterial wall of a coronary artery stenosis before and after 
angioplasty.
7
 The stenosis pre- and post-angioplasty was found to have a significant 
impact on the luminal PO2 values along the arterial wall and the calculated flux into the 
arterial wall. The geometries did not include stent struts, and the arterial wall was 
assumed to be homogeneous and of constant thickness.  
Tada (2010) continued his previous work modelling the oxygen transport and transient 
blood flow in a carotid bifurcation model by including a homogeneous arterial wall and 
neglecting the effects of a compliant arterial wall, as modelled previously by Tada and 
Tarbell (2006).
248,250
 The geometry was constructed from averaged dimensions taken 
from several previous studies: Ma et al. (1997), Bharadvaj et al. (1982), and Perktold 
and Rappitsch (1995).
15,142,194
 Three PO2 profile locations were adopted for comparison 
from in vivo measurement locations used by Santilli et al. in dog carotid arteries.
217
 One 
simplification implemented was that the curvature of the ICA was ignored which would 
produce a swirling flow within the ICA. This would not alter the WSS or oxygen flux 
within the carotid sinus, where two of the three measurement locations are situated. The 
region of low oxygen flux on the outer wall of the carotid sinus, as observed by 
previous authors, was predicted in this study also. In addition, it was found that the 
effect of oscillatory blood flow on the PO2 levels in the arterial wall was negligible. The 
three PO2 profile plots exhibited a considerable difference when compared with Santilli 
et al. as shown in Figure 4.6. A steep gradient at the luminal surface present in the 
results presented by Santilli et al. was not reproduced in these results. Additionally, the 
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results failed to predict the minima point in all three plots. The geometry used by Tada 
was adapted for use in Test Case 1, as described in Chapter 6. 
 
 
Figure 4.6: Transarterial wall PO2 profiles at three locations from Tada (2010).
248
 
Caputo et al. (2013) conducted an analysis of the haemodynamic conditions and oxygen 
transport in three geometries of stented coronary arteries with different centreline 
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curvatures.
23
 Initially, a stainless steel, balloon-expandable stent was implanted in a 
healthy RCA at a balloon-to-artery ratio of 1.4:1. After 14 days the stented artery was 
harvested and the stent was imaged using high resolution micro-CT scans. The stent 
geometry was then imported into a commercial FEA software where an idealised 
arterial wall was over-expanded and allowed to relax onto the stent geometry. This was 
done to obtain an accurate representation of the arterial wall prolapse without the 
neointimal growth present. The resultant geometry had a straight centreline that 
extended proximal and distal to the stented region. Two additional geometries were 
constructed whereby the proximal and distal regions had a curved centreline. The two 
radii of curvature were 36 and 20mm (labelled as CU36 and CU20 in Figure 4.7), which 
corresponded to the range of curvatures of human and porcine RCAs obtained from 
angiographic data. The simulations were steady-state and the bound oxygen was 
ignored. When the predicted results were compared with the histological data, areas of 
predicted low WSS (defined by Caputo as <0.4Pa) and low oxygen concentration were 
found to match with areas of increased NIH, with some sample plots shown in Figure 
4.7. This is the only 3D study of oxygen transport in stented arteries carried out to date 
which incorporates the stent struts, which were found to have a considerable impact on 
the local haemodynamics and oxygen transport. Because of the limitations in the 
oxygen transport model adopted it is possible that the extent of the hypoxic regions in 
the arterial wall was under-predicted. 
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Figure 4.7: Qualitative comparison of the oxygen concentration between the 
computational models: straight, and with a radius of curvature of 36 and 20 mm, 
labelled as CU36 and CU20, respectively, as modelled by Caputo et al. (2013).
23
 
Also shown on the right are the corresponding histological images at three selected 
sections. Black arrows indicate the wall region with the lowest oxygen 
concentration in the computational models and the greatest neointimal thickness in 
the histologies.
23
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4.3 Haemodynamic Analyses of Stented Arteries 
The local haemodynamics present in arteries have been shown to affect the biological 
processes which take place following stent implantation, as discussed in Chapter 2. 
CFD simulations are required for analysing the local haemodynamics within a stented 
artery because of the size of the arteries concerned and consequently, the difficulty in 
analysing the blood flow in vivo or in vitro. Additionally, the incidence and severity of 
ISR has been found to vary with stent type and therefore, comparison of stent types 
using CFD is warranted. Throughout the relatively short history of CFD analysis of 
stents there are three reoccurring themes: how stent design affects the local 
haemodynamics within the stented region, how realistic are the geometries used, and 
what haemodynamic variables are used to assess the designs. The first theme was 
discussed in Chapter 2. The second theme is common to the oxygen transport studies 
above and will also be apparent in relevant studies below. In reference to the third 
theme the range of haemodynamic variables used in assessing stent geometries, which 
endeavour to capture the flow features more accurately, is ever expanding and a select 
amount will be mentioned throughout this section and Section 4.4.  
LaDisa et al. (2003) were among the first to analyse the haemodynamic impact of 
stenting a coronary artery using CFD.
130
 In their study the arterial wall surface was 
modelled as a straight cylinder and the stent investigated was similar to the Palmaz-
Schatz stent (Johnson & Johnson, Fremont, CA, USA). They compared the WSS 
distribution within the stented geometry with that of an unstented geometry. The 
simulations were based on previous in vivo measurements of canine LAD coronary 
artery diameter and blood flow velocities before and after stent implantation.
131
 The 
results of this study showed that the stent geometry had a dramatic effect on the WSS 
distribution along the luminal surface including that the minimum WSS value decreased 
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by 77% in comparison with an unstented artery, and stagnation zones were localised 
around stent struts. Following this study LaDisa et al. conducted several more studies 
into how stent designs and deployment ratios affect the WSS and spatial WSSG 
distributions within stented coronary arteries. Following this, in a paper published in 
2004, LaDisa et al. assessed the impact of deployment diameter and stent strut 
properties including number, width and thickness, on the WSS distribution. Increasing 
the deployment ratio from 1.1:1 to 1.2:1 increased the area of the stented luminal 
surface exposed to low WSS (defined as <0.5Pa) 12-fold. Doubling the number of struts 
from four to eight resulted in a 2.75-fold increase in the luminal surface area exposed to 
low WSS. Reducing the strut thickness from 0.096 to 0.056mm caused the total area 
exposed to low WSS to decrease by approximately 87%. A reduction in stent strut width 
resulted in an increase of 9% of the stent area being exposed to low WSS. This study 
confirmed that stent design properties and deployment ratio could influence the local 
haemodynamic conditions and consequently, affect the biological processes post-stent 
implantation.  
In a paper published in 2005 LaDisa et al. assessed the impact of a more realistic 
representation of the arterial wall deformation on the transient WSS. The hypothesis 
was that in reality the arterial wall would straighten circumferentially between stent 
struts and if modelled this would produce different WSS distributions in comparison 
with idealised cylindrical stented arteries. To derive the circumferentially straightened 
geometries an automated construction algorithm was used. The WSS and the WSSG 
were assessed for two different geometries based on the Palmaz-Schutz stent and they 
concluded that the arterial wall deformation is important in determining the WSS 
distribution.  
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He et al. conducted a parametric study, published in 2005, of stent strut geometries 
using geometries comprising of just two stent struts in a flat configuration with and 
without a link strut.
93
 The authors assessed the geometries in terms of the normalised 
axial WSS and the percentage of the arterial wall luminal surface exposed to a low WSS 
threshold value of <0.5Pa. This was done for a variety of stent strut configurations and 
carried out under high and low flow conditions. The study confirmed that stent strut 
configuration could influence the local haemodynamics and, specifically, that struts 
should be, wherever possible, orientated parallel to the vessel axis to reduce flow 
recirculation and low WSS zones. 
 
Figure 4.8: Contour plots of the WSS magnitude on the arterial wall portion 
delimited by the links and the stent struts at the diastolic peak (0.16s) for each 
stent model, from Balossino et al. (2009).
6
  
Balossino et al., in a paper published in 2008, compared the effects of four different 
stent designs, similar to four commercially available stents, on the local haemodynamics 
within stented coronary arteries. Single units of each stent design were expanded 
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virtually using FEA in idealised arteries with simplified arterial plaque and the resultant 
geometries were analysed using a transient velocity inlet boundary condition. Given that 
the CFD geometries used were derived using FEA, and also included the presence of 
plaque, they were more representative of what would happen in vivo. The percentage 
area of the arterial wall luminal surface exposed to a low WSS threshold value of 0.5Pa 
at six time instants during the cardiac cycle was used to compare the four different stent 
designs, with the contour plots of the WSS magnitude at diastolic peak for each stent 
shown in Figure 4.8. Additionally, the effect of stent strut thickness on the WSS was 
assessed and interestingly, it was found that a thicker strut, in this instance, results in 
less of the arterial wall being exposed to low WSS. The authors note that this 
observation disagrees with previous studies and may be the result of modelling the 
pulsatile flow with a FEA-derived geometry; i.e. more realistic geometries than 
previous studies. The authors also analysed the peak WSS and noticed that the greater 
the distance between stent struts the higher the peak WSS values are. This study further 
confirmed the link between stent design parameters and the WSS distribution within a 
stented coronary artery.  
Murphy and Boyle in 2008 assessed the effects of increasing levels of physiological 
realism on the WSS and WSSG in stented coronary arteries. Similar to LaDisa et al. 
(2005), where the arterial wall was modelled with circumferentially straight sections 
between stent struts, Murphy and Boyle developed a novel methodology to predict the 
tissue prolapse occurring between stent struts to increase the accuracy of how the 
arterial wall surface was represented. Using Young’s equation and distance between the 
struts, a curved surface was generated to represent the tissue prolapse. Additionally, the 
effect of stent oversizing, where stents are typically implanted with a stent-to-artery 
diameter ratio of 1.1-1.2:1, was also assessed. Modelling the tissue prolapse and the 
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stent oversizing were both shown to affect the WSS and WSSG distributions in the 
stented coronary arteries in comparison with simplified straight cylindrical artery wall 
models. Therefore, increasingly realistic arteries were deemed necessary to accurately 
assess the haemodynamic conditions in stented coronary artery models. Following on 
from this study, Murphy and Boyle in 2010 carried out a transient CFD comparison 
study of three stent designs, as shown in Figure 4.9. The four variables used in the 
comparison were WSS, WSSG, wall shear stress angel gradient (WSSAG), and 
oscillatory shear index (OSI), and a detailed statistical analysis of the results was carried 
out. One of the key conclusions of this study was that just applying the threshold 
assessment technique to stent comparison was insufficient in elucidating the effects of 
stent implantation on coronary artery haemodynamics and further studies should include 
statistical analysis of the results.  
 
Figure 4.9: Solid models of the LAD arteries implanted with (from left to right) the 
PS stent, the GR-II stent and the Bx stent from Murphy and Boyle (2010).
172
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In a paper published in 2010, Pant et al. compared the haemodynamic conditions 
induced by five stent designs, similar to commercially available stents, in idealised 
stented coronary arteries. All simulations had a transient inlet velocity, the arterial wall 
was modelled as a straight cylinder and the only a quarter of the stented domain was 
modelled to exploit the periodic symmetry of the stents to reduce computational 
expense. The WSS and the modified oscillatory shear index (MOSI) were assessed and 
it was found that the length of the link struts in the cross-flow direction and their 
alignment with the main flow were critical factors in the haemodynamic performance of 
the stent designs.  
In terms of the generation of the geometries required for the CFD simulations of stented 
arteries there have been a variety of avenues pursued by different studies. Gundert et al., 
in a paper published in 2011, described a rapid and computationally inexpensive method 
to virtually implant stents in patient-specific artery models rendered from medical 
imaging data. According to this method, a parameterised version of the stent is 
geometrically flexed until its centreline follows the centreline of the implanted artery. 
This gives an idealised stent geometry which includes the stent struts in a patient-
specific model but neglects the stent and vessel deformation. Morlacchi et al. in a paper 
published in 2011 utilised a sequential approach of FEA followed by CFD to investigate 
the final kissing balloon technique for stenting a coronary bifurcation. A stent model 
was virtually expanded in an idealised atherosclerotic bifurcation model using FEA and 
the resultant geometry was analysed using CFD. Additionally, Chiastra et al. in two 
papers in 2012 and 2013 continued this work with a similar CFD analysis of stented 
coronary bifurcation models. The stents were virtually expanded using FEA within 
artery models constructed from pre-operative computed tomography angiography and 
conventional coronary angiography images. Transient CFD simulations were then 
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carried out and the TAWSS, relative residence time and OSI were assessed. In these 
studies the feasibility of virtually implanted patient-specific coronary bifurcation 
geometries for haemodynamic assessment was demonstrated. In terms of assessing the 
impact of using more realistic stented geometries, Martin et al. (2014) compared the 
transient haemodynamics within three stented geometries generated using FEA or 
purely idealised. The authors found that stent and vessel deformation had a significant 
impact on the local haemodynamics within a stented artery. Critically though, the 
computational cost of virtually expanding stent geometries using FEA is significant and 
therefore, in most instances the hardware and time expense would make this method 
unfeasible, at least for the time being. 
4.4 Helical Flow 
Experiments conducted by Caro on the dispersion of indicator flowing in simplified 
models of the circulatory system showed that large secondary motions were induced by 
bends in the models.
25
 It was postulated that these secondary motions had particular 
physiological importance in circulation, listing possible advantages as being the 
prevention of stagnation zones and flow separation at the arterial walls. Inspired by 
observations of spiral folds on the inner endoluminal surface of arteries using fibre-
optic angioscopy by Stonebridge and Brophy,
241
 postulated by Caro et al. as being 
helical distributions of lesions due to low WSS zones,
27
 Stonebridge et al. went on to 
show that blood flows in the right common and distal superficial femoral and the left 
common femoral arteries with a secondary rotational motion which produces an overall 
spiral (helical) flow. This was detected using Doppler ultrasound with the probe aligned 
perpendicular to the axial flow, as shown in Figure 4.10 along with a sample ultrasound 
image.
245
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(a)                                       (b) 
Figure 4.10 (a): The Doppler ultrasound set up used in the experiment described 
by Stonebridge et al.
245
 (b): This sample image clearly shows the characteristic 
red/blue split signifying helical flow as observed in vivo.
244
 Reproduced with 
permission from Vascular Flow Technologies. 
The terms spiral flow and helical flow are used interchangeably in the literature, but for 
the purpose of this literature survey, helical flow is the term used. The helical flow in 
arteries is induced by their non-planar curvature and the heart itself. It has been 
proposed that the secondary motion, i.e. the rotational motion, of the blood flow is 
induced by the twisting of the left ventricle during contraction,
149
 and then accentuated 
upon entering the aortic arch.
63,119
 This twisting is, in part, due to the structure of the 
ventricular myocardial band of the heart which has been found by Torrent-Guasp to be 
spatially orientated in the form of a helix.
257
 Brecher also observed that there existed a 
continuous negative pressure within the ventricle
21
 which Marinelli cited as evidence of 
a perpetual vortex within the ventricle,
148
 which provides the ventricular suction during 
the diastolic period, and possibly incites the initial helical flow. Helical flow had been 
observed before in the human aorta by Segadel and Matre
222
 and again by Kilner and 
Yang using magnetic resonance imaging (MRI),
119
 and by Frazin et al. in canine 
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thoracic and abdominal aortae using Doppler ultrasound,
63
 but the studies by 
Stonebridge et al. were the first to show that the helical flow was maintained in the 
peripheral arteries also. Suo concluded, following MRI and CFD analysis, that helical 
flow in the aorta could only be produced by including the specific aortic motion caused 
by the beating heart.
247
 Caro et al. published observations from MRI data of flow 
through healthy human arteries with non-planar curvature and branching which showed 
how these features appeared to significantly affect the haemodynamics, including 
WSS.
27
  
Many of the beneficial effects of helical flow in the arteries were originally only 
postulations by researchers in the area; however, there is growing evidence which 
support these postulations. Stonebridge et al. discuss how there are theoretical 
advantages to helical flow, including rotationally-induced stability, reduced turbulence, 
and a beneficial effect on mechanisms of endothelial damage.
245
 In a paper by Caro et 
al. it was highlighted that greater mixing and more uniform WSS was expected in the 
cardiovascular system which was found to be commonly non-planar.
27
 Doorly et al. 
found through CFD analysis that a simple modification to the geometry of an end-to-
side anastomosis, where the graft is rendered approximately helical, produced a 
profound effect on the flow, enhancing the swirling motion of the flow downstream.
52
 
Zabielski and Mestel concluded from a CFD analysis into helical flow around arterial 
bends that the non-planar curvature limits the severity of flow separation at the inner 
bend and reduces variation of the WSS.
271
 This was confirmed in a CFD analysis by 
Papaharilaou et al. of planar and non-planar end-to-side anastomoses where it was 
found that the introduction of an out-of-plane curvature produced a significant change in 
the spatial distribution of WSS and a 10% reduction in the time-averaged peak WSS 
magnitude.
189
 The spatial extent of the elevated oscillatory WSS regions was reduced in 
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the non-planar model in comparison with the planar model and, given that Ku et al. 
found a correlation between elevated oscillatory WSS and NIH, there are effectively 
less areas exposed to unfavourable, in terms of disease progression or ISR, flow 
conditions in the non-planar geometry.
128
 In a numerical study of vortical flow 
identification and flow transport in arterial graft geometries, Doorly et al. found that 
significantly greater particle mixing was prevalent in the non-planar geometry compared 
with the planar geometry, with continual transport of particles away from the wall, thus 
lessening near-wall particle residence times.
53
 Stonebridge et al. compared helical and 
non-helical flow patterns through stenoses using MRI in vitro and CFD modelling.
243
 In 
this study it was found that near-wall turbulence energy was considerably less with 
helical flow (0.025m
2
/s
2
) than non-helical flow (0.16m
2
/s
2
) beyond the stenosis, with 
turbulence being associated with substantial WSS fluctuations in both space and time.
146
 
The degree of helical flow has been found by Houston et al. to be reduced in 
atherosclerotic arteries, although a direct relationship between atherosclerotic lesions 
and the absence of helical flow has not been proven, and within these arteries the 
turbulent nature of the resulting flow encourages further development of the disease.
103
 
A study by Morbiducci et al. indicated that helical flow dampened WSS temporal 
gradients in aortocoronary bypass grafts.
164
 Morbiducci et al. also conducted an in vivo 
investigation into the helical flow patterns in the aortic region of five healthy humans 
using 4D phase-contrast MRI, and CFD analyses of the reconstructed aortic geometries. 
It was found that helical-blood-flow dynamics is common to healthy individuals, and 
that helical flow might be caused by natural optimisation of fluid transport processes in 
the cardiovascular system, aimed at obtaining efficient perfusion of blood and nutrients 
therein to the organs and tissue.
166
 In predicting these transport processes, and also those 
involved in atherogenesis, a paper by Chiastra et al. highlighted that flow properties 
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such as velocity, helicity and vorticity are primarily responsible, and that researchers 
should consider these bulk flow properties in addition to the WSS variables.
39
 Liu et al. 
conducted a CFD study of the transport of LDL in four models of human aortae and 
found that the helical flow induced in the aortic arch had a beneficial effect on LDL 
concentration at the arterial wall.
141
 Helical flow has also been shown to be instrumental 
in moderating shear-induced activation of platelets, which is a problem for some 
cardiovascular implants.
155,165,191,273
 Massai et al. found through CFD simulations of a 
reconstructed model of a left carotid bifurcation that an inverse relationship existed 
between the helical flow index (a variable for measuring the helical structure of the 
flow) and the probability of shear-induced activation of platelets.
155
  
An analysis by Paul and Larman using CFD of helical flow downstream of a 75% 
stenosis found that turbulent kinetic energy was reduced post stenosis.
191
 The helical 
motion provides rotational stability to the flow, reducing flow disturbance and 
turbulence, which is a beneficial effect. Conversely, as noted by Paul and Larman, 
helical flow also produced oscillating WSS in the post-stenosis model,
191
 which is 
considered a detrimental effect possibly causing damage to the endothelium. In addition 
to this, other researchers have speculated on whether the effects of helical flow are 
entirely beneficial. Frazin et al. considered that although the rotational element of the 
flow may be important physiologically for organ perfusion, pathologically, there may be 
a relation between the shear forces induced by helical flow and plaque deposition.
62
 A 
paper by Texon showed that “serpentine flow” in relatively straight vessels may also 
produce zones of diminished lateral pressure and atherosclerosis.
256
 A CFD study of 
helical grafts by Zheng et al. found that along with the benefits of increased WSS and 
swirling flow, there was also an enlarged pressure drop and low velocity concentrated in 
one area in a helical graft model which could lead to increased NIH or thrombosis.
274
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Pressure drop was found to be proportional to the helicity of an inlet flow into an 
idealised stented artery in a CFD study by Chen et al.
36
 CFD simulations conducted in 
this study showed pressure drops for the stent with swirling flow to be 164, 167 and 173 
Pa for inlet helicities of 3.5, 6.4 and 14.5 m/s
2
, respectively, whereas for the stent with 
normal inlet flow the pressure drop was 163 Pa. Beneficial effects of helical flow also 
noted in this paper were that the average lengths of the recirculation zones between the 
stent struts and OSI, a measure of the change in direction and magnitude of the WSS 
vectors during the cardiac cycle, were reduced with increasing helicity of the inlet flow, 
which enhanced the average WSS in comparison with normal flow.
36
 
Considering the correlation between adverse flow conditions and increased 
NIH,
10,74,91,97,122,188
 and the effects of the local haemodynamics on the other biological 
processes leading to ISR, discussed in Section 2, there are two particular stents which 
are embracing the beneficial theoretical effects of helical flow, i.e. increasing particle 
mixing, reducing areas of disturbed flow and providing a more uniform WSS, and 
endeavouring to restore this natural blood flow pattern in a stented artery.  
4.4.1 BioMimics 3D Helical Stent 
The BioMimics 3D helical stent, as shown in Figure 4.11, is being developed by Veryan 
Medical Ltd which has its head office in Horsham, West Sussex, UK and research and 
development based in Galway, Ireland. This stent appears to have evolved from a 
helical bypass graft, marketed as SwirlGraft, which incorporated Small Amplitude 
Helical Technology (SMAHT), developed at Imperial College London. The theory 
behind this technology is that a normal planar bend induces two equal but opposite 
Dean vortices within the flow, whereas in a non-planar bend, as found in SMAHT, one 
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of the vortices begins to dominate the other as the flow progresses through the bend, 
producing helical flow.  
 
Figure 4.11: BioMimics 3D helical stent. Reproduced with permission from Veryan 
Medical Ltd. 
Caro et al. compared SwirlGraft devices with conventional expanded 
polytetrafluorethylene (ePTFE) arteriovenous shunts in two pigs.
26
 Even though the 
experiment was limited by the number of pigs employed, the results of this study were 
still positive with consistently less thrombus formation and NIH in SwirlGraft devices 
compared with the conventional devices. Interestingly, when the porcine arterial 
sections were analysed, two seemingly helical ribbons of NIH were found which 
seemed to match with the predicted areas of low WSS in a CFD model of SwirlGraft. A 
clinical trial was carried out by Huijbregts et al. in which 20 patients requiring vascular 
access grafts were implanted with SwirlGraft.
107
 It was found that the graft was prone to 
thrombosis, possibly due to the loss of the helical geometry of the graft upon 
implantation. It was concluded by Huijbregts et al. that with modifications to 
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implantation techniques and the SwirlGraft design that the product might advance to a 
randomised controlled trial.
107
  
Veryan Medical has taken this same SMAHT technology and applied it to peripheral 
stent design in the form of the BioMimics 3D helical stent, shown in Figure 4.11. In 
addition to the helical flow benefits, the stent also includes design features such as 
tapered radial stiffness and collinear stent ends which, in theory, help in providing a 
more gradual change in the wall stress and luminal area between the unstented and 
stented portion of the artery, as opposed to a dramatic change which could form a 
stagnation zone in the flow, encouraging thrombus and neointimal formation. For 
peripheral stent implantation, in the femoral artery particularly, as the leg bends the 
stent must be flexible enough to allow movement and longitudinal slackening of the 
artery without stent fracture or the infliction of damage on the arterial wall. The 
BioMimics 3D helical stent has been assessed in this regard through a human cadaver 
study as stated on the company website (http://www.veryanmed.com/). In this study the 
BioMimics 3D stent and control straight stents were implanted in the lower and mid 
superficial femoral artery and the upper popliteal fossa of three cadavers and the knee 
joint was flexed over a range of angles. It was observed that the BioMimics 3D helical 
stent could increase its helicity and thus take up the slack in the artery upon flexion of 
the knee, while also avoiding permanent deformation, unlike the straight stents. This 
ability is deemed a valuable characteristic which could prolong the life of a peripheral 
stent by absorbing stresses which ordinarily could cause fracture. 
As mentioned earlier, studies by Lee et al. into the effects of supplemental oxygen on 
NIH and by Tarbell into mass transport of molecules, e.g. oxygen, into arterial walls 
and localisation of atherosclerosis and NIH, highlight the importance of flow conditions 
and oxygen flux into the arterial wall on the development of NIH.
135,252
 Coppola and 
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Caro, citing Tarbell and the link between a local lack of oxygen and both atherosclerosis 
and NIH, used CFD to examine the effects of arterial three-dimensionality on the 
distribution of WSS and the mass transport of oxygen from the blood flow into the 
arterial wall in a U-bend by modelling the blood vessels as either a cylindrical or helical 
conduit.
44
 It was shown that a helical geometry can reduce both the range and extent of 
low WSS regions and substantially increase the oxygen flux through the walls.  
 
Figure 4.12: Angiograph showing the BioMimics 3D helical stent and the 
conventional straight stent inserted in the contralateral (left) and common carotid 
artery (right) respectively.
228
 Reproduced with permission from Veryan Medical 
Ltd.         
Shinke et al. presented results from a pilot porcine trial where two pigs were implanted 
with a conventional stent in one common carotid artery and the BioMimics 3D helical 
stent in the contralateral artery, as shown in the angiograph in Figure 4.12.
228
 
Comparisons were made between the histological sections taken at three locations in the 
two arteries, as shown in Figure 4.13. As can be seen from these sections the extent of 
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NIH with the helical stent was far less than with the conventional one and thus it was 
concluded that the helical stent’s improved flow regime helped in minimising NIH. 
 
Figure 4.13: Histological sections of the stented arteries for the straight (control) 
stent and the BioMimics 3D helical stent one month post implantation. The 
sections shown correspond to proximal, middle and distal locations to the stented 
region.
228
 Reproduced with permission from Veryan Medical Ltd. 
The in vivo results from this porcine study were compared with CFD predictions by 
Coppola and Caro and the effects of varying the geometrical parameters, i.e. the 
amplitude and frequency of the helical shape, on the flow pattern, WSS, and oxygen 
flux to the arterial wall were studied.
45
 It was expected that the increased mixing effects 
of the geometry-induced secondary flows would modify the distribution of WSS and 
produce higher oxygen flux levels to the arterial wall. Results showed that increasing 
the amplitude of the helical geometry increased the WSS and oxygen flux to the vessel 
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wall, and that increasing the frequency increased the WSS but had no effect on the 
oxygen flux.
45
 Oddly, the results indicated that the inner curvature regions of the helical 
model are exposed to lower oxygen flux than in the corresponding straight stent case, 
and yet the development of NIH is lower in these regions, as shown by the porcine trial. 
The reasons for this were inconclusive; however, the overall results of the study were 
positive. 
 
Figure 4.14: Diagram of the helical geometry employed by Cookson et al. in a CFD 
analysis of the mixing behaviour in a helical pipe with two different helical 
geometries.
42
 
Cookson et al. conducted a CFD investigation of the mixing behaviour of a small 
amplitude helical pipe incorporating two different helical geometries, as shown in 
Figure 4.14.
42
 Helix A has an amplitude of 0.2 times the diameter of the pipe and Helix 
B has an amplitude of 0.5 times the diameter. This investigation was based on the 
hypothesis that increased mixing, induced by helical geometries, reduced thrombosis in 
grafts incorporating SMAHT and that by joining together two helical geometries of 
different amplitudes the mixing effect could be enhanced further without an excessive 
pressure loss across the device. This study followed on from a previous numerical study 
of single helical geometries by Cookson et al.
41
 The results of the investigation 
indicated that the mixing effect was improved upon in the combined helical geometry in 
comparison with the single helical geometry and that the pressure drop was found to be 
less in the combined helical geometry. These results show a possible improvement in 
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the original SMAHT design on which SwirlGraft and the BioMimics 3D helical stent 
are based. 
4.4.2 Vascular Flow Technologies Ltd Stent 
The BioMimics 3D helical stent induces a helical flow by imposing a helical geometry 
on the treated artery, while another stent technology, currently in development at 
Vascular Flow Technologies Ltd (VFT) based in Dundee, Scotland, induces helical flow 
through the use of a helical ridge placed on the inner surface of the stent. VFT (formerly 
Tayside Flow Technologies) is a spin-out company set up in 1998 from Tayside 
University Hospitals NHS Trust. The stent technology being developed by VFT is based 
on research by Stonebridge et al. into the naturally occurring helical flow found in 
studies of the cardiovascular system using Doppler ultrasound, as mentioned 
previously.
241,242,245
 The benefits of helical flow, discussed earlier, led VFT to design a 
bypass graft, which was similar to SwirlGraft in that its goal is to induce helical flow; 
however, instead of shaping the graft in a helical form which could be lost on 
implantation, this bypass graft incorporated a helical ridge at the distal end of the graft, 
which restored helical flow. Early clinical results from a first-in-man study were 
presented by Vermassen and Stonebridge in which 40 patients with peripheral arterial 
disease had the graft implanted.
263
 10 patients were assessed for the presence of helical 
flow at six months and in all 10 helical flow was evident, confirming that the graft 
induced helical flow. In addition, a patency-rate of 88% at one year follow-up was 
found for the 40 patients treated.
263
 
The company is currently developing a helical-ridge insert for stents, similar to the graft 
design, in order to induce helical flow in a stented artery. Two patents which have been 
filed give some details of this technology: European Patent EP1314406 (B1) and US 
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Patent US7721767 (B2).
104,105
 The former describes a partially helical-shaped ridge 
insert for a stent as shown in Figure 4.15, while the latter gives details of a method for 
determining the helix angle of a helical formation for a conduit. 
 
Figure 4.15: Axial and longitudinal views of the proposed helical-ridge insert for 
stents, adapted from European Patent EP1314406 (B1).
105
 Reproduced with 
permission from Vascular Flow Technologies. 
A conduit, as described in the US Patent, includes natural blood-flow tubing, stents, and 
artificial industrial equipment, e.g. a hose or pipe.
104
 The method described in this 
patent allows the determination of the optimum helix angle through the use of two 
characteristic curves. As shown in Figure 4.16, for a given mass flow rate in a given 
conduit the experimentally determined non-dimensional pressure drop and turbulent 
kinetic energy are plotted against the helix angle. The optimum helix angle would 
normally correspond to the angle at which the non-dimensional pressure drop and the 
non-dimensional turbulent kinetic energy are equal to zero, in this case at approximately 
7.5 degrees (notated as 52 in Figure 4.16); however, this may not always be the case.
104
 
In a preclinical porcine study by Houston et al., an unmodified control stent and a 
modified stent incorporating the helical-ridge insert were compared in a 45 day carotid 
cuff stenosis model.
102
 The cuff model is designed to mimic lesions that may occur 
downstream of a stent and to induce cell proliferation and ECM synthesis, both of 
which contribute to neointimal thickening. There was a statistically significant reduction 
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in intima/media ratios distal to the implanted region in the modified stent porcine 
models, with a high ratio indicating significant neointimal thickening, in comparison 
with the control stent porcine models. Using Doppler ultrasound it was confirmed that 
the modified stent maintained the natural helical flow within the arteries of all eight 
pigs, whereas, the control stent did not. An idealised plain-wall tube was compared with 
a tube with a helical ridge using CFD and results obtained predicted a reduction in 
turbulent kinetic energy downstream of a 50% stenosis in the helical-ridge model.  
 
Figure 4.16: Graph taken from US Patent US7721767. The variation of non-
dimensional pressure drop with the helix angle is notated as 50 and the variation of 
non-dimensional turbulent kinetic energy with the helix angle is notated as 51. The 
helix angle when both variables are equal to zero is notated as 52.
104
 Reproduced 
with permission from Vascular Flow Technologies. 
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4.5 Summary 
In this chapter a review of the existing literature was presented on the relevant topics for 
this study. The topics reviewed were oxygen transport analyses, haemodynamic 
analyses of stented arteries, and helical flow. Oxygen transport analyses vary in 
complexity with computationally-cheap wall-free analyses and simplified blood oxygen 
transport models that do not incorporate the bound oxygen common within the 
literature. Coupled blood-arterial wall analyses allow accurate assessment of the 
resultant oxygen distribution within the arterial wall, as also achieved in the test cases 
presented in Chapters 6, 7, and 8. Haemodynamic analyses of stented arteries are 
generally limited to WSS variables, but by analysing the oxygen transport also, one of 
the secondary effects of the abnormal haemodynamics within a stented artery can be 
investigated. In theory, helical flow, as reviewed here, could have beneficial effects on 
both the local haemodynamics and oxygen transport within stented arteries.  
Key points from this chapter include: 
 In vivo measurements with oxygen microelectrodes in animals are needed to 
learn more about the variations in oxygen transport. 
 Shear-dependent wall permeability model adopted by Rappitsch et al. (1997) 
was noted to not be valid for oxygen transfer through the wall. 
 Areas of predicted low mass transfer were found to correlate strongly with areas 
prone to intimal thickening in humans.
143
 
 Some previous studies neglected the bound oxygen transport and reasoned that 
the Sh with the bound oxygen would be 2.5 times the predicted Sh without the 
bound oxygen. This assumption will be assessed in Chapter 9. 
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 Moore and Ethier (1997) previously concluded that further studies of oxygen 
transport in large arteries must include the oxygen transport into an accurate 
model of the arterial wall.
162
 
 Several previous studies have noted that accurate representations of the arterial 
geometries is essential in order to predict the mass transfer. 
 Neglecting the compliance of the arterial wall and the pulsatility of the flow in 
simulations of oxygen transport in arteries is justifiable. 
 Helical flow is theorised to produce more uniform WSS, reduced high 
oscillating flow regions, greater particle mixing, reduced near-wall particle 
residence times, dampened WSS temporal gradients, and increased oxygen 
transport. Further analysis of this is presented in Chapters 8 and 9. 
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CHAPTER 5 
Chapter 5. Prelude to Test Cases 
5.1 Introduction 
As discussed in Section 3.4, Model 1 is the most advanced blood oxygen transport 
model which incorporates the oxygen bound within RBCs, the non-linearity of the 
oxygen exchange between the free and bound oxygen, and a variable shear-induced 
RBC dispersion coefficient. There are four additional models which have varying 
degrees of simplifications with the most simple of these, Model 5, most commonly used 
in the literature. To compare the five different models, two separate test cases were 
devised. Test Case 1 compared the transarterial wall PO2 profiles predicted in an 
idealised carotid bifurcation using the five models with measurements recorded by 
Santilli et al. in dog carotid bifurcations.
217
 In Test Case 2 the maximum and minimum 
transarterial wall PO2 profiles in a stented coronary artery predicted using the five 
models were compared with measurements from a separate study by Santilli et al. In 
this separate study transarterial wall PO2 profile measurements were taken within rabbit 
aortae, of similar size to human coronary arteries, which had been implanted with 3mm 
diameter stents.
218
 Additionally, the PO2 and the local Sh on the stented artery luminal 
surface predicted by each model were compared, along with the percentage volume of 
the arterial wall exposed to low and hypoxic levels of PO2.  
Following these two test cases a third test, Test Case 3, was constructed in which the 
most advanced model, Model 1, was applied to three sample stents to demonstrate how 
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different stent designs can impact the oxygen transport within a stented coronary artery. 
Finally, in Test Case 4 the predicted oxygen transport in a variety of helical stent 
geometries were assessed using Model 1. The goal of this test case was to elucidate the 
effects of increasing helical radius on the PO2 levels within the arterial wall of idealised 
stented coronary arteries. This will further build on previous studies on helical flow by 
analysing its impact on the local haemodynamics and oxygen transport within a stented 
artery, and assess helical flow in terms of its theoretical benefits, as reviewed in Chapter 
4. 
5.2 Modelling the Blood Flow 
For all simulations carried out as part of this study the meshes, generated in ANSYS 
ICEM meshing software (ANSYS Inc., Canonsburg, PA, USA), were imported into the 
CFD commercial software ANSYS CFX 15 (ANSYS Inc., Canonsburg, PA, USA) 
where the Navier-Stokes equations were solved to predict the blood flow within the 
luminal domain. All simulations were steady state as pulsatility has been shown to have 
a minimal effect on oxygen transport to the arterial wall.
124
 The density of blood was 
taken as 1060kg/m
3
 and the non-Newtonian nature of blood was modelled using the 
non-Newtonian Bird-Carreau model, with assigned values based on experimental data 
from Jung et al.
115
 The continuity and momentum equations were solved with a high 
resolution advection scheme and the convergence criteria were set to a maximum 
residual tolerance of 1×10-6.  
All simulations were carried out on the Irish Centre for High-End Computing (ICHEC) 
Fionn supercomputer using a maximum of five nodes, each with 2×12 2.4GHz Intel Ivy 
Bridge core processors and 64GB of RAM. The computer processor unit (CPU) time to 
reach convergence for each model in Test Cases 1 & 2 are given in Table 5.1 and there 
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is a clear pattern whereby Model 5 almost halves the CPU time required on the same 
meshes. This may be significant when computational resources are an issue, although, 
as will be demonstrated by these test cases simplification of the oxygen transport model 
has considerable limitations. The CPU run times for each stent in Test Case 3 are 
4.13×10
6
 s, 6.55×10
6
 s and 5.17×10
6
 s for Stent A, B and C, respectively, and for Test 
Case 4 the typical CPU time was ~5.0×10
6
 s. 
 
Test Case 
Model 1 2 
1 1.90×10
6
 s 4.13×10
6
 s 
2 1.07×10
6
 s 4.56×10
6
 s 
3 1.73×10
6
 s 4.49×10
6
 s 
4 1.09×10
6
 s 4.50×10
6
 s 
5 6.49×10
6
 s 2.62×10
6
 s 
Table 5.1: CPU run times in seconds for each simulation to reach convergence for 
all five models in Test Cases 1 & 2.  
5.3 Modelling the Oxygen Transport 
The PO2 in the blood and the arterial wall is modelled in ANSYS CFX 15 using an 
additional variable. Additional variables are defined in ANSYS CFX as non-reacting 
scalar components that are transported through a flow field but do not affect the 
continuity or momentum equations. The transport of the PO2 within the blood flow is 
governed by Equation 3.47 with flow variables affecting the transport through the 
substantial derivative term (
2PO t ). The diffusivity coefficient, D’, is represented 
by Equation 3.48 and the source term is controlled by Equation 3.49. Both D’ and the 
source term are evaluated explicitly, based on the previous time-step value for PO2, and 
CHAPTER 5: Prelude to Test Cases 
 
124 
 
a time-step independence study found no difference in the predicted PO2 results at 
smaller time-step increments. The PO2 is transported via diffusion only in the arterial 
wall with a fixed diffusivity coefficient, DT, and consumption modelled via a source 
term. The advection/diffusion equation for PO2 in the lumen domain was solved with a 
high resolution advection scheme, in line with recommendations by Carroll et al.,
29
 and 
the convergence criteria were set to a maximum residual tolerance of 1×10-6  in all 
domains. 
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CHAPTER6 
Chapter 6. Test Case 1 – Carotid Bifurcation 
6.1 Introduction 
To assess the accuracy of the oxygen transport models, as described in Chapter 3 and 
summarised in Table 3.1, experimental measurements are needed for comparison. 
Santilli et al. used an oxygen microelectrode to measure the transarterial wall PO2 
profiles in 11 dog carotid bifurcations.
217
 An idealised human carotid bifurcation 
geometry was constructed from detailed measurements taken from several 
studies.
128,142,248
 A dog carotid bifurcation geometry would be ideal for comparison; 
however, Santilli et al. reported that they used mongrel dogs, and only the wall 
thicknesses were reported with no luminal diameters given.
217
 The size of the arteries 
and the oxygen transport parameters within the arterial wall would vary according to 
different breeds of dogs. Therefore, the PO2 measurements by Santilli et al. are used 
here, as done previously by other researchers,
248–250
 for comparison with the predicted 
results for a human with the distance through the arterial wall scaled according to the 
thickness of the human artery. The five different models were used to simulate the 
oxygen transport in an idealised human carotid bifurcation, shown in Figure 6.1, 
adapted from Tada with, for the first time, the addition of a heterogeneous arterial 
wall.
128,142,248
 The carotid bifurcation offers two advantages for this study: there are 
different flow patterns present in it which will affect the oxygen transport, and because 
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the carotid sinus is prone to atherosclerotic plaque build-up it is an area of interest for 
oxygen transport modelling.   
6.1.1 Geometry Creation 
The geometry was constructed in Rhinoceros 3-D (McNeel, Indianapolis, IN, USA) and 
comprised of the common carotid artery (CCA) which bifurcates into the internal 
carotid artery (ICA) and the external carotid artery (ECA). To reduce computational 
expense half of the geometry was used with symmetry assumed along the centreline of 
the carotid arteries, thus ignoring the secondary curvature of the ICA.
248
 The secondary 
curvature has the greatest effect downstream of the measurement locations and 
therefore, would have no consequence on the results presented here. The thickness of 
the arterial wall in the carotid arteries, particularly the intima in the carotid sinus, has 
been shown to vary with location in human subjects.
128
 Accordingly, a variable intimal 
thickness ranging from 0.10 to 0.63mm was used, as shown in Figure 6.1. The intimal 
thicknesses correspond to the mean values of measurements from bi-planar angiographs 
from 57 patients, as listed in Table 6.1 with reference to Figure 6.2 (which shows the 
orientation of the polar coordinates in each arterial segment), adopted from Ku et al.
128
 
The media was assumed not to experience any thickening and was assigned a constant 
thickness of 0.60mm.  
The predicted and measured transarterial wall PO2 profiles were then compared at three 
of the six measurement locations as outlined by Santilli et al.
217
 One of the benefits of 
these locations numbered 1 - 3, in terms of assessing the blood oxygen transport 
models, is that they cover three distinct flow patterns: straight shear flow parallel to a 
wall, low shear recirculation flow and high shear flow directed towards the wall, 
respectively. 
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Figure 6.1: (a) Plan of the carotid bifurcation model with (b) cross-section X-X’ 
and (c) cross-section Y-Y’. The intima thickness is approximately 0.12mm 
throughout the common carotid artery (CCA) and the internal carotid artery 
(ICA), except in the outer wall of the carotid sinus and proximal to the ICA where 
it gradually increases to a maximum of 0.63mm in accordance with Ku et al.
128
 
This can be seen clearly in the cross-section X-X’.  
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Figure 6.2: Schematic representation of the locations at which the intimal 
thickness data from human carotid arteries were recorded along with the polar 
coordinate orientation used in each artery segment. It should be noted that in 
keeping with the original data from Ku et al. the orientation of the polar 
coordinates is different at location E compared with all other locations.
128
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Cross-Section Location 
Polar Position 
(°) 
Intimal Thickness 
(mm) 
A. CCA 
0 
90 
180 
270 
0.10 ±0.02 
0.15 ±0.03 
0.12 ±0.03 
0.10 ±0.02 
B. Proximal ICA 
0 
90 
180 
270 
0.14 ±0.05 
0.47 ±0.13 
0.63 ±0.17 
0.37 ±0.10 
C. Midpoint Carotid Sinus 
0 
90 
180 
270 
0.19 ±0.07 
0.24 ±0.05 
0.49 ±0.10 
0.31 ±0.07 
D. Distal Internal Carotid 
0 
90 
180 
270 
0.07 ±0.02 
0.06 ±0.01 
0.08 ±0.04 
0.09 ±0.04 
E. External Carotid 
0 
90 
180 
270 
0.27 ±0.15 
0.08 ±0.02 
0.12 ±0.05 
0.15 ±0.05 
Table 6.1: Intimal thicknesses as adopted from Ku et al.
128
 Only half of the 
bifurcation geometry used and therefore, only the measurements at 270° were used 
normal to the plane of symmetry. The polar positions for each segment are shown 
in Figure 6.2. 
6.1.2 Geometry Discretisation 
The mesh for Test Case 1 was generated using ANSYS ICEM meshing software 
(ANSYS Inc., Canonsburg, PA, USA). It comprised of hexahedral elements and was 
inflated into the luminal domain from the arterial wall surface with the height of the 
initial element set at 3μm in order to accurately capture the MTBL. This is in line with 
both the Validation Test Case 2 presented in Appendix A and from previous literature in 
the area of oxygen transport modelling.
203,248
 Following a mesh convergence study, as 
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discussed in Appendix B, the resultant mesh had a total of 973121 nodes broken down 
as follows: 501546 in the lumen domain, 295075 in the intima domain and 176500 in 
the media domain.  
6.1.3 Boundary Conditions 
A mass flow rate boundary condition of 0.00375kg/s, taken from a study by Tada,
248
 
was placed at the inlet of the CCA which corresponds to the averaged mass flow rate 
over the cardiac cycle, divided by two for the half geometry. Additionally, at the inlet 
PO2,in=100mmHg, which corresponds to the typical arterial value found in human 
arteries,
200
 and also the average luminal value recorded by Santilli et al.
217
 At both 
outlets PO2,out=0mmHg, a boundary condition that allows ANSYS CFX to 
automatically replace this value with the value attained iteratively from the solution 
process, and an entrainment boundary condition was imposed with a zero relative 
pressure. The mass flow rates at the two outlets were compared with the calculated 
transient mass flow rates from Tada and found a maximum difference of 5.68% in the 
averaged flow rate over the cardiac cycle at the ECA outlet. At the external wall 
boundary, which corresponds to the medial/adventitia interface, a constant 
PO2=75mmHg was imposed, which was the averaged PO2 value recorded at the 
adventitia by Santilli et al. At the arterial wall surfaces located at the inlet and outlets a 
zero flux PO2 boundary condition was imposed. 
6.2 Results and Discussion 
Figure 6.3 shows the predicted PO2 levels on the luminal surface for each of the models. 
The flow patterns are the exact same in each simulation; however, the predicted PO2 
levels clearly vary significantly depending on which blood oxygen transport model is 
adopted. In the following sections the results at the three prescribed locations are 
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compared with experimental results from Santilli et al., specifically, the transarterial 
wall PO2 profiles. The oxygen MTBL at each location was analysed in detail for each of 
the five models. 
 
Figure 6.3: Predicted PO2 levels along the luminal surface using the five different 
models, as summarised in Table 3.1. 
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Figure 6.4: Locations of transarterial wall PO2 profiles along with the predicted 
PO2 levels on the luminal surface using Model 1. 
For reference, Figure 6.4 shows the luminal surface PO2 levels as predicted by Model 1 
along with the locations of the three transarterial wall PO2 profiles. Location 1 is within 
a developing MTBL with a uniform distribution of PO2 circumferentially around the 
luminal surface with no flow disturbances. Location 2 is in a recirculation zone within 
the carotid sinus where the PO2 levels are significantly depleted. Looking at Figure 6.3 
it is clear that this low PO2 region is present in each simulation with all five models 
except for Model 3 where it is imperceptible because most of the luminal surface is 
exposed to low/hypoxic PO2 levels. Location 3 is adjacent to a high PO2 region at the 
bifurcation divide. A detailed analysis of each location for each model follows. 
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6.2.1 Location 1 
Location 1 is situated in the CCA where the flow is parallel to the luminal surface and 
within a developing MTBL, as shown in Figure 6.4. Figure 6.5 shows a cross-sectional 
slice at Location 1 with a contour plot of the predicted velocity magnitude. As shown, 
the blood flow at this location is undisturbed and is flowing parallel to the luminal 
surface. This means that the oxygen transport is predominantly diffusive perpendicular 
to the luminal surface at this location. For Models 1 and 2 D’ is affected by the local 
shear rate through the variable Dc. Figure 6.6 shows the predicted shear rate and Dc at 
Location 1. The shear rate is a typical shape for developing pipe flow with a maximum 
value of 437s
-1
 at the luminal surface. The Dc value correspondingly varies between a 
minimum value of 8.0×10
-12
m
2
/s within the centre of the lumen and a maximum value 
of 1.2×10
-10
m
2
/s within the MTBL at the luminal surface.  
 
Figure 6.5: Cross-sectional slice at Location 1 showing a contour plot of the 
predicted velocity magnitude.  
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The effect of a relatively high Dc value within the MTBL can be seen by comparing the 
results of both Models 1 and 3, and Models 2 and 4. Figure 6.7 shows the predicted 
PO2, dS/dPO2, D’, and S along a line at Location 1 for each model. Looking at Figure 
6.7(c) there is a clear difference in the predicted D’ values within the MTBL for Models 
1 and 3 where the only difference between the two models is that a variable Dc value is 
used for Model 1, and Dc=0m
2
/s for Model 3 (essentially ignoring the dispersion of 
RBCs). For Model 3, ignoring the dispersion of RBCs leads to lower PO2 values within 
the MTBL, and at the luminal surface, which is compounded by resultant higher 
dS/dPO2 values within the MTBL. This is also seen when comparing Models 2 and 4; 
however, the effect of neglecting the dispersion of RBCs is not as pronounced because 
the dS/dPO2  value is constant. Completely ignoring the contribution of the 
oxyhaemoglobin contained within the RBCs, i.e. Model 5, results in a higher D’ value 
and consequently, a higher luminal surface PO2 value compared with the other four 
models. The saturation of the oxyhaemoglobin, S, is shown in Figure 6.7(d) to follow a 
similar trend to the PO2 for each model with Model 3 showing the largest decrease. 
Interestingly though, S begins to decrease much closer to the luminal surface than PO2 
because of the slope of the oxygen disassociation curve is relatively low until PO2 
begins to fall below 60mmHg, Figure 6.7(b), as demonstrated best with Model 3. A 
high dS/dPO2 means that for a relatively large change in PO2 there is a corresponding 
large change in S; whereas, if dS/dPO2 is low, then a similarly large change in PO2 will 
only produce a small change in S. 
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Figure 6.6: Predicted (a) shear rate and (b) Dc along a line within the blood flow 
from the centre of the artery to the luminal surface at Location 1. 
 
Figure 6.7: Predicted (a) PO2, (b) dS/dPO2, (c) D’ and (d) S values along a line 
within the blood flow from a radius of 2.90mm to the luminal surface at a radius of 
3.00mm at Location 1. 
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Figure 6.8 shows the cross-sectional slice at Location 1 with a contour plot of the 
predicted PO2 levels using Model 1 which shows the PO2 levels within the arterial wall 
are circumferentially uniform due to the uniformity of the flow in this region. In terms 
of the transarterial wall PO2 profiles for Model 1 at Location 1, the predicted PO2 values 
show reasonable agreement with the experimental results in capturing the overall trend, 
as shown in Figure 6.9. The radial position of the predicted nadir in the PO2 levels is 
different to the nadir of the Santilli et al. experimental results. This may be due to 
different diffusion and consumption parameters within the dog arterial wall compared 
with the adopted values based on human arteries. Crucially though, at this location at 
least, the predicted PO2 levels do not fall below the hypoxic or low PO2 levels of 
10mmHg and 30mmHg. The predicted results using the other four models show a broad 
variation in comparison with Model 1. Model 2 gives a higher luminal surface value 
than Model 1 and consequently, overall higher PO2 values across the arterial wall. The 
predicted PO2 profile from Model 4 is very close to that predicted by Model 1 because 
taking Dc=0m
2
/s decreases the D’ value within the MTBL, and conversely, taking a 
constant value for dS/dPO2 at this location has the opposite effect of increasing the D’. 
This results in a D’ value for Model 4 adjacent to the luminal surface which is close to 
the D’ value predicted by Model 1, as shown in Figure 6.7(c). Model 3 predicts the 
lowest PO2 values on the luminal surface, and consequently, across the arterial wall. 
Model 5, on the other hand, predicts the highest PO2 values on the luminal surface and 
across the arterial wall. Crucially, it fails to predict the high PO2 gradient within the 
MTBL that is seen with Models 1-4. This will be discussed in greater detail separately 
in Section 6.2.4. 
From analysing the results at Location 1, where the blood flow is parallel to the wall, 
laminar and undisturbed, it can be concluded that inclusion of the bound oxygen has a 
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significant effect on the predicted PO2 levels within the MTBL. Counterintuitively, 
inclusion of the bound oxygen predicts lower PO2 levels when compared with a simpler 
model, Model 5. In addition, both neglecting the dispersion of RBCs and the variability 
of the slope of the oxygen disassociation curve also significantly impact the predicted 
results.  
 
Figure 6.8: Cross-sectional slice at Location 1 showing a contour plot of the 
predicted PO2 levels in all three domains. 
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Figure 6.9: Comparison of predicted and measured transarterial wall PO2 profiles 
at Location 1. Measurements adapted from Santilli et al. are shown for 
comparison and the distances through the arterial wall for these have been scaled 
to the size of a human carotid artery. 
6.2.2 Location 2 
Location 2 is situated on the outer side of the carotid sinus within the ICA where the 
flow is considerably different to that at Location 1. As shown in Figure 6.10, the 
velocity magnitude peak value is offset to the bifurcation side of the sinus with a 
relatively large low velocity recirculation zone present on the side of Location 2. The 
tangential velocity vectors on the slice surface are also shown in Figure 6.10 to 
highlight the presence of secondary motion within the sinus. This secondary motion is 
similar to that seen in previous studies of flow patterns in the human carotid bifurcation 
such as experimental work by Motomiya and Karino (1984) using transparent segments 
prepared from a human subject post-mortem.
168
 This is also demonstrated in Figure 6.11 
using streamtraces coloured according to PO2 levels which highlights how previously 
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oxygen depleted blood is turned over towards the outer surface of the carotid sinus 
where it enters a low velocity recirculation zone and further depleted.  
 
Figure 6.10: Cross-sectional slice at Location 2 showing a contour plot of the 
predicted velocity magnitude. The velocity vectors tangential to the slice plane are 
shown, with arbitrary length, to highlight the secondary motion present within the 
sinus.  
As mentioned before, D’ is affected by the local shear rate through the variable Dc for 
both Models 1 and 2. Figure 6.12 shows the predicted shear rate and Dc along a line at 
Location 2. The shear rate is maximum, for Location 2, at the centre of the artery with a 
value of 140s
-1
 and minimum adjacent to the luminal surface with a value of 9s
-1
. The 
Dc value correspondingly varies between a maximum value of 6.4×10
-11
m
2
/s within the 
centre of the lumen and a minimum value of 9.4×10
-12
m
2
/s within the MTBL adjacent to 
the luminal surface. Consequently, there is no significant increase in D’ caused by the 
shear rate and Dc. Physiologically, this means that the shear-induced dispersion of 
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RBCs does not increase the effective diffusivity of oxygen within the low velocity zone 
on the outer side of the carotid sinus, as would be expected. Note: the change in the 
slope of the plot of Dc at Location 2, Figure 6.12(b), is a reflection of the change in 
governing equation for Dc for values above and below a shear rate value of 100s
-1
.  
 
Figure 6.11: Streamlines passing through the cross-sectional slice at Location 2 
and 3 coloured according to predicted PO2 values using Model 1 along the 
streamlines. 
The effect of a relatively low Dc value within the MTBL can be seen by comparing the 
results of both Models 1 and 3, and Models 2 and 4. Figure 6.13 shows the predicted 
PO2, dS/dPO2, D’, and S along a line at Location 2 for each model. Looking at Figure 
6.13(c) Models 1 – 4 all predict very low D’ values within the MTBL and consequently, 
low luminal surface PO2 values. For Models 3 and 4, which ignore the dispersion of 
RBCs, show no difference in luminal surface PO2 values in comparison with Models 1 
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and 2 because Dc, as modelled in Model 1, has little effect on D’ as seen in Figure 
6.13(c). This is opposite to Location 1, as demonstrated by Figure 6.7(b), where a 
considerable difference was visible between the D’ values within the MTBL between 
the models that included Dc (Models 1 & 2) and those that did not (Models 3 & 4). 
Completely ignoring the contribution of the oxyhaemoglobin contained within the 
RBCs, i.e. Model 5, again here at Location 2 results in a significantly higher D’ value 
and consequently, a higher luminal surface PO2 value compared with the other four 
models. The saturation of the oxyhaemoglobin, S, is shown in Figure 6.13(d) to follow a 
similar trend to the PO2 for each model where it is included (Models 1 - 4). As seen at 
Location 1 as shown in Figure 6.7, S begins to decrease much closer to the luminal 
surface than PO2; however, unlike Location 1, all four models predict a significant drop 
in the S within the MTBL. Physiologically, this means that the bound oxygen content 
has a particularly significant contribution to the oxygenation of the arterial wall at this 
location; although because of the low velocity of the flow the PO2 levels fail to be kept 
sufficiently high to maintain the required supply to the arterial wall. 
 
Figure 6.12: Predicted (a) shear rate and (b) Dc within the blood flow at Location 2 
from centre of artery to the luminal surface. 
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Figure 6.13: Predicted (a) PO2, (b) dS/dPO2, (c) D’ and (d) S values along a line 
within the blood flow from a radius of 2.80mm to the luminal surface at a radius of 
3.29mm at Location 2. 
Figure 6.14 shows the cross-sectional slice at Location 2 with a contour plot of the 
predicted PO2 levels using Model 1. Because of the low velocity and recirculation zone 
in the sinus on the side of Location 2 the PO2 levels are hypoxic across the intima and a 
substantial portion of the media. Looking at Figure 6.15 there is a considerable 
difference between the predicted PO2 values and the experimental results from Santilli 
et al. There are several reasons for this, all stemming from the fact that the carotid 
bifurcation geometry used here is based on measurements from humans and the 
experimental results from Santilli et al. are from dog carotid arteries. In humans this 
location is commonly a site of intimal thickening, caused by atherosclerotic plaque 
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build-up, as included here with the total arterial wall thickness varying between 1.09mm 
and 0.84mm within the cross-sectional slice shown in Figure 6.14. Conversely, in dogs, 
as studied by Santilli et al., the wall thicknesses recorded were considerably thinner at 
154.0 ±4μm at Location 2.217 The effect of the intimal thickening in humans on the 
oxygenation of the arterial wall can be seen here with extensive hypoxic regions where 
cells would express VEGFs resulting in the penetration of vasa vasorum into the medial 
layer to increase the oxygen supply to the cells at this site.
262
  
 
Figure 6.14: Cross-sectional slice at Location 2 showing a contour plot of the 
predicted PO2 levels in all three domains. 
Analysing Figure 6.15, there is no significant difference between Models 1 and 3 
because the relatively low Dc has a negligible effect on the D’ within the MTBL for 
Model 1. This is also true for the small difference between Models 2 and 4. Model 5 
again predicts a much higher luminal surface PO2 value, although there is still a portion 
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of the arterial wall exposed to low and hypoxic PO2 levels. Interestingly, because all 
five models reach a nadir of 0mmHg the extent of the influence of the oxygen diffusing 
in from the adventitia is noticeable with the PO2 levels rising from a radius of 3.7mm up 
to the medial/adventitial interface at 4.35mm. This gives an effective range of oxygen 
diffusion at this location of 0.65mm; however, the PO2 levels become hypoxic at 
approximately half this distance. A similarly high PO2 gradient is observed at the 
location also which Models 1 – 4 predict but Model 5 does not. 
 
Figure 6.15: Comparison of predicted and measured transarterial wall PO2 
profiles at Location 2. Measurements adapted from Santilli et al. are shown for 
comparison and the distances through the arterial wall for these have been scaled 
to the size of a human carotid artery. 
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6.2.3 Location 3 
Lastly, Location 3 is situated on the inner side of the carotid sinus within the ICA where 
the flow is different to both previous locations. Figure 6.16 shows a cross-sectional slice 
at Location 3 with a contour plot of the predicted velocity magnitude and Figure 6.17 
shows the predicted shear rate and Dc at Location 3. The velocity magnitude peak value 
is offset to the inner side of the sinus, as shown in Figure 6.16, which has a noticeable 
effect on the shear rate as shown in Figure 6.17(a). The tangential velocity vectors on 
the slice surface are again shown in Figure 6.16 to highlight the presence of secondary 
motion within the sinus that has the effect of replenishing the oxygen at this location. 
This means that the oxygen transport has a greater contribution from the advection term 
of the transport equation in comparison with Locations 1 and 2. Additionally, for 
Models 1 and 2, D’ is affected by the local shear rate through the variable Dc. The shear 
rate is a reflection of the rate of change of velocity so looking at Figure 6.17(a) in 
combination with Figure 6.16 gives an understanding of why the shear rate along the 
line at Location 3 has a particular shape. In Figure 6.16 the closeness of the velocity 
contours reflect the rate at which the velocity is changing in a given region of flow. 
Within the first 1.0mm, going from the centre out, the shear rate is consistently above 
100s
-1
 which is reflective of the relatively gradual change in velocity in this region of 
flow. Moving radially out along the line the next 1.5mm sees very little change in the 
velocity as the line passes through the region of flow coloured according to the velocity 
range of 0.30 to 0.35m/s. The shear rate dips to a nadir value of 50s
-1
 within this region. 
Following this, with the peak velocity skewed towards the inner side luminal surface, 
the velocity changes rapidly from approximately 0.30m/s down to 0.00m/s at the 
luminal surface. This relatively rapid transition is reflected in the closeness of the 
velocity contours in Figure 6.16. The shear rate correspondingly rises to a peak value of 
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547s
-1
 and then drops to a value of 336s
-1
 at the luminal surface. The Dc value similarly 
varies between a minimum value of 3.2×10
-11
m
2
/s within the low shear rate region and a 
maximum value of 1.4×10
-10
m
2
/s at the peak shear rate point. Importantly, the Dc value 
drops to a value of 1.0×10
-10
m
2
/s within the MTBL at the luminal surface. 
Physiologically, this means that the dispersion of RBCs has a significant effect on the 
oxygen transport at this location. 
 
Figure 6.16: Cross-sectional slice at Location 3 showing a contour plot of the 
predicted velocity magnitude. The tangential velocity vectors are shown, with 
arbitrary length, to highlight the secondary motion present within the sinus. 
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Figure 6.17: Predicted (a) shear rate and (b) Dc within the blood flow at Location 3 
from centre of artery to the luminal surface. 
 
Figure 6.18: Predicted (a) PO2, (b) dS/dPO2, (c) D’ and (d) S values along a line 
within the blood flow from a radius of 3.23mm to the luminal surface at a radius of 
3.29mm at Location 3. 
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Figure 6.18 shows the predicted PO2, dS/dPO2, D’, and S along a line at Location 3 for 
each model. The relatively high Dc value increases D’ within the MTBL which can be 
seen by comparing the D’ values of both Models 1 and 3, and Models 2 and 4. Looking 
at Figure 6.18(c) there is almost no difference in the predicted D’ values within the 
MTBL for Models 1 and 2 (a minimum of 1.78×10
-10
m
2
/s and 1.79×10
-10
m
2
/s, 
respectively, at the luminal surface), that results in similar luminal surface PO2 values 
(74mmHg and 79mmHg, respectively). This is also the case with their respective 
dS/dPO2 values at the luminal surface (0.0022mmHg
-1
 and 0.0019mmHg
-1
, Model 1 
and 2 respectively). Model 3 again predicts a relatively low luminal surface PO2 value 
(39mmHg) with high dS/dPO2 and low D’ values within the MTBL. Model 4 predicts a 
lower luminal surface PO2 value (69mmHg) than Model 1. Completely ignoring the 
contribution of the oxyhaemoglobin contained within the RBCs, i.e. Model 5, again 
results in a higher D’ value and consequently, a higher luminal surface PO2 value 
(93mmHg) compared with the other four models. The saturation of the 
oxyhaemoglobin, S, as shown in Figure 6.18(d), is very similar in Models 1, 2, and 4 
because the PO2 levels are very similar and are all in a region on the oxyhaemoglobin 
curve that has a low slope and consequently, there is little change in S over small 
changes in PO2. Model 3 again predicts a greater drop in S, similar to the drop in PO2. 
Physiologically, this means that the bound oxygen content has less of an effect on the 
oxygenation of the arterial wall at this location in comparison with the other two 
locations, but the dispersion of the RBCs does play a crucial part in the overall oxygen 
transport at this location. 
At Location 3 the predicted PO2 value (66mmHg) for Model 1 just within the arterial 
wall matches well with the experimental results from Santilli et al. (64mmHg), as 
shown in Figure 6.19; however, the PO2 values across the arterial wall differ with those 
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recorded experimentally, which again are due to differences in consumption, diffusion 
and solubility of the oxygen in humans and dogs. Looking at Figure 6.20 it is clear how 
thin the MTBL is at Location 3 in comparison with Location 2 (approximately 0.05mm 
vs 0.5mm, respectively), which is caused by the off-centre velocity profile. There is 
little difference between the transarterial wall PO2 profiles predicted by Models 1 and 2 
because the dS/dPO2  value predicted by Model 1 adjacent to the luminal surface is 
similar to the constant value taken for Model 2. Model 3 again predicts a very low 
transarterial wall PO2 profile at this location. The transarterial wall PO2 values predicted 
by Model 4 are lower than those predicted by Model 1 because of the effect of the 
increased Dc value, as modelled by Model 1, is not included. Model 5 again predicts a 
much higher luminal surface PO2 value. As with the other two locations a high PO2 
gradient is observed at Location 3 using Models 1 – 4 but not with Model 5. 
 
Figure 6.19: Comparison of predicted and measured transarterial wall PO2 
profiles at Location 3. Measurements adapted from Santilli et al. are shown for 
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comparison and the distances through the arterial wall for these have been scaled 
to the size of a human carotid artery. 
 
Figure 6.20: Cross-sectional slice at Location 2 showing a contour plot of the 
predicted PO2 levels using Model 1 in all three domains. 
6.2.4 High PO2 Gradient in MTBL 
The results of each model at Locations 1, 2 and 3 within the human carotid bifurcation 
are presented in Figure 6.9, Figure 6.15 and Figure 6.19 respectively, along with 
experimental values recorded by Santilli et al. in dog carotid bifurcations. Models 1 - 4, 
which include the bound oxygen, predict a high gradient within the MTBL at all three 
locations that is also observed between the luminal and first arterial wall PO2 values in 
the experimental results from Santilli et al. Model 5, which does not include the bound 
oxygen, fails to predict this steep gradient. Previous studies have hypothesised that this 
high gradient in PO2 between the lumen and arterial wall is due to high oxygen 
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consumption by the endothelium,
259
 and this is currently an unresolved controversy in 
this field because it is not corroborated by in vitro studies. This controversy is covered 
in depth by both Vadapalli et al. and Tsai et al.
258,261
 In the results presented here, 
predictions by Model 1 show that the high gradient seen experimentally could be due to 
the complex balance between the free and bound oxygen contained within the MTBL, 
and the consumption within the arterial wall. This could be a very important 
consideration for future oxygen transport studies.  
To analyse this phenomenon in further detail the PO2, dS dPO2⁄ , D’ and S values for 
each model at Location 1, as shown in Figure 6.7, are referred to again. Model 1 and 3 
include the varying gradient of the dissociation curve, dS dPO2⁄ , in the calculation of 
D’. As shown in Figure 6.7(b), dS dPO2⁄ , increases rapidly within the boundary layer 
which numerically results in a decreased D’ within this region for both Model 1 and 3. 
What this means physiologically is that there are two exchanges taking place: the 
exchange of oxygen between the blood and the arterial wall, and the exchange of 
oxygen between the RBCs and the plasma, i.e. the bound and free oxygen. The free 
oxygen only constitutes 1.5% of the total oxygen contained within the blood,
200
 and 
therefore, the bound oxygen can have a significant effect on the exchange of oxygen 
between the blood and the wall by either acting as a large PO2 reservoir. This is 
exemplified by the difference in PO2 between the models that include the bound 
oxygen, Models 1 - 4, and the one that does not, Model 5. It is clear from the results that 
the high gradient is not a result of modelling just the RBC dispersion (Models 1 and 2) 
or by assigning a variable dS dPO2⁄  value within the domain (Models 1 and 3), but just 
by including the bound oxygen only. 
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6.3 Conclusion 
This test case was undertaken to assess the five blood oxygen transport models in an 
idealised artery and to compare the predicted results to experimental measurements at 
three locations taken in dog carotid arteries. When the results were analysed the most 
significant observation was that the most advanced model, Model 1, predicted a high 
PO2 gradient at the luminal surface. This is the first time that this has been observed in 
computational models and matches well with experimental measurements. Critically, 
this may help settle a controversial issue in the area of oxygen transport modelling 
which is explained in a paper by Tsai et al. (2010).
258
 Specifically, the high gradient in 
the PO2 levels adjacent to the arterial wall luminal surface were observed 
experimentally which led to some researchers to assume that the endothelium consumes 
vastly more oxygen than the typical VSMCs in the arterial wall. This assumption is not 
backed up by experimental data on cultured ECs. Here, for the first time, the high PO2 
gradient has been predicted and appears to be a consequence of the balance between the 
free and bound oxygen, and the consumption within the arterial wall.  
In addition to the above conclusion, this test case also confirms that simplifying the 
blood oxygen transport model leads to significant differences in the predicted PO2 
levels on the luminal surface and also within the arterial wall. Critically, Model 5, the 
most commonly used blood oxygen transport model in the literature, failed to predict 
the steep PO2 gradient adjacent to the luminal surface and significantly over-predicted 
the amount of oxygen diffusing into the arterial wall. This will be further demonstrated 
in Test Case 2 in the following chapter. 
Finally, an obvious limitation of this work is evident in the results, namely that the 
arterial wall oxygen transport model is not accurate with predicted PO2 values across 
the arterial wall falling below the experimental measurements. This may be in part due 
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to the difference between physiological differences between dogs and human arteries. 
Also, the intima and media are modelled as homogeneous materials with different 
consumption, diffusivity and oxygen solubility. In reality, macrophages, plaques and 
penetrating vasa vasorum which could exist in vivo would alter these values 
significantly. Certainly, at Location 2, an area which is prone to lesion development, 
could have a cellular composition and consequently, oxygen transport governing 
parameters very different to those which exist in a healthy artery.  
6.4 Summary 
In this test case the oxygen transport within an idealised geometry of a human carotid 
bifurcation was predicted using five different oxygen transport models with varying 
degrees of simplification. The results were compared with experimental results from a 
study of oxygen levels across the arterial wall of carotid arteries at three locations in 11 
mongrel dogs.  
The results indicate that: 
 Simplifying the blood oxygen transport model has significant effects on the 
predicted arterial wall oxygen levels.  
 Further work is needed in deriving crucial parameters for the oxygen diffusion 
and consumption within the arterial wall to vacillate more accurate prediction of 
oxygen levels.  
 A high PO2 gradient observed in experimental studies was recreated here for the 
first time using the oxygen transport models that incorporate both bound oxygen 
and free oxygen. This may have important implications for future work in this 
area.  
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The next chapter describes Test Cases 2, where the same five models were used in 
analysing the oxygen transport in a stented coronary artery, and Test Case 3, where 
Model 1 is used to compare three different stent designs.  
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CHAPTER 7 
Chapter 7. Test Cases 2 & 3 – Stented Coronary Arteries 
7.1 Introduction 
ISR is a continuing problem for coronary artery stent design. NIH is one of the key 
biological processes that can result in ISR, and has been found to be exacerbated by 
hypoxia and disturbed haemodynamics within the stented region.
134,135
 Test Case 2 
assesses the predicted PO2 levels and Sh using the five blood oxygen transport models, 
as summarised in Table 3.1, within a realistically-deformed stented coronary artery. As 
part of this assessment the maximum and minimum PO2 transarterial wall profile plots 
within the stented region are compared with in vivo experimental measurements from 
stented rabbit aortas of similar size from Santilli et al.
218
 Test Case 3 then compares the 
predicted PO2 levels and Sh, as modelled using the most advanced blood oxygen 
transport model, within the realistically-deformed stented coronary arteries of three 
different stent designs. 
7.2 Geometry Creation 
Three different stent designs, shown in Figure 7.1, were investigated in this study and 
are referred to as Stent A, Stent B and Stent C with their differing geometrical 
properties listed in Table 7.1.
153
 Stent A resembles the BX Velocity stent (Cordis of 
Johnson & Johnson, Fremont, CA, USA), Stent B resembles the S7 AVE stent 
(Medtronic, Fridley, MN, USA) and Stent C resembles the thick strut Multilink RX 
Ultra stent (Abbott Laboratories, Lake Bluff, IL, USA). The tri-folded balloon-tipped 
CHAPTER 7: Test Cases 2 & 3 – Stented Coronary Arteries 
 
156 
 
catheter, used in the structural analysis described below, resembles the configuration of 
the Raptor balloon-tipped catheter (Johnson & Johnson).  
Stent A B C 
Stent configuration Closed-cell Open-cell Open-cell 
Strut thickness 0.14 mm 0.10 mm 0.13 mm 
Strut width 0.13 mm 0.10 mm 0.10 mm 
Link configuration Peak-to-peak Peak-to-peak Peak-to-valley 
Link type Flexible Non-flexible Non-flexible 
Link shape N-shaped Straight Straight 
Link width 0.10 mm 0.08 mm 0.10 mm 
Table 7.1: Geometrical properties of the three investigated stents.
153
 
The realistically-deformed stented artery geometries were obtained from non-linear 
finite element analyses (FEA) carried out using ABAQUS (Dassault Systèmes, 
Providence, RI, USA). These structural analyses consisted of the expansion of the 
sample stents using the realistic model of a tri-folded balloon-tipped catheter within an 
idealised coronary artery as shown in Figure 7.2. Each of the three stents were assumed 
to be manufactured from 316L stainless steel and a rate-independent elastic-plastic 
material model with isotropic hardening was adopted to describe their mechanical 
behaviour. The elastic-plastic response was modelled on the basis of data reported by 
Murphy et al., who conducted uniaxial tension tests of 316L stainless steel struts.
170
 
Likewise, the mechanical behaviour of the guide wire, catheter shaft, and angioplasty 
balloon was described using isotropic linear elastic material models with their linear 
elastic response described using data from Mortier et al., who employed a realistic 
model of the Raptor balloon-tipped catheter to evaluate the mechanical impact of stent 
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deployment within a bifurcated coronary artery.
167
 The thicknesses of the intima, media 
and adventitia were 0.24, 0.32, and 0.34mm respectively, and their mechanical 
behaviour was described using isotropic hyperelastic material models with their non-
linear elastic response adopted from data reported by Holzapfel et al.
100
 Holzapfel et al. 
carried out experimental analysis of 13 human LAD coronary arteries harvested within 
24 hours of death.  
The computational domain was 20mm long with the arterial lumen set at a stent-free 
diameter of 2.7mm and external arterial wall diameter of 4.5mm. The stents had an 
8.0mm unexpanded length and were expanded using a pressure load, which varied with 
each stent design, within the balloon to achieve a deployment ratio of 1.1:1. Once 
expanded, depending on the stent strut configuration, the overall length of the stent 
changes: Stent A 7.7mm, Stent B 7.4mm, and Stent C 8.3mm. This can be seen clearly 
in Figure 7.3 where Stent C is noticeably longer than the other two stents when 
completely expanded. As a side note, also noticeable in Figure 7.3 is the apparent 
corrugation of the arterial wall luminal surface, i.e. the surface is not completely 
smooth. This is because of the mesh size and type used for discretising the arterial wall 
for the FEA, and has a perceptible effect on the variables of interest which use gradients 
in their calculation, namely WSSG and Sh. For the purpose of this study though the 
overall distributions are still clear for both variables. 
The mechanical behaviour of the coronary arterial wall is highly non-linear, 
predominantly because of the collagen fibres within, which stiffen the arterial wall at 
higher stress levels.
72
 This non-linearity is accounted for by using third-order Ogden 
hyperelastic material models for each layer of the arterial wall. These hyperelastic 
material models were fit to the appropriate experimental data from Holzapfel et al. with 
different hyperelastic material constants adopted for each layer, which showed good 
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agreement with experimental data, as described by Martin.
150
 The FEA solution was 
carried out using ABAQUS/Explicit solver with multiple contact surfaces and friction 
included. As shown in Figure 7.2(b), as the pressure load is increased the ends of the 
stent begin to expand first. This is referred to as dog-boning, because of the shape, and 
is commonly observed in the literature.
152,236,251
 Once the fully expanded configuration 
is reached, as in Figure 7.2(c), the balloon was deflated, Figure 7.2(d), and the stent 
recoils slightly and settles into its final expanded configuration. Further details of these 
analyses are discussed elsewhere.
150,153
 The final expanded configuration of both the 
stent and the arterial wall was then exported from ABAQUS to Rhinoceros 3-D where 
the geometry was adapted for CFD analysis. This adaption involved removal of small 
sliver regions, which would disrupt the mesh generation, where the stent surface would 
be malapposed to the luminal surface that are caused largely by mismatched mesh 
patterns. Entry and exit regions, 32mm in length, were added proximal and distal to the 
stented region to ensure that the haemodynamics were not affected by the boundary 
conditions. These regions also included 4mm length of intima and media to ensure that 
the oxygen MTBL had developed adequately. Only the intima and media layers of the 
arterial wall were needed for the oxygen transport analysis as the adventitia is supplied 
with oxygen by vasa vasorum within it, as discussed in previous chapters. The stented 
region itself for each stent was defined as the 12mm long region where the diameter of 
the artery at the extremities has returned to its unstented value. The stented region for 
each stent is shown in Figure 7.3. 
Only Stent A was used for comparison of the five different blood oxygen transport 
models in Test Case 2. All three stents were compared using the most advanced model, 
i.e. Model 1, in Test Case 3 for the purpose of demonstrating the effects of different 
stent designs on the PO2 values on and within the arterial wall. 
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Figure 7.1: The three stents analysed. The final deformed configuration is shown. 
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Figure 7.2: FEA-predicted deployment of Stent A, as carried out by Martin et al. (2014), using a tri-folded balloon-tipped catheter 
within an idealised coronary artery with a heterogeneous multi-layered arterial wall incorporating an intima, media and adventitia.
153
 
(a) Initial configuration with a pressure load=0.00MPa, (b) expansion of balloon with a pressure load=0.50MPa, (c) maximum expansion 
with a pressure load=1.10MPa, and (d) the final deformed configuration with a pressure load=-0.01MPa. 
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Figure 7.3: The stent and luminal surface within the stented region for the three 
stents analysed. 
7.2.1 Geometry Discretisation 
Similar to Test Case 1 the geometry was imported into ANSYS ICEM meshing 
software for discretisation. An unstructured mesh topography was adopted for all three 
stented artery geometries comprising of tetrahedral and prism elements. The mesh 
inflation parameters established in the validation test case were taken as a basis for the 
mesh convergence studies of the stented coronary artery geometry. The surface mesh 
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was generated using the Octree Method which was used as a basis for the volume mesh 
created using the Delauney Method. Finally, prism layers were added at the luminal 
surface (eight layers) and within the media (eight layers). This meshing procedure is 
recognised for its generation of good quality meshes for CFD using ANSYS ICEM 
mesh generation software. The Octree Method is a robust method that is reliable for 
complicated geometries and the Delauney Method produces a volume mesh which has a 
smoother volume mesh transition between adjacent elements. This smoother transition 
results in improved aspect ratios, which in turn helps with solution convergence. The 
prism layers are required for accurate prediction of both the haemodynamics and the 
PO2 boundary layer at the luminal surface. Recommendations by previous researchers 
in this area were taken into account in the mesh generation and also confirmed by the 
mesh convergence study, the results of which are presented in Appendix B. For 
instance, it was found that for accuracy in predicting the oxygen transport at the luminal 
surface at least three layers of prisms off the luminal surface within the MTBL are 
required. This is in agreement with previous work by Tada, and Coppola and Caro in 
this area.
43,248
 For the meshes generated here eight prism layers were used because areas 
of flow disturbance resulted in a thickened MTBL which required additional prism 
layers, in comparison with previous authors, for it to be accurately captured. Figure 7.4 
shows a cross-section of the mesh employed for Stent A.  
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Figure 7.4: Cross-section of mesh employed for Stent A at mid-point of stented 
region. Refinement was applied on the stent surface and prism layers were used on 
the luminal surface, and also within the arterial wall, to ensure accurate capture of 
both the haemodynamic and PO2 transport features. 
7.2.2 Boundary Conditions 
For the stented artery models the following boundary conditions were implemented. At 
the inlet of the fluid domain a fully developed Hagen-Poiseuille velocity profile was 
imposed with Vmean=0.2313m/s, which results in an average volume flow rate of 
40ml/min which is within the range of typical basal values seen in human LAD 
coronary arteries in vivo.
112
 Also, at the inlet PO2,in=100mmHg, which is normal arterial 
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blood PO2.
200
 At the outlet an entrainment boundary condition with a zero relative 
pressure was set with PO2,out=0mmHg. PO2 was free to transfer across the 
luminal/arterial wall surface, and across the intima/media interface surface. On the stent 
surface a PO2 zero-flux condition was imposed. On the media/adventitia interface 
surface PO2=45mmHg, as used by Richardson,
206
 and on the wall surfaces located either 
end of the arterial wall section a zero flux boundary condition was imposed. 
7.3 Results and Discussion - Test Case 2 
Figure 7.5(a) and (b) show the maximum and minimum PO2 transarterial wall profile 
plots within the stented domain for all five models which were taken at the position of 
maximum and minimum luminal surface values. For comparison the measurements by 
Santilli et al. from rabbit aortic arteries on day 1 following stent implantation with 3mm 
internal-diameter stents are also shown.
218
 The stents used by Santilli et al. were 
manufactured by Cordis, although it was not stated specifically that the BX Velocity 
stent was used. The balloon used was a 3.0mm outer diameter balloon, which was also 
used in the FEA simulations presented here. In their study, the exact measurement 
location within the stented domain is not provided and therefore, the maximum and 
minimum profiles for each model are presented here alongside the experimental results. 
Assuming the experimental results are taken as being reflective of the PO2 values 
present in a similar size human coronary artery, as modelled here, then Model 1 is again 
shown to produce the steep PO2 gradient and is within the range of luminal surface PO2 
values observed experimentally. Model 5 again over-predicts the amount of oxygen 
being transported to the luminal surface and there is an absence of the steep PO2 
gradient at both locations. Models 2 and 4 also over-predict the oxygen flux into the 
arterial wall, and Model 3 again significantly under-predicts it. Both Models 1 and 3, 
and Models 2 and 4 are quite similar at the minimum location because the minimum 
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luminal surface PO2 values for all five models are within a low velocity recirculation 
(almost stagnate) zone next to a stent strut and the shear rate is low which consequently 
means the Dc value is also low, i.e. almost negligible in this case. The uneven section of 
the transarterial curves within the lumen in Figure 7.5(b) are also attributed to this 
recirculation zone downstream of the stent strut at this location.  
Differences in the PO2 transarterial wall profile predicted by the simulations and the 
experimental results from Santilli et al. are attributed to differences in arterial wall 
properties of different species. For example, looking in more detail at the PO2 
transarterial wall profiles it would appear that the diffusion of oxygen through the 
intima of the rabbit aortae may be higher than in the human coronary arteries as 
modelled here. This would be supported by looking specifically at the maximum PO2 
transarterial wall profile of Model 1 which shows the closest luminal surface PO2 value 
to the experimental results. A higher diffusivity would shift the curve (in red in Figure 
7.5(a)) over towards the experimental measurements by Santilli et al.; additionally, the 
consumption value would also vary. Further work would need to be carried out to 
confirm this and could again highlight the differences in arterial wall tissue properties 
observed across different species.  
The effect of the higher consumption value for the human coronary artery as adopted in 
the intima domain in these simulations is clearly distinguishable in Figure 7.5(a) with a 
considerably steeper curve in the first approximately 0.15mm (less than 0.24mm set for 
the intima because of stretching caused by the stent implantation) from the luminal 
surface to an approximate radius of 1.70mm in comparison with the slope of the PO2 
transarterial wall profile from this point to the outer boundary.  
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Figure 7.5: (a) Maximum and (b) minimum transarterial PO2 profiles for each 
model applied to the deformed coronary artery geometry virtually implanted with 
Stent A. Measurements adapted from Santilli et al. are shown for comparison and 
the distances through the arterial wall for these have been scaled to the size of a 
human coronary artery.
218
 The minimum PO2 luminal surface value for each 
model is located within a recirculation zone immediately downstream of a stent 
strut which produces a severe drop and variable slope in PO2 profile in Figure 
7.5(b). The luminal surface is shown as a vertical dashed-dotted line. Note: 
locations of maximum and minimum PO2 transarterial profiles for each model are 
shown in Figure 7.6. 
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Figure 7.6: Locations of predicted maximum and minimum luminal surface PO2 
values within the stented region for each model which were used for the profile 
plots in Figure 7.5. To give an indication of the gradient of the PO2 along the 
surface at the maximum locations Figure 7.8 shows a line plot of the PO2 along line 
A-A’.     
Contour plots of the PO2 and Sh are shown in Figure 7.7(a) and (b) respectively. When 
analysed in conjunction with the line plots along the axial cross-section A-A’ (Figure 
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7.8) the effects of each model become apparent. The difference between Model 1 and 
the simpler models is striking. Firstly, the plots of the PO2 values along the luminal 
surface in Figure 7.7(a) show quite a large variability across the five models with the 
extent of the difference clear in the PO2 line-plot in Figure 7.8. The areas of low PO2 
values (<30mmHg) around the stent struts which are apparent with Model 1 do not 
appear with Models 2, 4 and 5, with Model 5 predicting very little variation in PO2 on 
the luminal surface with the lowest value being 64mmHg. Model 3, which neglects the 
RBC dispersion, predicts very low PO2 levels on the luminal surface that translate into 
very little oxygen diffusing into the arterial wall. Interestingly though, Model 3 predicts 
very high Sh values along the surface because the Sh is based on the gradient of PO2 
normal to the surface, which is very high for Model 3 as seen previously in Figure 7.5. 
This highlights a possible disadvantage in using the Sh as a basis for analysis in the 
form adopted here as it uses the PO2 gradient normal to the wall. 
 
Hypoxic PO2 
(<10mmHg) 
Low PO2 
(<30mmHg) 
D'min D'max 
Model 1 12.6% 72.8% 1.12E-11 3.51E-10 
Model 2 0.0% 14.3% 9.05E-11 2.56E-10 
Model 3 36.6% 80.8% 6.13E-12 2.08E-10 
Model 4 0.0% 33.9% 8.58E-11 8.58E-11 
Model 5 0.0% 0.0% 1.20E-09 1.20E-09 
Table 7.2: Percentage volume of the arterial wall exposed to hypoxic and low PO2 
within the stented region for each model along with the minimum and maximum 
D’ values present within the blood flow. 
The relatively small variation in PO2 values observed along the luminal surface for 
Model 5 translates to very little variation predicted in the local Sh also. For Models 1 – 
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4 there is a similarity in the regions of low and high Sh, with low Sh (values tending 
towards the calculated Da≈17) predicted in regions where the flow is separating away 
from the luminal surface and high Sh predicted in regions where the flow is reattaching, 
i.e. where the flow is directed towards the wall and oxygen transport through convection 
is high. The peaks of high Sh observed with Models 1 – 4 are dampened considerably 
for Model 5 to the extent that the reattachment points are unrecognisable on the luminal 
surface plots. Da itself could not be used as a threshold value in this case since none of 
the models actually predicted the local Sh to drop below 17 on the luminal surface even 
though significant portions of the arterial wall were predicted to be exposed to hypoxic 
PO2 levels. This may highlight a limitation of using Da as a threshold value for low Sh.  
Greater amounts of neointimal thickening have been shown to occur in areas with PO2 
values of less than 30mmHg, and hypoxia exists where the PO2 levels drop to below 
10mmHg.
34,218
 Thus, how much of the arterial wall is exposed to PO2 values below 
these two thresholds is of importance in predicting the possibility of excessive 
neointimal thickening and potential ISR. As shown in Table 7.2, the five models studied 
here predict a broad range of percentage volumes of the arterial wall exposed to low 
PO2 (<30mmHg). For example, Model 5 predicts that none of the stented arterial wall is 
exposed to low PO2, as opposed to Model 1 predicting 72.8% of the stented arterial wall 
is exposed to low PO2 with 12.6% exposed to hypoxic conditions. Model 2, which 
neglects the non-linearity of the oxygen disassociation curve, differs significantly in the 
amount of hypoxic and low PO2 regions (0% and 14.3% respectively) within the arterial 
wall compared with Model 1. Model 3, which neglects the shear-dependent dispersion 
of RBCs, predicts extensive hypoxic and low PO2 regions within the stented region 
(36.6% and 80.8% respectively). The PO2 levels drop off severely within the MTBL for 
Model 3 because the slope of the oxygen disassociation curve, dS/dPO2 , increases 
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significantly, reducing the D’, as demonstrated in the analysis at each location in Test 
Case 1. This results in the lowest D’ value of the five models, as shown in Table 7.2, 
which in turn results in the lowest PO2 luminal surface values throughout the stented 
region, as shown in Figure 7.7. Model 4 is similar to Model 2 in the regard that it 
predicts that none of the arterial wall within the stented region is exposed to hypoxic 
PO2 levels. Critically, this broad variability in predicted hypoxic and low PO2 regions 
within the stented region again highlights the disadvantages of simplifying the blood 
oxygen transport model. 
CHAPTER 7: Test Cases 2 & 3 – Stented Coronary Arteries 
 
171 
 
 
Figure 7.7: Predicted (a) PO2 and (b) Sh on the luminal surface within the stented region.  
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Figure 7.8: Predicted PO2 and Sh along line A-A’.  
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7.4 Results and Discussion - Test Case 3 
Investigating the results from all three stented arteries requires first to analyse the 
haemodynamics, and then the oxygen transport within each domain and how it’s 
affected by the haemodynamics and arterial wall deformation. Finally, the predicted 
haemodynamics and oxygen transport results are compared alongside the restenosis 
rates for each stent. 
7.4.1 Haemodynamics 
Figure 7.9 shows the predicted WSS and WSSG within the stented region for each stent. 
Table 7.3 shows the percentage luminal area of the stented region which is exposed to 
low WSS <0.5 Pa. Low WSS is correlated with increased NIH.
127
 As reviewed in 
Chapter 2, previous studies have shown that increased expression of pro-thrombotic 
agents, inflammatory cell adhesion molecules, and VSMC growth factors by ECs occurs 
in response their exposure to WSS below 1.0 – 1.2 Pa, although the effects are 
considered more severe below 0.5 Pa. Also, as mentioned in Chapter 2, a study of stent 
implantation in rabbits showed that ECs are still present adjacent to stent struts 
immediately post-implantation. This is crucial here because as shown in Figure 7.9(a) 
the areas that experience WSS values below 0.5 Pa are predominantly adjacent to stent 
struts. Stent A is predicted to perform the best of the three stents with 31.3% of the 
luminal area within the stented region exposed to low WSS, in comparison with 35.4% 
and 36.3% for Stent B and Stent C, respectively. Where the endothelial layer is 
destroyed within the stented region, in interstices between stent struts, VSMCs can be 
exposed to the blood flow.
208
 According to the predicted WSS distributions for each 
stent here, as shown in Figure 7.9(a), any areas where VSMCs may be exposed to the 
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blood flow the WSS is below physiological WSS values, ranging from 0.5 – 1.0 Pa, 
which encourages VSMCs to proliferate.  
The WSSG is also plotted for each stent in Figure 7.9(b). High WSSG (>0.85 Pa/mm) 
has been shown to increase endothelial permeability that causes increased 
macromolecule uptake.
195
 It is assumed here that the endothelium offers no resistance to 
oxygen transport; however, increased endothelial permeability could lead to increased 
uptake of leukocytes causing increased inflammation in areas predominately around 
stent struts. The percentage of the luminal surface within the stented region which is 
exposed to WSSG values above 0.85 Pa/mm are shown in Table 7.3 for each stent. 
Significantly less of the luminal area is exposed to high WSSG values for Stent A 
(42.0%) than both Stent B (53.1%) and Stent C (53.9%). Therefore, the ECs within the 
stented region for Stent A would experience, in theory, less endothelial permeability in 
comparison with Stent B and Stent C. 
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Stent A B C 
Low PO2 (<30mmHg) 72.8% 74.2% 68.9% 
Hypoxic PO2 (<10mmHg) 12.6% 14.3% 5.3% 
Luminal Low PO2 
(<30mmHg) 
62.7% 64.1% 57.2% 
Luminal Hypoxic PO2 
(<10mmHg) 
11.9% 5.0% 2.4% 
Low WSS (<0.5Pa) 31.3% 36.3% 35.4% 
High WSSG (>0.85Pa/mm) 42.0% 53.1% 53.9% 
Interface Area 99.75mm
2
 95.43mm
2
 99.11mm
2
 
Restenosis Rate 31.4% 10.1% 25.8% 
Table 7.3 Percentage volume of the arterial wall exposed to low and hypoxic PO2 
within the stented region for each stent along with the lumen/arterial wall interface 
area within the stented region and restenosis rate, as taken from the following 
clinical trials at 6-month follow-up: Stent A, ISAR-STEREO-II, Stent B, 
DISTANCE and Stent C, ISAR-STEREO-I, and discussed in Section 7.4.3. 
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Figure 7.9: Predicted (a) WSS and (b) WSSG on the stented artery luminal surface for the three stents analysed. 
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7.4.2 Oxygen Transport 
Comparing the three stent designs by concentrating solely on the percentage luminal 
area exposed to low WSS or high WSSG does not give sufficient detail on how the 
haemodynamics can affect the biological processes taking place within the arterial wall 
post-implantation. In this study here the inclusion of the oxygen transport allows 
analysis of the effects of the haemodynamics post-stent implantation on one aspect that 
can directly affect the cells within the arterial wall, not just on the luminal surface. 
Table 7.3 lists the predicted percentage volume of the arterial wall for each stent 
exposed to low and hypoxic PO2 values. Stent C is predicted to perform the best of the 
three stents with only 68.9% of the arterial wall exposed to low PO2 and only 5.3% 
exposed to hypoxic conditions. For Stent A 72.8% exposed to low PO2 and 12.6% of 
the arterial wall is predicted to be exposed to hypoxic conditions. Stent B has the 
highest percentage volume exposed to low PO2 at 74.2% and 14.3% of the arterial wall 
is exposed to hypoxic PO2 levels. Figure 7.10(a), (b), and (c) show the distribution of 
the percentage volume of the arterial wall within the stented region exposed to PO2 
values in bins of 5 mmHg. Comparing the three stents, it is predicted that none of the 
arterial wall for Stent C is exposed to PO2 values below 5 mmHg, compared with 1.1% 
and 3.1% of the arterial wall for Stent B and Stent A, respectively. Included in these 
histograms are the percentage volume of the arterial wall that is present in the intima for 
each PO2 bin range. This analysis shows that in the case of these idealised arterial walls, 
with no plaque present, only the intima experiences hypoxic PO2 levels, with the 
assumption that the intima remains intact. This would be in agreement with previous 
studies that found that the media is predominantly supplied with oxygen from the 
adventitial vasa vasorum. In this case, with hypoxia present within the intima, 
penetration of the media by the vasa vasorum would be induced.  
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To ascertain why each stent performs differently, in terms of oxygen transport, further 
investigation is warranted. Looking again at the WSS and WSSG luminal surface plots 
presented in Figure 7.9, along with the PO2 and Sh luminal surface plots, and PO2 axial 
cross-sectional plots for Stents A, B and C, as shown in Figure 7.11, and Figure 7.12. 
When Figure 7.12 is analysed it becomes apparent that the design of Stent C, with stent 
struts that are well-spaced out and link struts which are aligned with the flow, results in 
reduction in the size of the low and hypoxic PO2 zones. Interestingly, the prolapse of the 
arterial wall between the struts allows increased oxygen convection into the wall 
downstream of each strut, which is apparent in Figure 7.11(b) with high Sh in these 
regions. This detail would not have been captured effectively with an idealised non-
deformed arterial wall. Immediately apparent in Figure 7.11(a) and Figure 7.12 is that 
the N-shaped link struts in Stent A, which are predominantly aligned perpendicular to 
the flow, cause an extended region of recirculation zones and consequently low PO2 
values on the luminal surface. This further suggests the dominance of the augmented 
haemodynamic environment caused by stent implantation on the oxygen flux. For Stent 
B, the smaller interstrut areas relative to Stents A and C mean that the arterial wall does 
not prolapse into the lumen to the same extent as with the other two stents, as seen in 
Figure 7.13 and Figure 7.14. Additionally, the lumen/arterial wall interface area, i.e. the 
area exposed to the blood flow within the stented region, for Stent B is less than both 
Stents A and C because of the greater number of stent struts. It would appear that these 
particular design features of Stent B cause more of the arterial wall to be exposed to low 
and hypoxic PO2 levels in comparison with Stent C.  
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Figure 7.10: (a, b & c) Predicted percentage volume of the arterial wall and intima, 
both normalised with respect to the arterial wall volume within the stented region, 
exposed to PO2 values in bins of 5mmHg for each stent. (d, e & f) Predicted 
percentage area of the stented luminal surface exposed to WSS values in bins of 
0.125Pa normalised with respect to the total luminal area within the stented region 
for each stent.  
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Figure 7.11: Predicted (a) PO2 and (b) Sh on the stented artery luminal surface for the three stents analysed. 
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Figure 7.12: Axial cross-section of predicted PO2 in both the arterial wall and lumen within the stented region for the three stents 
analysed. The interfaces between all three domains are clearly outlined. 
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Although, it is clear that it is not simply a case of decreased lumen/arterial wall interface 
area which impinges the PO2 flux into the arterial wall since Stent A has a similar 
interface area to Stent C, as shown in Table 7.3, but produces low and hypoxic PO2 
percentage volumes only marginally better than Stent B. Therefore, there are additional 
factors involved. Particular to this study here, the realistically-deformed arterial wall is 
different for each stent, specifically the medial and intimal thicknesses vary within the 
stented region for each stent.  
Figure 7.13 and Figure 7.14 show these thicknesses along two axial cross-sections for 
each stented artery geometry. When these are analysed it is clear that the arterial wall 
stretches when the stent is implanted, and that this stretching reduces the thickness of 
the arterial wall within the stented region to different extents depending on the stent 
design. The stretching acts circumferentially and axially, and for Stent C, which 
elongates in the axial direction from a length of 8.0mm crimped to a length of 8.3mm in 
final deployment configuration, it appears that the axial stretching thins the arterial wall, 
specifically the media, within the stented region. The percentage change in the volume 
of the arterial wall within the stented region for Stent A is -0.2%, for Stent B -2.5% and 
for Stent C -7.0%. Therefore, for Stent C there is a significant difference in the amount 
of the arterial wall that requires oxygen delivery. The media shows a -11.6% reduction 
for Stent C compared with -0.4% and -4.7% for Stents A and B, respectively. This 
comparative reduction is clear in Figure 7.13 and Figure 7.14 where Stent C shows a 
much lower medial thickness along two different axial cross-sections. This hypothesis is 
supported by the fact that the luminal surface PO2 threshold percentage values, as 
shown in Table 7.3, do not directly match the arterial wall PO2 threshold values. For 
instance Stent B has 5.0% of the luminal surface exposed to hypoxic PO2 levels, 
compared to 11.0% and 2.4% for Stents A and C respectively. Yet, Stent B has the 
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highest percentage volume of the arterial wall exposed to hypoxic PO2 levels (14.3%) 
compared with 12.6% and 5.3% for Stents A and C respectively. Note: the arterial wall 
volume displaced out of the stented region is still present in the computational domain 
as the arterial wall is modelled in the structural analysis as almost incompressible, it is 
just pushed out of the stented region. This is indicated by the slightly higher thickness 
of the media (0.33mm) on the extremities of the stented region in Figure 7.14. This 
would not be captured by a non-deformed idealised geometry. 
On inspection of Figure 7.15, Figure 7.16, and Figure 7.17 it can be seen that higher 
values of Sh coincide with reattachment zones where both the WSSG is high and the 
WSS is increasing in the direction of flow. It is possible that within these reattachment 
zones increased infiltration of cytokines, mitogens, leukocytes, and thrombotic elements 
into the arterial wall could also occur leading to increased NIH. Therefore, increased 
oxygen transport by convection may come at a price of increased convection of pro-
restenotic agents within the blood stream into the arterial wall at these locations. Also 
clear from Figure 7.15, Figure 7.16, and Figure 7.17 is that the predicted PO2 luminal 
surface values are closely related to the WSS; however, the percentage volumes 
exposed to low and hypoxic PO2 levels in the arterial wall do not match the percentage 
luminal areas exposed to low WSS, as shown in Table 7.3 and is also clear by 
comparing the histograms in Figure 7.10. This draws the conclusion that even though 
the WSS and luminal PO2 values seem to follow similar trends along the luminal 
surface in Figure 7.15, Figure 7.16, and Figure 7.17, the percentage of low WSS cannot 
act as a predictor of the extent of low and hypoxic PO2 levels within the arterial wall. 
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Figure 7.13: Line plots of the medial and intimal thicknesses within the stented 
region for each stent along an axial cross-section with the corresponding predicted 
PO2 values within the arterial wall. Cross-sections are taken at same location as A-
A’, B-B’ and C-C’ as shown in Figure 7.15, Figure 7.16, and Figure 7.17, 
respectively. 
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Figure 7.14: Line plots of the medial and intimal thicknesses within the stented 
region for each stent along an axial cross-section with the corresponding predicted 
PO2 values within the arterial wall. These cross-sections were taken perpendicular 
to the previous set in Figure 7.13. 
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Figure 7.15: Predicted PO2 and WSS, and Sh and WSSG along line A – A’. 
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Figure 7.16: Predicted PO2 and WSS, and Sh and WSSG along line B – B’. 
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Figure 7.17: Predicted PO2 and WSS, and Sh and WSSG along line C – C’. 
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7.4.3 Comparison with Restenosis Rates 
The angiographic restenosis rates for each commercially available coronary stent that 
resemble the three stents are presented in Table 7.3, along with the percentage volume 
of the arterial wall exposed to low and hypoxic PO2 levels. These rates were taken from 
the following clinical trials at 6-month follow-up: Stent A, ISAR-STEREO-II, Stent B, 
DISTANCE and Stent C, ISAR-STEREO-I. Stent B is predicted to perform the worst, 
in terms of volumetric percentages of low (74.2%) and hypoxic (24.3%) PO2 within the 
arterial wall, but shows the lowest restenosis rate (10.1%). Stents A has slightly lower 
percentage volumes of low (72.8%) and hypoxic (12.6%) PO2 within the arterial wall 
and has the highest restenosis rate (31.4%). Stent C is predicted to have significantly 
less percentage volume of the arterial wall exposed to low (68.9%) and hypoxic (5.3%) 
PO2 levels but has a lower restenosis rate (25.8%) in comparison with Stent A, but 
significantly higher than Stent B (10.1%). Looking solely at the amount of the arterial 
wall exposed to low and hypoxic PO2 levels Stent C is predicted to perform the best out 
of the three stents; however, this does not match with the restenosis rates. Considering 
ISR is a multifactorial process, there may be some other issue with this stent, e.g. 
structural damage of the arterial wall or areas of low wall shear stress, which is not 
captured by oxygen transport models alone. With all these elements that can affect the 
biological processes within an implanted artery, it is difficult to determine which 
element dominates.  
Possibly the extent of damage inflicted on the arterial wall by stent implantation may 
also play a role in the risk of ISR. Martin (2014) analysed the equivalent stress (ES), 
time-averaged WSS, OSI and RRT using the same three stent geometries (along with an 
additional three). Of the three stents presented here, Stent A had the highest maximum 
ES (83.84 kPa) and the highest mean ES (10.7 kPa). Stent B was predicted to exert a 
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maximum ES of 58.98 kPa and a mean ES of 8.83 kPa on the arterial wall, and Stent C 
a maximum ES of 74.37kPa and a mean ES of 9.21kPa. Plots of the ES distribution 
within the arterial wall and on the luminal surface are shown in Figure 7.18. For Stent 
A, for example, which is predicted to perform the worst in terms of ES, the area 
exposed to the highest ES is around the N-shaped link struts. This area is also shown to 
experience hypoxic PO2 levels, low WSS and high WSSG. Possibly the combined 
effects of the high stress exerted on the arterial wall, the adverse local haemodynamics 
and hypoxic PO2 levels within a focussed area of the stented region for Stent A leads to 
higher restenosis rates. This is conjecture at this point and for significant statistical 
power more geometries would need to analysed than just the three presented here.  
One difference between Stents A and C, and Stent B is that Stent B is predicted to 
create a more uniformly circular luminal cross-section, as opposed to more polygonal 
cross-section with Stents A and C. A typical transverse cross-section is shown for each 
stent in Figure 7.19. In a study by Garasic et al. the authors found that stent geometries 
with 12 struts per cross-section had 50% to 60% less mural thrombus, and two-fold less 
neointimal area than identical stents with only eight struts after 28 days in rabbits.
69
 The 
authors also observed increased macrophage numbers in the 12-strut stented arteries 
which was explained by the observation that leukocytes cluster around stent struts.
69
 
This would support the theory that the leukocyte adhesion is increased in regions of 
recirculation and low WSS which are generally located adjacent to stent struts. 
Interestingly, in their study the increased macrophage cell count in the 12-strut stented 
arteries did not translate into increased NIH at 28 days. Possibly, the inflammatory cells 
impact is only noticeable after the 28 day period in rabbits as noted by the authors.  
Given that factors, in addition to the oxygen transport and the local haemodynamics, 
that also affect the biological processes that can result in ISR, possibly a more complete 
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and comprehensive assessment methodology is necessary in predicting the implications 
of stent designs on the adverse outcomes post-implantation. Such a methodology would 
need to incorporate most of the factors discussed here, although the extent to which 
each factor affects the overall result is debateable and currently unknown. 
 
Figure 7.18: Equivalent stress (ES) for each stent design as predicted by Martin.
150
 
Note: the adventitia layer is also included in these plots. 
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Figure 7.19: Transverse cross-sectional plots for each stent. 
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7.5 Conclusions 
Test Case 2 confirms the limitations of simplifying the blood oxygen transport model, 
as discussed in Chapter 6, with some additional points to note. The steep PO2 gradient 
observed adjacent to the luminal surface at all three locations in Test Case 1 is also 
visible here in the PO2 profile plots in Figure 7.5 and significantly, Model 5 fails to 
predict it again in this test case. Critically, this test case shows that adopting the Sh as a 
measure of the oxygen flux into the arterial wall can be problematic if using a simplified 
blood oxygen transport model. This is vividly portrayed in both Figure 7.7 and Figure 
7.8. In Figure 7.7 a stark difference is visible between the Sh predicted by Model 1 
compared with Model 5 with none of the sharp peaks in Sh downstream of the stent 
struts predicted by Model 1 visible when Model 5 is used. This is further demonstrated 
in Figure 7.8 where the line graph of the predicted Sh for Model 5 is flattened in 
comparison with all the other four models. Therefore, a simplified blood oxygen 
transport model, as adopted in most oxygen transport studies in the literature, fails to 
predict these peaks in Sh observed downstream of stent struts. Additionally, some 
researchers have used the results presented by Moore and Ethier (1997) to justify the 
use of a correction factor of 2.5 to the Sh when applying a simplified blood oxygen 
transport model which ignores the bound oxygen.
44,203
 As shown clearly in Figure 7.8 
this would not suffice in accounting for the use of a simplified model. 
Test Case 3 demonstrates that the oxygen transport can be significantly affected by stent 
design with the three stent designs exhibiting significantly different percentages of the 
arterial wall exposed to hypoxic PO2 levels. This is not simply a case of how much of 
the luminal area is exposed to the blood as shown by the fact that the hypoxic volume 
percentages do not correlate with the luminal surface interface areas for each stent. Stent 
struts angled perpendicular to the flow can significantly affect the amount of oxygen 
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transferred into the arterial wall from the blood flow, which is clearly seen for Stent A 
in Figure 7.11. Critically, this test case shows the value of an accurate oxygen transport 
model in improving designs of cardiovascular devices. Additionally, the benefit of using 
realistically-deformed stented artery geometries, as generated here using FEA, is 
demonstrated here because some features, such as prolapse and stretching of the arterial 
wall, which would not be generated accurately otherwise are shown to affect the 
predicted results. Further investigation is warranted possibly incorporating plaque 
within the arterial wall or by using a patient-specific geometry which provides an 
avenue for future study. 
7.6 Summary 
In Test Case 2, presented here, the five blood oxygen transport models were compared 
within a realistically-deformed stented geometry.  
The results showed that: 
 The models that incorporate the bound oxygen again predicts a steep gradient in 
the PO2 transarterial profile at the luminal surface that matches well with the 
experimental data from Santilli et al. 
 Model 1 shows the best agreement with regard to the luminal surface value with 
the experimental data from Santilli et al. 
 There are some differences observed in the arterial wall oxygen transport 
properties possibly because of dissimilarities between species. 
 Simplifying the blood oxygen transport model, by ignoring non-linearities and 
the oxy-haemoglobin, have significant effects on the accuracy of the results 
generated.  
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In Test Case 3 the most advanced blood oxygen transport model was used to compare 
three different stent designs. The results demonstrated that  
 There were significant differences between the three stent designs assessed in 
terms of the oxygen transport into the arterial wall. 
 Therefore, stent design affects the amount of oxygen reaching cells within the 
arterial wall. 
 One stent, Stent C, had significantly less of the arterial wall predicted to be 
exposed to hypoxic PO2 levels which was caused in part by the stretching of the 
arterial wall upon implantation as predicted by FEA. 
 Another consequence of this was that the amount of the arterial wall exposed to 
hypoxic PO2 levels was not correlated with the amount of the luminal surface 
exposed to hypoxic PO2 levels. 
 This highlights one of the advantages in using realistically-deformed geometries, 
although computational expense may be an issue. 
In the next chapter, the haemodynamics and the oxygen transport, modelled using 
Model 1, are analysed in helical-flow-inducing stent designs and compared with a 
straight stent of similar length. 
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CHAPTER 8 
Chapter 8. Test Case 4 – Helical-Flow-Inducing Coronary 
Stents 
8.1 Introduction 
The local haemodynamics and oxygen transport can both, in theory, affect the long-term 
outcome of stent implantation, as discussed in Chapter 2, and helical flow has been 
theorised to improve both, as discussed in Chapter 4. In this chapter Test Case 4 
assesses the effects of inducing helical flow on the haemodynamics and oxygen 
transport in stented coronary arteries. First, the background and justification for a 
helical-flow-inducing coronary stent are discussed. Second, the methodology for 
geometry and mesh creation is described briefly. Finally, in the results section both the 
haemodynamics and the oxygen transport are analysed.  
8.2 Background 
Helical flow has been theorised to provide several haemodynamic benefits for the 
reduction of ISR in stented arteries. As described previously in Section 4.4.1 the 
BioMimics 3D stent is a self-expanding nitinol stent, developed for the treatment of 
peripheral artery disease, which induces helical flow in a treated artery. Helical-flow-
inducing stents have not yet been deployed in coronary arteries; however, there is 
justification for the use of a similar stent for the treatment of CAD. In theory, a helical-
flow-inducing BMS may offer a viable alternative to a DES in cases where it is not 
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suited and may give additional benefits compared with a conventional BMS, as 
discussed below. 
When a patient is diagnosed with CAD there are recommendations on the best treatment 
options or pathways. Depending on the severity of the disease a change of diet or statins 
may be prescribed; however, in cases of acute coronary syndromes, stable angina and 
myocardial infarction with ST-segment elevation, CABG and angioplasty with stenting 
are both appropriate treatment options.
180
 CABG is generally only undertaken in cases 
of multi-vessel disease; although, it may not be suitable if the patient is quite frail. 
When deciding on what stent to implant, DESs are generally recommended given their 
superior performance in clinical trials when compared with BMSs.
70,181
 Clinical 
scenarios favoring a BMS over a DES are when non-elective surgery is required, 
expected poor compliance with DAPT, intolerance/allergy to aspirin or 
clopidogrel/prasugrel/ticagrelor, bleeding risk, and indication for long-term 
anticoagulation.
14
 Patients who have a high bleeding risk are those with a history of 
congestive heart failure, cerebrovascular disease, hepatic or renal disease, and diabetes 
mellitus, or simply that they are of advanced age.
229
 Both those who have a high 
bleeding risk and those who will undergo a surgical procedure within the following year 
may not be able to comply with the one year DAPT required for DES implantation (a 
BMS only requires one month).
68
 Also, in relation to expected poor compliance with 
DAPT, when an interventional cardiologist is making the decision between a BMS and 
a DES it is prudent to predict the likelihood that the patient will comply with the long-
term DAPT. Current guidelines also recommend avoiding DES implantation in the 
presence of financial barriers to prolonged DAPT or social barriers that may limit 
patient compliance.
33
 A BMS is seen as a valuable alternative to a DES for large 
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vessels, for patients with myocardial infarction with ST-elevation, and for saphenous 
vein graft stenosis.
14
 Therefore, there is still a role for BMSs in the treatment of CAD. 
In addition to ISR, and late and very late stent thrombosis, neoatherosclerosis is a 
relatively new observed phenomenon which occurs more frequently and earlier with 
DESs than with BMSs.
190
 One study where the authors reviewed histology findings 
from 299 autopsy cases (197 BMS and 209 DES lesions) found that the incidence of 
neoatherosclerosis was greater in DES lesions (31%) than in BMS lesions (16%), 
although thin-cap fibroatheromas or plaque rupture were more frequent with BMSs than 
DESs.
177
 This is significant because plaque rupture can cause a thrombotic event 
leading to myocardial infarction. Therefore, beyond the elution period of a DES there is 
an argument for having a stent in place which not only combats ISR but also produces 
flow characteristics which are atheroprotective. Additionally, the BioMimics 3D stent is 
a self-expanding stent and although most current coronary stents are balloon-expandable 
there are reasons for the use of self-expanding stents in the coronary arteries. Self-
expanding stents can have a smaller cross-sectional profile, which can offer an 
advantage for tortuous vessels, they experience reduced foreshortening in comparison 
with balloon-expandable stents,
220
 and also they can decrease rates of stent 
malapposition.
19
  
Therefore, a self-expanding BMS which is atheroprotective by inducing helical flow 
would be beneficial for angioplasty procedures in the coronary arteries, particularly for 
long lesions that are considered a risk factor for ISR.
120
 With this justification in mind 
the following test case was undertaken to see if there are any advantages, in terms of 
haemodynamics and oxygen transport, to the implantation of a helical-flow-inducing 
stent in the left coronary artery and to assess the previously theorised benefits of helical 
flow in this context.   
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8.3 Methodology 
The geometries developed for the assessment of helical-flow-inducing stent designs 
were based on the BioMimics 3D stent which induces helical flow by imposing a helical 
shape on the artery. This is different to the other method of a helical ridge within the 
stented region, as described previously in Section 4.4.1. The BioMimics 3D stent is a 
self-expanding nitinol stent developed for the treatment of peripheral artery disease, 
with specific application to the femoral artery. In the case of the popliteal femoral 
artery, a typical diameter and length of stent required are 6.0mm and 100.0mm, 
respectively. The BioMimics 3D stent is described as having a central helical region 
with transition regions either end to help merge the helical region with the straight 
artery, as shown in Figure 8.1.  
 
Figure 8.1: Schematic of a typical BioMimics 3D stent.
264
 
The same stent configuration was adopted here for assessment of helical flow in a 
stented coronary artery, with the diameter set at 3.0mm and the length of the stent 
centreline set at 20.0mm. 20.0mm is considered a long coronary stent that could be used 
for a correspondingly long atherosclerotic lesion, which is one of the risk factors for 
ISR in coronary arteries.
60
 One straight stent geometry and five helical geometries were 
constructed with the helical radius increasing from 0.2mm to 1.0mm. The helical 
section length was set at 10mm with 5mm allowed for the transition regions at either 
end of the helical section which serve to smoothly change the centreline from a straight 
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line to a helical shape and visa-versa, as shown in Figure 8.2. The maximum helical 
radius, given the restrictions on the length of stent, was found to be 1.0mm because any 
further increase in the helical radius was found to result in an unrealistically deformed 
outer arterial wall surface within the transition regions. Additionally, for the same 
reason, the helical section itself consisted of one complete turn. The arterial wall 
thicknesses adopted were the same as used in the previous coronary artery test cases 
with the intima and media assigned thicknesses of 0.24 and 0.32mm, respectively, as 
adopted from Holzapfel et al.
99
 
 
Figure 8.2: Centrelines of the helical stent geometries constructed with a maximum 
helical radius of 1.0mm. Note the helical section is highlighted in red. 
One feature to note is that the length of the centreline was set at 20.0mm; therefore, as 
the helical radius increased the straight-line distance between the proximal and distal 
ends decreased accordingly. This can be seen clearly in Figure 8.2 and Figure 8.3. The 
maximum change in the straight-line distance between the two ends is 2.3mm. 
Additionally, the artery centreline is shifted by a maximum of 1.0mm from its original 
position, assuming an initially straight artery. These two geometrical consequences of a 
helical centreline would have the effect of straining the artery during and after stent 
implantation and the question arises as to what is a reasonable amount of strain. To 
answer this one would have to look at how much strain is placed on the arterial wall 
Helical Section Transition Transition 
1.0mm 
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during stent implantation in a partially blocked coronary artery. For example, consider a 
normally 4.0mm diameter coronary artery (luminal cross-sectional area of 12.6mm
2
) 
with a 70% reduction in luminal cross-sectional area due to the presence of an 
atherosclerotic lesion. The unstented luminal cross-sectional area is 3.8mm
2
 which, 
assuming a circular cross-section, has an unstented diameter, Du, of approximately 
1.1mm. With the further assumption that if the artery was stented the luminal diameter 
increases to the previous 4.0mm (stented diameter, Ds), then the circumferential strain, 
εc, is as follows: 
 
c
u
D 2.9
266%
D 1.1

     (3.73) 
Implantation of a helical stent and changing the overall length between the proximal and 
distal ends by a maximum of 2.3mm (∆L) over a length of 20mm (Lo) would induce 
considerably less strain, albeit longitudinal strain, L , i.e., 
 
L
o
L 2.3
11.5%
L 20

     (3.74) 
and consequently stress, on the arterial wall than the strain induced by the change in 
luminal cross-sectional area. This issue may warrant further investigation using FEA, 
but is beyond the scope of this work. In total six simulations, i.e one straight stent and 
five helical stents, were carried out and numbered Stent 1 to Stent 6, with increasing 
centreline helical radii of 0mm (straight stent), 0.2mm, 0.4mm, 0.6mm, 0.8mm and 
1.0mm, respectively, as shown in Figure 8.3. 
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Figure 8.3: Elevation and end views of the geometries of the six stents modelled.  
The geometries were created in Rhinoceros 3D and were based on the Multilink Vision 
(Abbott Laboratories, Lake Bluff, IL, USA) coronary stent strut configuration. This 
strut configuration was used because the link struts allow for a degree of longitudinal 
expansion, as needed by the helical stents, the strut configuration is used already in the 
coronary arteries while the BioMimics 3D configuration is used in the peripheral 
arteries, and also, exact dimensions of a coronary version of the BioMimics 3D stent are 
CHAPTER 8: Test Case 4 – Helical-Flow-Inducing Coronary Stents 
 
203 
 
unknown. To create the stent geometries the strut configuration was first cut from a 
planar surface, then wrapped into circular form, and finally aligned along the relevant 
helical centreline. The arterial wall, and entry and exit regions were also created in 
Rhinoceros 3D.  
The completed geometries were imported into ANSYS ICEM, and the same mesh 
parameters used in Test Cases 2 & 3 were adopted for computational domain 
discretisation. The typical total node count for each mesh was approximately 14 million, 
with approximately 2.5, 2.8 and 8.7 million nodes in the media, intima and lumen 
domains respectively. As an example, Figure 8.4 shows the mesh density used for Stent 
6 on the luminal surface and within the arterial wall. The boundary conditions used 
were the same as those adopted in Test Cases 2 & 3. All simulations were again carried 
out on the ICHEC Fionn supercomputer using two nodes, each with 2 × 12 2.4 GHz 
Intel Ivy Bridge core processors and 64 GB of RAM. Approximate time to reach 
convergence was 1770 CPU hours.  
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Figure 8.4: Mesh density used for Stent 6 on (a) the luminal surface, and (b & c) 
within the three volume domains. 
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8.4 Results 
The percentage volumes of the arterial wall within the stented region exposed to low 
(<30mmHg) and hypoxic (<10mmHg) PO2 levels for each stent modelled, with helical 
radii ranging from 0mm to 1.0mm, are plotted in Figure 8.5. It is clear from this graph 
that there is a downward trend in the percentages as the centreline helical radius 
increases. Overall, between Stent 1, the straight stent, and Stent 6, the helical stent with 
a centreline helical radius of 1.0mm, the low PO2 percentage volume decreases from 
75.0% to 68.7% and the hypoxic percentage volume decreases from 28.4% to 22.4%. 
Although there is only a relatively small reduction, relative to the total amount, in the 
volume of the arterial wall exposed to low PO2, the change in volume exposed to 
hypoxic PO2 is significant, i.e. a 21.1% reduction within the stented region.  
 
Figure 8.5: Percentage volume of the arterial wall exposed to low and hypoxic PO2 
levels versus helical radius of the stent centreline. 
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Table 8.1 gives that the luminal-surface area-averaged values of the PO2, Sh and WSS 
within the stented region of each stent. Again there is a clear trend in all three variables 
in that the area-averaged PO2, Sh and WSS all increase with increasing centreline 
helical radius. This preliminary analysis of the results appears positive, in terms of 
reducing the amount of the arterial wall exposed to hypoxic PO2 levels and reducing 
adverse WSS conditions; however, it does not give the complete story. Before further 
analysing the oxygen transport the haemodynamics created by each stent are first 
analysed, in particular the development of helical flow and its effects on the WSS and 
WSSG within the stented region.  
 Area-Averaged over Stented Luminal Surface 
Stent No 
PO2 
[mmHg] 
Sh 
WSS 
[Pa] 
1 21.1 119 0.60 
2 21.3 119 0.60 
3 22.1 120.1 0.60 
4 24.1 124.4 0.62 
5 26.4 131.3 0.64 
6 27.9 135.9 0.68 
Table 8.1: Area-averaged PO2, Sh and WSS for the six selected stents. These values 
were obtained by area-averaging over the luminal surface within the stented 
region. 
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8.4.1 Analysis of Haemodynamics 
Figure 8.6 and Figure 8.7 show the WSS and WSSG distributions for the six selected 
stents. Stent 1 produces the lowest area-averaged WSS, as seen in Table 8.1, and in 
comparison with the other five stents, has the most uniform distribution of WSS within 
the stented region. As the helical radius increases two distinct ribbons of low and high 
WSS develop, as shown in Figure 8.6. Also clearly visible in Figure 8.6 is that a large 
area of low WSS (<0.5Pa) develops in the proximal transition region of Stents 4, 5, and 
6, and also in the distal transition region of the three stents, as shown in Figure 8.14(a), 
Figure 8.15(a), and Figure 8.16(a). These are caused by the sudden change in direction 
of the flow in the transition regions. Once the helical flow is established between these 
regions the secondary motion appears to increase the WSS. Physiologically, because 
there is a concentrated area of the luminal surface exposed to low WSS this could lead 
to increased NIH within this region.  
The histograms presented in Figure 8.8 give a good insight into the change in WSS 
induced by increasing the helical radius. For Stents 1 – 3 all, or at least 99%, of the 
luminal surface is exposed to WSS values below the physiological value of 1.5Pa. For 
Stent 1 particularly, 64% of the luminal surface is exposed to WSS values ranging 
between 0.5 – 1.0Pa. As the helical radius increases with each successive helical stent 
the WSS becomes less concentrated within this range as both the maximum WSS 
increases and the amount of the luminal surface exposed to low WSS also increases. 
Thus, the range of WSS values that the luminal surface is exposed to broadens when 
helical flow is induced. This result contradicts the literature which lists a more uniform 
WSS distribution as one of the benefits of helical flow.
27
 Notably, the percentage area 
exposed to atheroprotective WSS values, i.e. >1.5Pa, increases with helical radius with 
Stents 4, 5, and 6 exposed to 2.5%, 6.0%, and 7.9%, respectively, as shown in Table 
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8.2. Conversely, the percentage luminal surface area exposed to low WSS increases 
from 34.3% for Stent 1 and plateaus at approximately 43% for Stents 4, 5, and 6, as also 
shown in Table 8.2.  
This increase in the range of WSS from Stent 1 to Stent 6 predicted to occur on the 
luminal surface also results in a relatively small increase in the amount of the luminal 
surface exposed to high WSSG (>0.85 Pa/mm), as shown in Table 8.2 and Figure 8.7. 
For the helical stents shown here increasingly high WSSG is present as the helical 
centreline radius increases, as shown in the histograms in Figure 8.9, with the range of 
WSSG values steadily rising. High WSSG is commonly observed within a stented 
artery where the flow separates from and reattaches to the wall upstream and 
downstream of the stent struts respectively (as demonstrated in Chapter 7). Here, the 
flow within the helical stented arteries is directed more towards the arterial wall in the 
high WSS ribbon region. Directing the blood flow towards the arterial wall clearly has 
benefits in terms of increasing the oxygen transport into the arterial wall, as discussed 
below; however, increased advection of other elements within the blood would also take 
place. For instance there would be increased advection of platelets, cytokines and 
mitogens in the blood towards the wall which could lead to increased NIH in this 
region. Additionally, the increase in WSSG within the high ribbon could lead to 
problems with re-endothelialisation and increased inflammation with high WSSG linked 
to increased inflammatory marker expression by ECs.
211,212
 
Helical flow is characterised by a secondary circular motion of the flow on a plane 
perpendicular to the main flow direction. For the purpose of visualising helical flow the 
LNH for each stent is presented which gives both a visual representation of the flow 
vortices, and also an indication as to the degree that the helical flow extends beyond the 
stented region, as seen in Figure 8.10. Additionally, the contour plots of the velocity 
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magnitude with the secondary flow streamlines at five slice locations perpendicular to 
the centreline are presented for each stent in Figure 8.11 to Figure 8.16. 
First, in visually analysing the velocity contours and the streamlines at each of the slice 
locations for Stent 1, see Figure 8.11(h – l), the maximum velocity is seen to remain 
within the centre of the lumen throughout and the dominant flow disturbances are being 
caused by stent struts that create small recirculation regions downstream. As the helical 
centreline radius increases with each subsequent stent the induced secondary flow 
becomes more prevalent. For Stent 2 there is the clear existence of two vortices on the 
three slices within the stented region, see Figure 8.12(i – k). Normally these exist in 
circular conduits with centrelines which curve along a plane where the momentum of 
the flow carries it towards the outer wall of the curved conduit where it divides into two 
counter-rotating vortices, known as Dean vortices. In the geometries presented here the 
secondary flows are established in a different manner. The maximum velocity region 
maintains its central alignment, with reference to a straight line between the entry and 
exit regions, driven by its momentum through the helical section, and where the flow 
deviates the most from this central maximum velocity region is where the secondary 
flows are strongest, with the slower moving blood recirculating back into this faster 
region. This secondary flow thus increases mixing within the blood flow which is 
interpreted as a beneficial effect by not having the same blood within the low velocity 
region continually along the length of the stent. 
For Stent 3 these vortices are also visible in the velocity and streamline plots in Figure 
8.13(i – k), and crucially one vortex begins to dominate over the other which is a sign of 
developing helical flow. The domination of one vortex over the other is clear also in the 
LNH plot in Figure 8.10, where the only vortex visible, due to its strength, is the 
clockwise rotating one. Again the maximum velocity skews slightly more towards the 
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outer surface which in turn further increases the WSS magnitude along this ribbon 
within the stented region, as shown in Figure 8.13(a). Also visible, in terms of the WSS, 
is that there is a ribbon of low WSS developing along the inner curve of the stented 
region, see Figure 8.13(a), as a consequence of the skewed velocity profile, see Figure 
8.13(i – k). For Stent 4 the clockwise rotating vortex begins to dominate earlier as the 
flow transits through the stented region, although the anti-clockwise vortex becomes 
more visible, and also extends further downstream, as seen in Figure 8.10 and Figure 
8.14(i & j). This trend continues which each successive helical stent with the clockwise 
rotating vortex becoming established earlier in the stented region and extending further 
beyond it, see Figure 8.10, the velocity skewing more towards the outer wall of the 
curved artery, and the values of WSS and WSSG increasing within the high ribbon 
region, as shown in Figure 8.6 and Figure 8.7.  
Helical flow is also thought to reduce the size of recirculation zones within a straight 
stented artery, as discussed in Chapter 4.
36
 Recirculation zones are created upstream and 
downstream of stent struts when the flow separates away from the arterial wall surface 
and their effects in relation to the biological processes are summarised in Chapter 2. 
Briefly, recirculation zones create conditions at the arterial wall surface that promote 
increased thrombus formation, inflammation and NIH within the stented artery. To 
quantify the volume of the blood within the stented region which undergoes 
recirculation the volume of the luminal domain experiencing retrograde longitudinal 
velocity was measured. The results are presented in Table 8.2 where it is apparent that 
the volume of the stented region experiencing recirculation is doubled for Stent 6 
relative to Stent 1. The percentage volume values are all extremely low; however, it 
should be noted that these recirculation areas are all adjacent to the arterial wall luminal 
surface and, therefore, could have a considerable effect on the biological processes 
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within the arterial wall at these locations. This result contradicts the previous literature 
on this subject which theorises that helical flow reduces recirculation zones.
36
 
Stent 
No 
Retrograde 
Flow 
[×10
-10
m
3
] 
Retrograde 
Flow 
[%] 
Low WSS 
(<0.5Pa) 
[%] 
WSS 
(>1.5Pa) 
[%] 
WSSG 
(>0.85Pa/mm) 
[%] 
1 1.5 0.11 34.3 0 68.5 
2 1.51 0.11 35.2 0 67.6 
3 1.53 0.11 38.5 0 68.4 
4 1.63 0.12 42.2 2.5 67.0 
5 1.99 0.14 43.8 6.0 71.0 
6 3.05 0.22 43.6 7.9 75.4 
Table 8.2: Volume and percentage of the stented lumen that experiences 
retrograde longitudinal velocity, and the percentage of the luminal surface within 
the stented region that experiences low (<0.5 Pa) WSS, atheroprotective (>1.5 Pa) 
WSS, and high WSSG (>0.85 Pa/mm).  
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Figure 8.6: Contour plots of WSS within stented region for the six selected stents. 
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Figure 8.7: Contour plots of WSSG within stented region for the six selected stents 
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Figure 8.8: Normalised area of the stented luminal surface exposed to a WSS range 
of 0 – 2.5Pa in bins of 0.125Pa.   
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Figure 8.9: Normalised area of the stented luminal surface exposed to a WSSG 
range of 0 – 10.0Pa/mm in bins of 1.0Pa/mm.   
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Figure 8.10: Iso-surface plots of LNH for the six selected stents. 
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Figure 8.11: Results for Stent 1 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice 
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is 
towards the reader. 
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Figure 8.12: Results for Stent 2 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice 
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is 
towards the reader. 
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Figure 8.13: Results for Stent 3 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice 
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is 
towards the reader. 
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Figure 8.14: Results for Stent 4 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice 
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is 
towards the reader. 
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Figure 8.15: Results for Stent 5 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice 
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is 
towards the reader. 
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Figure 8.16: Results for Stent 6 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice 
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is 
towards the reader. 
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8.4.2 Analysis of Oxygen Transport 
The changes in haemodynamics created by inducing helical flow have significant 
influence on the oxygen transport from the blood into the arterial wall which is apparent 
when the luminal surface PO2 and Sh contour plots in Figure 8.17 and Figure 8.18 are 
analysed. As shown in Figure 8.5, between Stent 1 and Stent 6 the percentage volume of 
the arterial wall exposed to low PO2 decreases from 75.0% to 68.7% and the percentage 
volume exposed to hypoxic PO2 decreases from 28.4% to 22.4%.  It is clear from Figure 
8.17 that even though there is an overall reduction in the volume of the arterial wall 
exposed to hypoxic PO2 levels the reduction is not uniform on the luminal surface; 
instead, similar to the WSS, increased oxygen transport is observed in a helical ribbon 
through the stented region. Looking again at Figure 8.17 there are essentially two 
helical ribbons of opposing high and low PO2 levels distributed along the length of the 
stented region. These high and low helical ribbons are also present in the Sh, WSS and 
WSSG plots, and are a result of the helical centrelines governing the geometries of the 
five helical stents, and the induced secondary motion of the flow towards the outside of 
the curved lumen. 
Figure 8.19 shows the percentage volume of the arterial wall exposed to PO2 values in 
bins of 5mmHg and also the proportion of each bin that is within the intima. What is 
clear from this figure is that the impact of helical flow affects the intima and the media 
disproportionately. For Stent 1 28.4% of the arterial wall is exposed to hypoxic PO2 
levels, but the media only accounts for 4.2% of that. For Stent 6 22.4% of the arterial 
wall is exposed to hypoxic PO2 levels with the media proportion only reducing to 3.6%. 
Conversely, the intima represents 24.2% of that total for Stent 1 and reduces to 18.8% 
for Stent 6. In Figure 8.19 it can be seen that the percentage of the arterial wall within 
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the intima that is hypoxic is significantly reduced with relatively slight increases in all 
bins from 15 – 75mmHg. Contrary to this, the proportion of the arterial wall that is 
within the media and also hypoxic is not significantly reduced by increasing the helical 
centreline radius. This can be further seen in Table 8.3, where the individual 
percentages of the intima, media, and the complete arterial wall exposed to hypoxic and 
low PO2 are given. Most tellingly the percentage of the intima exposed to hypoxic PO2 
levels reduces from 62.0% to 48.5%, and the percentage of the media exposed to 
hypoxic PO2 levels reduces from 6.9% to 5.9%.  
The flow disturbances caused by the stent struts limit the amount of oxygen diffusing in 
from the lumen in all the stent geometries; however, with the helical stents there is 
increased advection towards the arterial wall within the high PO2 ribbon, for example as 
seen in Figure 8.14(b). Consequently, the high PO2 ribbon marks the region where the 
underlying arterial wall experiences higher PO2 levels which can be seen in the cross-
sectional plots shown in Figure 8.14(c – g). Crucially, the low PO2 ribbon does not have 
a significant effect on the amount of the arterial wall exposed to hypoxic PO2 levels for 
one reason – only the intima is significantly affected by the luminal surface PO2 levels. 
The media layer is predominantly supplied with oxygen through diffusion from the 
outer interface, representing, physiologically, the interface with the adventitia, and the 
intima layer is supplied through diffusion from the luminal surface, as demonstrated 
previously in Test Case 3. Following on from this, the intima within the arterial wall in 
the straight stent model already experiences a considerable amount of hypoxic PO2 
levels (62.0% of the intima for Stent 1) within the stented region due to stent struts 
disrupting the luminal blood flow. Finally, even though the luminal surface within the 
high PO2 ribbon experiences PO2 levels that reach up to values as high as 80 – 90mmHg 
in Stent 6, compared with 20 – 40mmHg in Stent 1, the low PO2 ribbon does not change 
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to the same degree with a considerable amount of the luminal surface still experiencing 
PO2 levels within the 20 – 30mmHg range, similar to the same area within Stent 1.  
Therefore, helical flow does improve the oxygen transport into the arterial wall within a 
stented artery, although not uniformly as it only improves it within a high PO2 helical 
ribbon within the stented region. The question arises as to what this might mean 
physiologically. This is similar to the results seen in the previous test cases where the 
media remains relatively unaffected, in terms of oxygenation, by changes in 
haemodynamics within the lumen because of the oxygen supply from the outer interface 
with the adventitia (as expected). The intima though is affected considerably. Given that 
in reality stents are placed within arteries that have experienced atherosclerotic plaque 
build-up, the intima could already have been infiltrated by inflammatory cells and 
undergone some degree of intimal hyperplasia before stent implantation. Decreasing the 
percentage volume of the intima exposed to hypoxic PO2 levels could aid in the healing 
of this crucial layer, particularly coupled with the potential haemodynamic benefits, as 
discussed above. However, the degree to which it may aid the healing process post-
stent-implantation is debateable and would require further work to elucidate. 
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 Intima Media Arterial Wall 
Stent 
Hypoxic 
[%] 
Low  
 [%] 
Hypoxic 
[%] 
Low  
[%] 
Hypoxic 
[%] 
Low  
[%] 
1 62.0 92.0 6.9 64.2 28.4 75.0 
2 61.4 91.7 7.0 64.4 28.2 75.1 
3 57.8 90.8 6.8 64.3 26.7 74.6 
4 53.3 87.7 6.9 63.2 25.0 72.7 
5 51.5 83.6 6.7 61.9 24.2 70.4 
6 48.5 81.3 5.9 60.7 22.4 68.7 
Table 8.3: The percentage volume of the intima, media, and arterial wall (both 
intima and media together) exposed to hypoxic (<10mmHg) and low (<30mmHg) 
PO2 levels for six selected stents. 
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Figure 8.17: PO2 on the luminal surface within the stented region for the six 
selected stents. 
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Figure 8.18: Sh on the luminal surface within the stented region for the six selected 
stents. 
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Figure 8.19: Predicted percentage volume of the arterial wall and intima exposed 
to PO2 values in bins of 5mmHg for the six selected stents. 
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8.5 Discussion 
Helical flow has been shown here to increase oxygen transport into the arterial wall 
within a stented coronary artery with the volume of the arterial wall exposed to hypoxic 
PO2 levels decreasing by 21.1% between a straight stent (Stent 1) and a stent with 
helical centreline radius of 1.0mm (Stent 6). This reduction in hypoxic PO2 levels is not 
uniform throughout the arterial wall with the region experiencing increased oxygen 
transport only within a helical ribbon within the stented region that also experiences 
high WSS and WSSG. Additionally, the intima is significantly more affected by the 
change in haemodynamics and, consequently, the oxygen transport and reduction in 
hypoxic PO2 levels, in comparison with the media. Given that physiologically the 
intima experiences severe trauma during stent implantation, and also, prior 
atherosclerotic lesion development, the fact that its oxygenation is also significantly 
affected by changes in local haemodynamics gives added importance to improving these 
local haemodynamics. When these local haemodynamics were analysed it was found 
here that with increasing helical centreline radii the percentage of the luminal surface 
exposed to atheroprotective WSS, and low WSS both increase. Unfortunately, the 
region that experiences atheroprotective WSS also experiences high WSSG values that 
are associated with increased inflammation and difficulties in re-endothelisation. The 
transition regions within each helical stent geometry are areas that are prone to low 
WSS due to the change in the flow direction in these regions. A more gradual transition 
with a longer stent could result in more favourable WSS conditions within this region. 
The LNH plots show that the helicity of the flow can extend to almost a full stent length 
beyond the stented region for Stent 6. 
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8.6 Conclusions 
Helical flow, as induced here, is a double-edged sword with increased advection of 
oxygen towards the luminal surface collocated with a ribbon of high WSSG. 
Additionally, there is a diametrically opposite ribbon of low WSS which could lead to 
increased NIH along the length of the stent in this region. Whether or not the added 
benefit of atheroprotective WSS values and increased intima oxygenation out-weighs 
the adverse effects of high WSSG is a question that these numerical models cannot 
answer at present and instead may only come with further in vitro and in vivo work.  
This is the first time the predicted oxygen transport within helical-flow-inducing stent 
designs has been simulated using an advanced oxygen transport model which 
incorporates both the free and bound oxygen. Additionally, this is the first time, to the 
author’s knowledge, that the haemodynamics within several helical stents have been 
analysed where the stent struts have been incorporated in the geometries, thus providing 
a more realistic representation of a stented artery immediately post-implantation. 
8.7 Summary 
The results of Test Case 4 were presented here in which the effects of helical-flow-
inducing stents on the haemodynamics and oxygen transport within stented coronary 
arteries were analysed. Six stented coronary artery geometries with increasing helical 
centreline radii, from 0mm to 1.0mm, were modelled and the results compared. These 
results indicate that helical flow has potentially beneficial and adverse effects on both 
the WSS patterns and the oxygen transport within a stented coronary artery. Chapter 9 
will summarise the conclusions drawn here from this test case, and those from the 
previous three test cases, along with the novelty, limitations, and recommendations of 
this work.  
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CHAPTER 9 
Chapter 9. Conclusions 
9.1 Introduction 
Hypoxia in arterial walls contributes to the formation of foam cells and affects the 
severity of inflammation in atherosclerotic lesions, causes VSMCs to express growth 
factors which could lead to increased NIH, and can induce EC apoptosis.
20,134,215,216,252
 
Rabbits treated with supplemental oxygen following graft-to-artery anastomosis had 
reduced NIH.
135
 The biological processes, thrombosis, inflammation, NIH and re-
endothelialisation, instigated following stent implantation can result in ISR and can 
potentially all be influenced by the amount of oxygen reaching the cells within the 
arterial wall. Therefore, predicting the amount of oxygen which will reach the tissue 
cells within the walls of a stented vessel is of benefit in determining how well a stent 
would perform post-implantation. In fact, predicting oxygen transport in the 
cardiovascular system has applications beyond stents and could include the modelling 
of atherosclerotic lesion development and the assessment of other cardiovascular 
devices. Helical flow has been hypothesised to improve both the local haemodynamics 
and the arterial wall oxygenation within stented arteries.  
The aim of the research undertaken here was to develop an advanced oxygen transport 
model that incorporates both the free oxygen dissolved in plasma and the bound oxygen 
contained in RBCs, and also accounts for the shear-induced dispersion of RBCs, which 
could be used to assess stent designs. As part of this over-arching aim, comparison of 
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the results generated in 3D geometries using the advanced oxygen transport model and 
the simpler models with experimental measurements from Santilli et al. was carried out. 
Showing how this advanced oxygen transport model could then be used to assess three 
different stent designs demonstrated the importance and viability of the methodology. 
The advanced oxygen transport model was also used to assess the ability of helical flow 
to improve oxygenation of the arterial wall in stented coronary arteries. In addition, the 
effect of helical flow on the local haemodynamics within a stented coronary artery were 
analysed. 
9.2 Novelty 
The work undertaken as part of this thesis has several novel aspects that deserve 
mentioning: 
 It is the first time that an advanced blood oxygen transport model has been 
developed that incorporates both free and bound oxygen, and a shear-dependent 
RBC dispersion coefficient. 
 It is the first time that the simplifications of blood oxygen transport models, 
which are prevalent in the literature, have been assessed in 3D geometries and 
their effects on the PO2 profile within the arterial lumen and wall have been 
analysed. 
 It is the first time that the oxygen transport has been modelled in three different 
stent designs with the predicted low and hypoxic PO2 volumes within the arterial 
wall assessed. 
 It is the first time that the oxygen transport within several helical-flow-inducing 
stent designs has been predicted incorporating a heterogeneous arterial wall. 
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Although many previous studies analysing the blood flow within a stented vessel have 
analysed the haemodynamics, predominantly WSS-based variables, this study aimed to 
elucidate how the haemodynamics affects the oxygen delivery to the arterial wall. Thus, 
this study goes beyond the luminal surface and shows how the local haemodynamics 
can have a significant impact on the biological processes within the arterial wall through 
augmented delivery of oxygen to the cells contained within. For example, Test Case 3 
shows how the oxygen transport into the arterial wall can be affected by different stent 
designs and also, how the WSS, as plotted on the luminal surface within the stented 
region, does not act as an accurate predictor of the extent of hypoxic regions within the 
arterial wall. Test Case 4 demonstrates how the methodology developed can be applied 
to improve coronary stent designs by studying the oxygen transport in several helical-
flow-inducing stent designs. This may assist in the design of future cardiovascular 
devices. 
9.3 Limitations 
Computational modelling of any sort when dealing with a real-world event/process 
inevitably incorporates some degree of uncertainty and simplifications based on well-
thought-out assumptions. In the case of computational modelling of oxygen transport 
within the cardiovascular system there are some simplifications made for several 
reasons, which include a lack of experimental data to confirm what parameter values to 
adopt, inability of current software to accurately model some aspects of the problem, 
and computational expense.  
Lack of experimental data is an issue in predicting the oxygen transport within the 
arterial wall which leads to some assumptions, for instance assuming a homogeneous 
composition. The inability of current software to accurately model some aspects is 
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exemplified by the fact that current CFD models of blood flow, which generally is 
composed of several cellular constituents, assume a homogeneous medium (this also 
falls under computational expense). Without more experimental data and more powerful 
software and hardware there is little that can be currently done to avoid these limitations 
and consequently the assumptions made. 
In terms of limitations of the methodology presented here, and possible avenues for 
future work, the shear-dependant dispersion of RBCs is a haemodynamic flow feature 
that is not fully understood. Additionally, at low shear rates RBCs are known to form 
rouleaux which could impact both their dispersion and the oxygen transport. Therefore, 
future studies of this phenomenon may improve the predictive capability of the model. 
This may be improved by particle based CFD software which could model all the 
constituent cells of blood including the RBCs. All the simulations carried out as part of 
this study were steady state with the assumption of rigid arterial walls. The assumption 
of steady state was used because of the computational cost of transient simulations of 
the geometries presented here would be extremely high and also, given how low the 
diffusivity of oxygen is within plasma and within the arterial wall, the effect of 
pulsatility has been shown to have a minimal effect.
124
 Also, the haematocrit is 
considered to be constant throughout the fluid domain when in reality there is a reduced 
haematocrit within the plasma skimming layer at the luminal surface. This could affect 
the predicted steep gradient in the PO2 levels within the blood adjacent to the luminal 
surface, although to what extent would need further investigation. Some numerical work 
undertaken by Krüger (2016) modelling a suspension of deformable RBCs and nearly 
rigid platelets using a combination of the lattice-Boltzmann, immersed boundary and 
finite element methods produced results where the plasma skimming layer was 
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observable.
126
 This type of work could serve as a basis for future work looking at the 
effect of the plasma skimming layer on the oxygen transport into the arterial wall. 
One aspect which was not varied was the parameters defining the oxygen transport 
within the arterial wall. In reality, for stented arteries the presence of plaque, and 
additionally, the structural damage caused to the arterial wall by stent implantation, 
could result in a much higher oxygen demand within the arterial wall. Thus, the values 
shown here in this study are conservative estimates of the PO2 levels and in reality the 
situation could be significantly worse. Clearly, as shown by the results at Location 2 in 
Test Case 1, more accurate representations of each layer of the arterial wall, including 
plaque, and their diffusion/reaction parameters based on cellular composition would be 
required for more patient-specific analysis; unfortunately, these are not available at 
present. Additionally, given the complexity of the biological processes that can lead to 
ISR, as described in Chapter 2, the power of the predictive models presented here is 
limited. In truth they only present an idealised snap-shot of the stented artery. Thrombus 
formation and inflammation begin to occur immediately upon stent implantation, but 
given their scale at which they occur modelling them in the geometries presented here 
would be extremely computationally expensive. As such the models presented here 
assume uniform oxygen consumption throughout the arterial wall, when in reality with 
leukocytes transmigrating into the arterial wall these would increase the oxygen 
consumption.
157
 With this in mind the simulations presented here, even though they are 
designed at a larger scale than the biological processes take place, do serve to give an 
indication of the oxygen levels and highlight areas of potential hypoxia. This provides 
an important step in reaching more accurate, patient-specific models that could be 
improved with advanced imaging techniques such as optical coherence tomography and 
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elastography which potentially could provide information at close to a cellular level in 
patient-specific arteries that may aid in the design of future more discrete models.  
The presence of malapposed struts was not considered in the test cases presented here. 
Previous studies have found that malapposed struts can affect the local haemodynamics 
within the stented region;
12
 therefore, consequently they would affect the oxygen 
transport. This limitation may be addressed in future work using patient-specific 
geometries. Additionally, although current medical imaging technology has allowed the 
acquisition of patient-specific geometries, attaining the governing transport parameters 
would be very challenging. Given the aforementioned correlations between hypoxia and 
IH, with the addition of patient-specific geometries and parameters this methodology 
could be a considerable aid to the both the design of future implantable devices and also 
to the tailored analysis of the impact of these devices on individual patients.  
9.4 Main Conclusions/Recommendations 
The conclusions/recommendations of this study can be divided into two separate 
categories:  
 Conclusions/recommendations for oxygen transport modelling 
 Conclusions/recommendations for stent design 
9.4.1 Oxygen Transport Modelling 
Three important conclusions for future analyses of oxygen transport modelling are 
inferred by this study.  
First, ignoring the oxyhaemoglobin content within the RBCs leads to large errors in the 
PO2 gradient within the MTBL and, consequently, the prediction of hypoxic regions 
within the arterial wall. The standard simplified model which ignores oxyhaemoglobin, 
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i.e. Model 5, and is crucially the most commonly-used model in the literature, over-
predicts the PO2 levels in both the carotid bifurcation and stented coronary artery test 
cases presented here. It therefore presents an overly optimistic view of the risk of IH 
caused by low and hypoxic PO2 levels.  
Second, neglecting the shear-induced dispersion of RBCs also affects the accuracy of 
the predicted results which is also shown in Test Cases 1 and 2.  
Third, the use of a correction factor in the Sh results when neglecting the bound oxygen 
in the blood oxygen transport model can lead to inaccurate results in comparison with a 
more advanced model, i.e. Model 1. 
The first conclusion deserves elaborating on further as the PO2 gradient within the 
MTBL has been a source of controversy in the area of oxygen transport modelling 
which remains unresolved at present. The steep PO2 gradient, seen in Figures 6.10, 6.16, 
6.20, and 7.5, which has been observed in experimental measurements, has led to a 
debate as to the role of the endothelium in oxygen transport as highlighted by Tsai et al. 
(2010).
258
 In this study here the diffusion across the lumen/arterial wall interface has 
been modelled with no resistance and no additional consumption in line with other 
studies in oxygen transport in arteries.
23,203,248
 According to in vivo measurements of the 
PO2 across the arteriole and arterial walls in animals, there is a high PO2 gradient at the 
wall going from the lumen into the arterial wall.
217,218
 Previous studies have concluded 
that this gradient is due to extremely high oxygen consumption by the endothelial cells, 
for example in the study by Shibata et al.
226
, which have been thoroughly reviewed by 
Tsai et al.
259
 However, when ECs have been cultured and studied in vitro the 
consumption levels predicted have not matched with levels recorded by these 
studies.
169,192
 Thus, the mismatch between in vivo and in vitro measurements has led to 
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uncertainty as to what effect the endothelium has on PO2 gradients. The results 
presented in this study would suggest that the endothelium does not consume a 
significantly higher proportion of the oxygen being transferred into the wall than other 
cells in arteries, in agreement with in vitro measurements using cultured ECs. Instead 
the steep gradient is caused by the balance between the free and bound oxygen with the 
bound oxygen acting a large store/sink for oxygen.  
 
Figure 9.1: Artist’s representation of a transarterial wall PO2 profile as measured 
using an electrode probe at Location 1 (in line with the locations described in 
Chapter 6) within a dog carotid artery by Santilli et al.
217
  
In addition, it is assumed by previous studies that the luminal measurements taken from 
Santilli et al. are just inside the lumen as the probe is advanced through the arterial wall. 
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In actuality, Santilli et al. give an artist’s representation of the transarterial wall oxygen 
profile as recorded by the chart recorder from Location 1, as shown in Figure 9.1. In 
their study it is mentioned that there is “a combination of respiratory movement, 
pulsatile blood flow, electrode movement and electrical noise” which causes this saw-
toothed pattern.
217
 These effects, combined with the accuracy of the electrode probe 
used, i.e. its sphere of influence, is discussed by Tsai et al.
259
 In their review on the 
subject, they suggest that it is doubtful that the PO2 value given is representative of the 
actual value on the luminal surface and more likely an average of the PO2 value within a 
volume around the probe which could include the MTBL. 
From the results for Models 1 – 4 presented in Test Case 1 and 2, which include the 
bound oxygen, the high PO2 gradient that is recorded by in vivo studies is reproduced in 
the predicted PO2 transarterial profiles. This would lead to the conclusion that it is not 
the consumption or resistance of the endothelium which creates the high gradient seen 
in vivo, but the properties of the blood itself. Specifically, because of the slope of the 
oxyhaemoglobin curve between 10 and 40mmHg, the RBCs act as both a sizeable 
source and a sink for free oxygen. Thus, physiologically, the interaction between both 
the free and bound oxygen within the MTBL can significantly affect how much oxygen 
is delivered to the arterial wall. 
Critically, in the studies which conclude that the endothelium must consume vastly 
higher amount of oxygen than what is seen in vitro, this conclusion is based on 
evaluation of oxygen mass transport from the lumen into the arterial wall using simple 
diffusion calculations similar to Model 5, as presented in Chapter 3. Additionally, a 
study by Vadapalli et al. concluded that most of the reported values of intravascular 
oxygen flux are overestimated, which could explain some of the differences seen in 
vivo.
261
 Additionally, it should be noted that many of the studies which support the high 
CHAPTER 9: Conclusions 
 
241 
 
oxygen consumption of the endothelium were carried out in arterioles and capillaries, 
and possibly the endothelium consumption would vary with the size of the vessel. 
Therefore, consideration of the findings presented here may be important for future 
studies of this area. This is clearly an area where future study is needed to fully 
understand the processes taking place and more work, which would include in vivo, in 
vitro, and numerical simulation, could shed light on these issues. 
The second and third conclusions are related to the simplifications made in the blood 
oxygen transport model, as detailed in Chapter 3, in previous studies. These are made to 
reduce the computational expense of the simulations. For instance, by neglecting the 
bound oxygen, and consequently, the shear-dependent nature of the RBC dispersion, 
reduces the complexity and ensures convergence of simulations with larger timesteps, 
and therefore, are less computationally expensive. However, as demonstrated here in 
Test Cases 1 and 2 neglecting the bound oxygen in the blood oxygen transport model 
leads to large errors which cannot be accounted for using a simple correction factor. 
Therefore, some of these long-standing simplifications must be called into question 
when the results generated could be significantly different from the actual physiological 
process. More work is needed in this area. 
9.4.2 Stent Design 
From Test Case 3 it is clear that stent strut configuration can have a considerable impact 
on the amount of oxygen reaching the underlying arterial wall cells. Stent A was 
predicted to perform the worst which is predominantly caused by the N-shaped link 
struts. These link struts, which are aligned perpendicular to the main blood flow, create 
large volumes of hypoxic zones adjacent to the recirculation zones upstream and 
downstream of the struts. Stent B suffers slightly from a decreased interface area caused 
by the amount of struts present in the design. Stent C has the combination of both large 
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intra-strut areas and also less low WSS zones caused by struts aligned perpendicular to 
the main blood flow. It is clear from the results of Test Case 3 that the predicted 
oxygenation levels within the arterial wall are not predictable by the interface area 
presented to the luminal blood or by the WSS values plotted on the luminal surface 
within the stented region. Additionally, in terms of assessing stent designs the benefit of 
realistically-deformed stented arteries, as derived using FEA, is demonstrated in this test 
case because some features, such as prolapse and stretching of the arterial wall, which 
would not be generated accurately otherwise are shown to affect the predicted results. 
Helical flow has been hypothesised to help reduce ISR when induced within a stented 
region, as reviewed in Chapter 4. It presents certain theoretical benefits such as reduced 
recirculation zones, more uniform WSS, and increased oxygen transport into the arterial 
wall. Test Case 4 aimed to assess these benefits for a specific well-defined application, 
i.e. a 20mm stent with a 10mm one-turn helical section. Briefly, the results presented in 
Chapter 8 indicate that helical-flow-inducing stents do increase the overall amount of 
oxygen transfer into the arterial wall; although, only in a helical ribbon within the 
stented region. This is also true in relation to the WSS with two diametrically-opposite 
ribbons; one high, one low, present within the stented region. The WSSG shows a 
similar distribution which could lead to adverse consequences in terms of re-
endothelialisation and inflammation. Additionally, the amount of the blood flow 
experiencing retrograde flow, which would signify recirculation zones, is shown to 
increase with increasing helical centreline radius. Therefore, helical flow in stent 
designs is beneficial to some extent for oxygen transfer into the arterial wall, but could 
have adverse effects with increased WSSG and recirculation zones. How influential one 
aspect is in comparison to the other would require further research. Because of the 
specific restraints placed on the geometry, for instance the length and only one helical 
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turn, some of the benefits of helical flow found by other researchers may not exist in 
this specific test case but may appear with the longer stents that are used in peripheral 
arteries. 
9.5 Future Work 
As detailed in the limitations section above, the parameters defining the oxygen 
transport within the arterial wall need to be better defined with more experimental work. 
Specifically, the effects of an atherosclerotic lesion on the parameters governing oxygen 
transport would be beneficial for predicting necrosis in affected arteries. The blood 
oxygen transport model needs further validation with simple comparison test cases 
between in vitro measurements and in silico results. A comparison of the effects of 
geometry simplifications used commonly in CFD studies on the predicted oxygen 
transport within stented arteries would be of benefit. This study would take a similar 
form to a study by Martin et al. (2014) whereby the arterial wall oxygenation predicted 
using realistically-deformed stent geometries, as presented here in Chapter 7, could be 
compared with the arterial wall oxygenation predicted using non-deformed, simplified 
stent geometries.
153
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  APPENDIX A 
A. Validation of ANSYS Software 
A.1 Introduction 
To validate the accuracy of the WSS values predicted by the ANSYS CFX 15.0 
software used in this study Validation Test Case 1 was devised. Validation Test Case 1 
compares the normalised velocity profile and WSS values predicted using the ANSYS 
CFX 15.0 to those calculated from the Blasius solution for laminar flow over a flat 
plate. In addition to this, Validation Test Case 2 was designed to validate the transport 
equation used in ANSYS CFX 15.0 to model the oxygen transport in the blood. This 
validation test case compares the Sh predicted using ANSYS CFX 15.0 to the Lévêque 
analytical solution of the Graetz-Nusselt problem. First, the boundary layer theory is 
discussed below followed by the derivation of the boundary layer equations. 
A.1.1 Boundary Layer Theory 
Consider the 2D incompressible viscous flow over a flat plate, as shown in Figure A.1, 
where the inlet velocity of the fluid is U∞. This inlet velocity is constant, with no 
vertical gradient, in the entry region before the fluid meets the leading edge of the flat 
plate. When the fluid meets the front edge and flows along the flat plate, the fluid 
particles directly adjacent to its surface are slowed to a stop, because of frictional forces, 
which numerically is modelled as a “no-slip” boundary condition. The fluid particles 
neighbouring these particles are then in turn slowed by the viscous force between them 
and the stationary fluid particles. Each layer of neighbouring fluid particles, with 
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increasing distance normal to the surface, travels at a slightly higher velocity in 
comparison with the preceding layer. This results in the characteristic velocity profile, 
as shown in Figure A.1, with the velocity increasing until it reaches the free-stream 
velocity, U∞. The thickness of the boundary layer, δ, is defined as the vertical distance 
extending from the flat plate surface, where the fluid is stationary, to the point where u 
is 99% of U∞. As the flow moves along a flat plate the boundary layer grows with more 
fluid particles retarded by their neighbouring slower particles. Eventually the boundary 
layer transitions from laminar to turbulent. To help predict where this transition may 
occur the Reynolds Number, Re, is used which is defined as the ratio of inertial forces 
to viscous forces. For a flat plate the local Re at any position, x, along the plate is 
calculated as follows: 
 
x
Ux
Re



  (A.1) 
where ρ is the density of the fluid, x is the distance from the leading edge of the plate 
and μ is the dynamic viscosity of the fluid. The flow within the boundary layer exhibits 
different characteristics at different Re with approximate ranges and characteristics 
given in Table A.1. 
As listed by White (2010), there are three techniques for analysing flows over a flat 
plate: CFD, experimentation and boundary layer theory. The third technique, boundary 
layer theory, was first formulated by Ludwig Prandtl in 1904 and the resulting boundary 
layer equations were solved, only for laminar flow, by his student Heinrich Blasius in 
1908. The derivation of the boundary layer equations is presented below. 
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Re Range Description of Flow Characteristics 
  0 < Re <  1 Highly viscous laminar “creeping motion 
     1 < Re < 100 Laminar, strong Re dependence 
100 < Re < 10
3 
Laminar, boundary-layer theory useful 
 10
3
 < Re < 10
4 
Transition to turbulence 
 10
4
 < Re < 10
6
 Turbulent, moderate Re dependence 
10
6
 < Re < ∞   Turbulent, slight Re dependence 
Table A.1: Re ranges and the flow characteristics exhibited within the boundary 
layer. Adapted from White (2010).
268
 
 
 
 
 
 
Figure A.1: Typical boundary layer development along a flat plate within a 2D 
flow example. 
Within the boundary layer viscous forces exert an influence over the velocity profile 
while outside of the boundary layer the flow is considered inviscid where viscous forces 
are small relative to inertial forces. 
U∞ y
  U 
x 
u 
δ 
U∞ 
Flat Plate 
Inviscid Flow 
Viscous Flow 
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A.1.2 Derivation of the Boundary Layer Equations 
To analyse the 2D incompressible viscous flow over a flat plate, as described above, the 
continuity equation and the momentum equations are needed: 
 u v
0
x y
 
 
 
 (A.2) 
 2 2
2 2
u u P u u
u v
x y x x y
      
       
       
  (A.3) 
 2 2
2 2
v v P v v
u v
x y x x y
      
       
       
 (A.4) 
These should be solved for u, v and P with the imposed typical boundary conditions: 
no-slip at the plate surface, an inlet velocity, and an outlet zero pressure boundary. To 
solve these equations is actually too difficult in their present form, so some 
approximations need to be made. First, Prandtl deduced that if the characteristic 
Reynolds Number, ReL, is very large then the shear layer must be very thin resulting in 
the following approximations: 
 v u  (A.5) 
 u u
x y
 
 
  (A.6) 
 v v
x y
 
 
 (A.7) 
When applied to the y-momentum equation, Equation (A.4), this results in the 
simplification: 
 P
0
y



  
(A.8) 
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which essentially means the pressure only varies with respect to x, and the y-momentum 
equation can be neglected entirely. In the x-momentum equation, Equation (3.57), the 
pressure gradient term can be calculated using Bernoulli’s equation as applied to the 
outer inviscid flow, i.e. 
 P dP dU
U
x dx dx

  

  
(A.9) 
Additionally, one of the second derivatives within Equation (3.57) can be neglected due 
to the previous approximations, i.e. 
 2 2
2 2
u u
x y
 
 
  
(A.10) 
All of these assumptions and simplifications results in the three equations of motion 
being reduced down to Prandtl’s two boundary layer equations: 
 u v
0
x y
 
 
 
 (A.11) 
 u u dU 1
u v U
x y dx y
  
  
   
  (A.12) 
where τ is the shear stress and is given by: 
 u
y

  

  for laminar flow (A.13) 
 u
u 'v '
y

   

  for turbulent flow (A.14) 
where these are solved for u and v, which are both functions of x and y within the 
boundary layer, with the following boundary conditions imposed: 
 At y=0 (flat plate surface)                          u v 0    (no-slip condition) (A.15) 
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 At y=δ (outer edge of boundary layer)       u U(x)                                                           (A.16)
The boundary layer equations for laminar flow are mathematically parabolic and are 
solved numerically by beginning at the leading edge and marched downstream.
268
 
Blasius conceived the analytical solution to the equations in 1908 by showing that the 
dimensionless velocity profile, u/U, is a function of a single composite dimensionless 
variable, η: 
 u
'( )
U
 f   (A.17) 
 1/2U
y
x
 
   
 
  (A.18) 
where the prime denotes differentiation with respect to η, and   is the kinematic 
viscosity. Once Equations (A.17) and (A.18) are substituted into the boundary layer 
equations the problem can be reduced to a single third-order non-linear ordinary 
differential equation for f : 
 1
0
2
 f''' ff''   (A.19) 
where the boundary conditions become: 
 At y = 0:                                      (0) (0) 0 f f'   (A.20) 
 As y :                                     ( ) 1.0 f'   (A.21) 
Equation (A.19) is known as the Blasius equation and can be solved for the velocity 
profile within the boundary layer.  
Based on this solution of the velocity profile within the boundary layer the WSS along 
the flat plate can also be subsequently predicted. WSS, w , for laminar flow is defined 
as: 
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w
y 0
u
y 

  

  (A.22) 
To put this in terms of η, from Equation (A.17): 
 u U ( ) f'   (A.23) 
 u
U ( )

 

f''  (A.24) 
From Equation (A.18): 
 12U
y x
    
  
  (A.25) 
Therefore, using the chain rule: 
 1
2
w
y 0
0
Uu
U ( )
y x




     
                 
f''   (A.26) 
From Table A.2: ( )f'' =0.332 at η=0, and thus, the WSS, w (x) , can be calculated 
using:  
 1/2 1/2 1.5
w 1/2
0.332 U
(x)
x
 
    (A.27) 
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η ( )f  ( )f'  ( )f''  
0.00000 0.00000 0.00000 0.33203 
0.20000 0.00664 0.06640 0.33196 
0.40000 0.02656 0.13275 0.33144 
0.60000 0.05973 0.19892 0.33005 
0.80000 0.10610 0.26469 0.32736 
1.00000 0.16556 0.32975 0.32298 
1.50000 0.37011 0.48675 0.30256 
2.00000 0.64997 0.62972 0.26674 
2.50000 0.99624 0.75121 0.21740 
3.00000 1.39671 0.84599 0.16136 
3.50000 1.83757 0.91298 0.10777 
4.00000 2.30559 0.95546 0.06424 
4.50000 2.78995 0.97946 0.03398 
5.00000 3.28306 0.99149 0.01591 
∞ ∞ 1 0 
Table A.2: Blasius solution in terms of η. 
A.2 Validation Test Case 1 
In order to validate the ANSYS CFX 15.0 software a validation test case was 
constructed. The velocity profiles and WSS values along a flat plate predicted by 
ANSYS CFX 15.0 were compared with the Blasius solution. First, a 3D geometry of a 
fluid domain with a flat plate along one face was constructed, with dimensions as shown 
in Figure A.2. The flat plate was 1.0m long with a no-slip boundary condition imposed 
on the surface. The domain was given a height of 1.6m with an opening boundary 
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condition placed on the upper surface to allow for unrestricted development of the 
boundary layer. An entry region was added upstream of the flat plate 0.1m long which 
ensures the inlet boundary condition does not interfere with the solution along the flat 
plate. A velocity of 0.5m/s (U∞) was placed at the inlet and water was used as the 
domain fluid with a density of 998kg/m
3
 and a kinematic viscosity of 8.899×10
-4 
Pa.s. 
The geometry was discretised using a hexahedral mesh with 85626 nodes as shown in 
Figure A.3. Inflation mesh refinement was designated at the front edge of, and along, 
the flat plate to ensure accurate capture of the boundary layer. The convergence 
criterion for the solution was a maximum residual of 1×10
-6
 with a high resolution 
advection scheme used. 
To compare the results predicted by ANSYS CFX 15.0 and the Blasius solution three 
variables were analysed: u*, v*, and WSS, where the relevant calculations are shown in 
Table A.3: 
  ANSYS CFX 15.0 Blasius Solution  
 u*   
u
U
  ( )f'  (11.1) 
 v*   
1
2
v
U
U x


 
 
 
  
    
1
2
   f' f  (11.2) 
 WSS= i ij n  
1/2 1/2 1.5
1/2
0.332 U
x
 
 (11.3) 
Table A.3: The relevant calculations for u*, v*, and WSS within ANSYS CFX 15.0 
and according to the Blasius solution. 
The results were imported into TecPlot 360 2012 for post-processing. Both u* and v* 
were sampled at three locations at distances 0.25m, 0.50m and 0.75m from the leading 
edge of the flat plate, and these were compared with the values calculated using the 
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Blasius solution. Additionally, the WSS predicted by ANSYS CFX 15.0 along the flat 
plate was compared with the WSS calculated using the Blasius solution. The boundary 
layer velocity profiles, Figure A.4 and Figure A.5, and the WSS, Figure A.6, predicted 
by ANSYS CFX 15.0 show good agreement with the Blasius solution. This validates 
the WSS predicted by ANSYS CFX 15.0 and shows that the program is behaving as 
expected in this regard. 
 
Figure A.2: Details of the computational domain geometry created for Validation 
Test Case 1. 
1.6m 
1.0m 0.1m 
Flat Plate 
Opening 
Inlet 
U=0.5m/s 
Entry Region 
Outlet 
Validation of ANSYS Software 
 
288 
 
 
Figure A.3: Mesh created for Validation Test Case 1. 
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Figure A.4: Boundary layer velocity profiles, u* vs η, predicted by ANSYS CFX 
15.0 at three locations with distances from the leading edge of the flat plate of 
0.25m, 0.50m and 0.75m. The Blasius solution is shown for comparison. 
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Figure A.5: Boundary layer vertical velocity profiles, v* vs η, predicted by ANSYS 
CFX 15.0 at three locations with distances from the leading edge of the flat plate of 
0.25m, 0.50m and 0.75m. The Blasius solution is shown for comparison. 
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Figure A.6: WSS values predicted along the flat plate by ANSYS CFX 15.0 plotted 
against the distance from the leading edge of the flat plate, x. The WSS predicted 
by the Blasius solution is shown for comparison. 
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A.3 Validation Test Case 2 
As a validation of the transport equations used in ANSYS CFX 15.0, results from a 
simulation of the developing PO2 boundary layer in a straight tube using Model 5 were 
compared with the Lévêque analytical solution of the Graetz-Nusselt problem for the 
development of a thermal boundary layer in a straight tube. This problem is analogous 
to the developing mass transport boundary layer in fully developed laminar flow in a 
straight tube. This is a standard validation test case, as used in previous studies, where 
the local Sh predicted along the tube wall, with a constant PO2 boundary condition, is 
compared with the Sh as calculated using the Lévêque analytical solution.
117,248
 For the 
simulation a five degree circumferential wedge of the tube was modelled, as shown in 
Figure A.7(a). The mesh was generated in ANSYS Meshing with refinement at the start 
of the tube wall and prism layers inflated off the tube wall to accurately capture the 
MTBL. The following boundary conditions were applied: a fully-developed Hagen-
Poiseuille velocity profile, with mean velocity Vmean=0.116m/s, applied at the inlet with 
PO2,in=100mmHg, a zero pressure entrainment at the outlet, and a no-slip boundary 
condition set on the tube wall with PO2,w=0. The diameter of the tube, Dia=2.7mm, is 
equivalent to the average diameter of the unstented LAD geometries modelled for Test 
Cases 2 and 3. 
The Lévêque solution was calculated based on a Reynolds number Re=75, typical of the 
left coronary artery, and Sc=3538 as calculated using:  
 
b
μ
Sc=
ρD
 (A.31) 
where the dynamic viscosity μ=0.0044Pa.s (volume-averaged for the domain). The Sh 
for the Lévêque analytical solution was calculated for a constant wall boundary 
condition using: 
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x
Diax*=
ReSc
 (A.32) 
  Lévêq
1-
ue
3Sh =1.08 x*  (A.33) 
where x* is a dimensionless axial distance which accounts for differing rates of 
concentration boundary layer growth due to convection and diffusion
253
 and x is the 
axial distance from the inlet.  
 
Figure A.7: (a) The mesh employed for Validation Test Case 2, (b) the PO2 
boundary layer in a tube using Model 5 in an axial cross-section. 
A comparison of the predicted and calculated Sh is shown in Figure A.8. The Lévêque 
analytical solution and the predicted results using Model 5 compare very well, which 
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confirms that Model 5 is producing the expected results and that the mesh density is 
sufficient for capturing the flow and oxygen transport accurately.  
 
Figure A.8: Comparison of the predicted Sh using Model 5 with the Lévêque 
analytical solution of the Graetz-Nusselt problem. The axial distance is normalised 
with respect to the diameter of the tube with zero corresponding to the start of the 
tube wall. 
A.4 Summary 
Both validation cases presented in this appendix serve to demonstrate that the 
commercial software, ANSYS CFX 15.0, is accurately predicting the fluid dynamics 
and the mass transport. Both validation cases show good agreement with analytical 
solutions, Blasius and Lévêque.  
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 APPENDIX B 
B. Mesh Convergence 
B.1 Introduction 
In this appendix the mesh convergence studies undertaken for all four test cases, 
Chapters 6-8, are described. Mesh convergence studies comprise of refining a mesh 
until the results are considered mesh independent, i.e. when the results do not change by 
a user-specified tolerance with further refinement of the mesh. Accurate capture of the 
MTBL for this work was one crucial aspect of the mesh convergence. Model 1 was used 
for all the mesh convergence studies as it includes all non-linearities, and also because 
the MTBL observed, as demonstrated in Chapters 6 and 7, has an extremely steep 
gradient, which make the results susceptible to adverse effects from poor meshing. 
Following the mesh convergence studies the details of the meshes employed for each 
test case are listed along with figures to visually demonstrate the mesh densities used. 
B.2 Mesh Convergence 1 – Prism Layers to Capture MTBL 
Critical to accurate modelling of the oxygen transport is the refinement of the mesh 
within the MTBL, which is thinner than the velocity boundary layer. The geometry used 
was a 5° wedge with three domains: lumen, intima, and media, as shown in Figure 
B.1(a). The meshes used for the Validation Test Case 2 (Lévêque solution) and Test 
Case 1 (carotid bifurcation) are both hexa-dominant meshes and also, for this mesh 
convergence study. Three meshes were created and the only parameter that was varied 
was the height of the first layer inflated off the luminal wall surface: Mesh 1 – 6.7µm, 
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Mesh 2 – 3.8µm, and Mesh 3 – 1.2µm. An inflation rate of 1.2 was used in all three 
meshes. Mesh 3 is shown in Figure B.1(b) to demonstrate the structure of the mesh used 
with refinement at the wall and the beginning of the arterial wall segment. 
The boundary conditions used were a parabolic velocity profile with a maximum 
velocity of 0.2313m/s and PO2,in=100mmHg set at the inlet, entrainment with a 0Pa 
relative pressure and PO2,out=0mmHg set at the outlet, symmetry conditions set on the 
wedge sides, free slip and zero PO2 flux set at entry wall, PO2=45mmHg set at media 
outer wall, and free PO2 flux set across all domain interfaces. 
B.2.1 Results 
Figure B.1(c) shows a contour plot of the PO2 across a longitudinal slice within all three 
domains. A line plot of the PO2 along the arterial wall luminal surface for each mesh 
from the start of the wall surface to the end of the domain is shown in Figure B.2. As 
can be seen from this figure the difference between Mesh 2 and Mesh 3 is minimal and 
within a tolerance of 5%, with a maximum difference of 0.7%. From this mesh 
convergence study the height of the first inflation layer for all meshes was set at 3µm. 
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Figure B.1: (a) Diagram of set-up for Mesh Convergence Study 1, (b) Mesh 3 
outline, and (c) contour plot of PO2 along slice within all three domains showing 
how the MTBL develops. 
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Figure B.2: Line plot of PO2 along the arterial wall luminal surface from the start 
of the arterial wall to the end of the domain. 
B.3 Mesh Convergence 2 – Carotid Artery 
This mesh convergence study was undertaken with the same carotid artery geometry, 
created using Rhinoceros 3D, with the measurements as discussed in Chapter 6. For 
Test Case 1 the transarterial wall PO2 profiles at three locations, as shown in Figure B.3, 
were the results of interest. Thus, these results were monitored for two different mesh 
densities which are referred to as Carotid Mesh 1 and Carotid Mesh 2. The mesh 
statistics for both meshes are displayed in Table B.1, and Figure B.4 and Figure B.5 are 
presented to give an indication of the mesh densities adopted for both meshes.  
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Figure B.3: Carotid bifurcation model with locations of transarterial wall PO2 
profiles of interest highlighted. 
Table B.1: Node counts for the three domains (lumen, intima, and media) within 
the two carotid meshes adopted for the mesh convergence. 
Number of Nodes Carotid Mesh 1 Carotid Mesh 2 
Lumen 501546 2604504 
Intima 295075 429200 
Media 176500 635284 
Total 973121 3668988 
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Figure B.4: (a) The luminal surface mesh and (b-d) cross-sectional views of the 
volume mesh at the three locations for Carotid Mesh 1. 
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Figure B.5: (a) The luminal surface mesh and (b-d) cross-sectional views of the 
volume mesh at the three locations for Carotid Mesh 2. 
B.3.1 Results 
The transarterial wall PO2 profiles at each location for both meshes are presented in 
Figure B.6, and it is clear from this figure that there is no significant difference between 
the results at these three locations with the maximum deviation seen at Location 3 with 
a percentage difference between the luminal surface PO2 value of 2.1% (1.4mmHg 
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difference). Thus, Carotid Mesh 1 was adopted for all simulations undertaken for Test 
Case 1. 
 
Figure B.6: Transarterial wall PO2 profiles at all three locations for Carotid Mesh 
1 and Carotid Mesh 2. 
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B.4 Mesh Convergence 3 – Stented Coronary Artery 
This mesh convergence study was undertaken to elucidate the mesh parameters to be 
adopted for Test Cases 2, 3 and 4 in which stented coronary artery geometries were 
used. 
B.4.1 Geometry 
A smaller stent geometry was used for the mesh convergence study, as shown in Figure 
B.7, which is shorter than the stents used in all the test cases and differs in several ways 
to the stent geometries used in Test Cases 2 and 3 in Chapter 7. First, the geometry was 
not generated using FEA and therefore, there is no deformation of the stent or arterial 
wall surface. Additionally, there is no over-expansion of the stent which would cause 
the stented region to have a larger diameter than the unstented artery. This was done so 
that the effect of the overexpansion would not impact the results; therefore, keeping the 
geometry as simple as possible with the focus on the refinement of the MTBL on the 
stented arterial wall luminal surface, and accurate capture of the diffusion within the 
arterial wall. The stent design used resembles the Multilink Vision coronary stent 
(Abbott Laboratories, North Chicago, IL, USA) with a 3.0mm internal diameter.  
B.4.2 Geometry Discretisation 
The meshing methodology adopted is the same as mentioned in Chapter 7; a volume 
mesh was created using the Delaunay Method, which ensures smooth transition from 
small to larger cells, from a surface mesh which was created using the Octree Method. 
Prism layers (eight) were created along luminal and stent surfaces to accurately capture 
the MTBL. Prism layers were also used within the arterial wall to ensure accurate 
capture of the transarterial wall PO2 profiles. 
Mesh Convergence 
 
304 
 
 
Figure B.7: Idealised stent geometry used for mesh convergence study (a segment 
of the stent geometry used for Test Case 4). Note: additional entry and exit regions 
(each 32mm long) are not shown. 
B.4.3 Test 1 - Luminal Surface 
With the size of the initial prism layer adjacent to the luminal surface fixed from the 
first mesh convergence study described in Section B.2, the next sizing parameter to 
refine for the stented coronary artery geometries was the luminal surface and stent strut 
element size within the stented region. Thus, to ensure mesh convergence of the oxygen 
transport results three separate meshes were generated where only the luminal surface 
and stent strut element size within the stented region was varied, with the smallest cell 
size implemented in Mesh 3. This resulted in three separate meshes, numbered one to 
three, with node counts of 34232, 75518, and 91637 on the luminal surface within the 
stented region. The three meshes are shown in Figure B.8.  
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Figure B.8: Meshes 1, 2, and 3 with stented region luminal surface node counts of 
34232, 75518, and 91637 respectively. 
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B.4.3.1 Test 1 – Results 
First, to confirm that the WSS values on the luminal surface of the stented region are 
converged Table B.2 presents the area-averaged (AA), maximum and minimum WSS, 
and WSSG values predicted on the luminal surface for each mesh, along with Figure 
B.9 and Figure B.10 which show the WSS and WSSG distribution on the luminal 
surface. Given that an accepted user-specified tolerance for the percentage change in 
values between meshes is 5.0%, it is clear from both the table and figures that the WSS 
and WSSG are converged on the luminal surface for all the meshes. This is expected 
because the mesh refinement required for the haemodynamic variables would not be as 
high as for the oxygen transport. The WSSG shows a slight variability in the maximum 
value, but this has no significant effect on the AA WSSG value. 
Table B.3 details the AA, maximum and minimum PO2 and Sh values predicted on the 
luminal surface for each mesh, while Figure B.11 and Figure B.12 show the PO2 and Sh 
distributions on the luminal surface. The PO2 values can be considered converged in 
Mesh 2 as further refinement results in no significant difference in the AA, maximum or 
minimum PO2 values predicted on the luminal surface. This is supported by the PO2 
distribution plots presented in Figure B.11.  
For the Sh there is a large variation in the maximum and minimum values. This is 
because the Sh is calculated using the normal gradient in PO2 off the luminal surface, as 
shown in Equation (3.54) in Chapter 3. Any slight variation in the PO2 gradient normal 
to the wall produces a noticeable effect on the Sh value. What is clear from the 1% 
difference in the AA Sh on the luminal surface between Meshes 2 and 3 is that the 
minimum and maximum values are extreme outliers which do not affect the overall 
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distribution significantly. This is also demonstrated clearly by analysing the predicted 
Sh distribution in Figure B.12, which shows little difference in the predicted contour 
levels on the luminal surface for Meshes 2 and 3.  
To demonstrate that the prism layers implemented in the mesh generation accurately 
capture the MTBL Figure B.13 shows the PO2 distribution around a stent strut and 
across the intima for Mesh 2. The mesh is also displayed. As shown, eight layers were 
inflated off the luminal and stent surfaces with at least three or four prism layers falling 
within the MTBL. Three layers is the minimum required to accurately capture the high 
PO2 gradient, as seen in Test Cases 1 and 2. 
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WSS [Pa] 1 Diff. (1-2) 2 Diff. (2-3) 3 
Max 1.22 1% 1.21 0% 1.21 
AA 0.67 0% 0.67 1% 0.66 
Min 0.00 0% 0.00 0% 0.00 
WSSG [Pa/mm] 1 Diff. (1-2) 2 Diff. (2-3) 3 
Max 12.00 47% 6.33 -84% 11.66 
AA 1.38 1% 1.37 -3% 1.41 
Min 0.00 0% 0.00 0% 0.00 
Table B.2: The predicted maximum, area-averaged, and minimum WSS and 
WSSG values calculated on the luminal surface of the stented region for Meshes 1, 
2, and 3. 
Sh [-] 1 Diff. (1-2) 2 Diff. (2-3) 3 
Max 465.37 -47% 248.38 50% 372.07 
AA 129.34 -14% 111.77 -1% 110.84 
Min 18.14 -11% 16.11 -66% 5.45 
PO2 [mmHg] 1 Diff. (1-2) 2 Diff. (2-3) 3 
Max 71.34 -15% 60.54 0% 60.55 
AA 32.30 -19% 26.02 0% 26.02 
Min 12.30 -35% 7.95 0% 7.95 
Table B.3: The predicted maximum, area-averaged, and minimum Sh and PO2 
values calculated on the luminal surface of the stented region for Meshes 1, 2, and 
3. 
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Figure B.9: Predicted WSS distribution for Meshes 1, 2, and 3. 
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Figure B.10: Predicted WSSG distribution for Meshes 1, 2, and 3. 
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Figure B.11: Predicted PO2 distribution for Meshes 1, 2, and 3. 
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Figure B.12: Predicted Sh distribution for Meshes 1, 2, and 3. 
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Figure B.13: Typical prism layers mesh used on the luminal surface to capture the 
MTBL, which is seen as the region lower than 90mmHg at the luminal surface. 
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B.4.4 Test 2 – Arterial Wall  
The percentages of the arterial wall exposed to low PO2 (<30mmHg) and hypoxic PO2 
(<10mmHg) are needed for Test Cases 2, 3, and 4, therefore, in addition to the previous 
test, two additional tests were undertaken to ensure that the mesh refinement was 
appropriate.  
First, the effect of refinement of the luminal surface mesh outside of the stented region 
on the results within the stented region was assessed. Figure B.14 shows the two meshes 
used to assess if increasing the mesh density on the luminal surface upstream and 
downstream of the stented region, i.e. the region of interest, produced any significant 
effect on the predicted oxygen transport. This refinement had the effect of increasing the 
node count within the lumen for Mesh 2 and Mesh 2a were 2308558 and 2761248, 
respectively. 
Second, the effect of further refinement of the intima layer was assessed. Cross-
sectional views of the meshes employed in the second test are shown in Figure B.15 
with Mesh 2b having the increased intima mesh density provided by prism layers on the 
inner and outer surface of the intima. The node count within the intima for Mesh 2 and 
Mesh 2b were 634154 and 1510538, respectively. 
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Figure B.14: Mesh density on the luminal surface for Meshes 2 and 2a. 
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Figure B.15: Cross-sections of Mesh 2 and Mesh 2b showing the mesh density 
within the arterial wall and around a stent strut within the lumen. 
B.4.4.1 Test 2 – Results 
The results of the additional tests conducted to ensure mesh convergence are presented 
in Table B.4 which shows the predicted percentage volume of the intima exposed to 
PO2 values over a range of 0-30mmHg for Meshes 2, 2a, and 2b. The media was not 
included in this as the PO2 levels within the intima are more strongly influenced by the 
luminal surface PO2 values (as discussed in Chapters 7 – 9). The additional refinement 
of the intima or the refinement of the luminal surface mesh outside of the stented region 
does not produce any significant change in the predicted PO2 levels within the intima. 
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Table B.4: Percentage volumes of intima exposed to PO2 range 0-30mmHg and the 
totals <30mmHg and <10mmHg for Meshes 2, 2a, and 2b, along with the difference 
between them. 
  
PO2 [mmHg] 
Mesh 2 Diff. Mesh 2a Diff. Mesh 2b 
[%] (2-2a) [%] (2-2b) [%] 
0-5 6.8 0.1 6.7 1.3 5.5 
5-10 46.1 -0.2 46.4 0.6 45.6 
10-15 22.3 -0.4 22.7 -0.4 22.7 
15-20 11.7 0.1 11.6 -0.4 12.1 
20-25 6.6 0.1 6.5 -0.3 6.9 
25-30 3.3 0.1 3.2 -0.3 3.6 
Total <30 96.77 -0.2 96.96 0.4 96.38 
Total <10 52.91 -0.2 53.07 1.8 51.08 
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B.5 Meshes Employed in Test Cases 2 and 3  
The node counts for the three stent geometries used in Test Cases 2 and 3 are shown in 
Table B.5. Additionally, Figure B.16 to Figure B.21 show the mesh density on the 
luminal surface and within the three volume domains for each stented coronary artery 
geometry analysed in Test Cases 2 and 3. 
Mesh Stent A Stent B Stent C 
Lumen 5148910 5030463 5084752 
Intima 1703823 1699687 1696288 
Media 1687966 1661928 1645520 
Total 8540699 8392078 8426560 
Table B.5: Node counts for the three stent geometries used for Test Cases 2 and 3. 
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Figure B.16: (a) Geometry of Stent A with the two areas highlighted to shown 
where (b) and (c) are located. (b) Mesh density around stent struts, (c) Mesh 
density transitioning from stented region to unstented region. 
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Figure B.17: (a) Longitudinal cross-section and (b) transverse cross-section 
showing the mesh density at the luminal surface and across the arterial wall for 
Stent A.  
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Figure B.18: (a) Geometry of Stent B with the two areas highlighted to shown 
where (b) and (c) are located. (b) Mesh density around stent struts, (c) Mesh 
density transitioning from stented region to unstented region. 
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Figure B.19: (a) Longitudinal cross-section and (b) transverse cross-section 
showing the mesh density at the luminal surface and across the arterial wall for 
Stent B.  
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Figure B.20: (a) Geometry of Stent C with the two areas highlighted to shown 
where (b) and (c) are located. (b) Mesh density around stent struts, (c) Mesh 
density transitioning from stented region to unstented region. 
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Figure B.21: (a) Longitudinal cross-section and (b) transverse cross-section 
showing the mesh density at the luminal surface and across the arterial wall for 
Stent C.  
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B.6 Meshes Employed in Test Case 4 
The node counts for the six stents used in Test Case 4 are shown in Table B.6 
Additionally, Figure B.22 and Figure B.23 show the mesh density on the luminal 
surface and within the three volume domains for just one of the helical stent geometries 
analysed in Test Case 4. 
Mesh HS 01 HS 02 HS 03 HS 04 HS 05 HS 06 
Lumen 8132554 8292765 8442955 8545144 8686147 8766917 
Intima 2512188 2573811 2627794 2672542 2731482 2768639 
Media 2264040 3083466 2443055 2504670 2543354 2566802 
Total 12908782 13950042 13513804 13722356 13960983 14102358 
Table B.6: Node counts for the six helical stent meshes used in Test Case 4. 
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Figure B.22: (a) Geometry of Helical Stent 6 with the two areas highlighted to 
shown where (b) and (c) are located. (b) Mesh density around stent struts, (c) Mesh 
density transitioning from stented region to unstented region. 
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Figure B.23: (a) Longitudinal cross-section and (b) transverse cross-section 
showing the mesh density at the luminal surface and across the arterial wall for 
Helical Stent 6.  
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B.7 Conclusions 
Following the mesh convergence studies presented in this appendix the mesh 
parameters were set for each simulation analysed in the four test cases. Accurate capture 
of the MTBL was ensured with at least three prism layers within MTBL, as described in 
Section B.2. In comparison with previous studies of haemodynamic variables a more 
refined luminal surface mesh was required to accurately capture the oxygen transport. 
As a side note, this, along with the low diffusivity used, makes the analysis of oxygen 
transport much more computationally expensive. 
 
 
 
 
 
